
<html lang="en"     class="pb-page"  data-request-id="cc227bd7-4b4e-490b-b57d-ae19b5705344"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b00348;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway" /></meta><meta name="dc.Creator" content="Heather  Hobbs" /></meta><meta name="dc.Creator" content="Gianpaolo  Bravi" /></meta><meta name="dc.Creator" content="Ian  Campbell" /></meta><meta name="dc.Creator" content="Maire  Convery" /></meta><meta name="dc.Creator" content="Hannah  Davies" /></meta><meta name="dc.Creator" content="Graham  Inglis" /></meta><meta name="dc.Creator" content="Sandeep  Pal" /></meta><meta name="dc.Creator" content="Simon  Peace" /></meta><meta name="dc.Creator" content="Joanna  Redmond" /></meta><meta name="dc.Creator" content="Declan  Summers" /></meta><meta name="dc.Description" content="4-(Pyrimidin-4-yl)morpholines are privileged pharmacophores for PI3K and PIKKs inhibition by virtue of the morpholine oxygen, both forming the key hydrogen bonding interaction and conveying selecti..." /></meta><meta name="Description" content="4-(Pyrimidin-4-yl)morpholines are privileged pharmacophores for PI3K and PIKKs inhibition by virtue of the morpholine oxygen, both forming the key hydrogen bonding interaction and conveying selecti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 8, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00348" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00348" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00348" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00348" /></link>
        
    
    

<title>Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00348" /></meta><meta property="og:title" content="Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0016.jpeg" /></meta><meta property="og:description" content="4-(Pyrimidin-4-yl)morpholines are privileged pharmacophores for PI3K and PIKKs inhibition by virtue of the morpholine oxygen, both forming the key hydrogen bonding interaction and conveying selectivity over the broader kinome. Key to the morpholine utility as a kinase hinge binder is its ability to adopt a coplanar conformation with an adjacent aromatic core favored by the morpholine nitrogen nonbonding pair of electrons interacting with the electron deficient pyrimidine π-system. Few selective morpholine replacements have been identified to date. Herein we describe the discovery of a potent non-nitrogen containing morpholine isostere with the ability to mimic this conformation and its application in a potent selective dual inhibitor of mTORC1 and mTORC2 (29b)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00348"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00348">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00348&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00348&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00348&amp;href=/doi/10.1021/acs.jmedchem.9b00348" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6972-6984</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00339" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00386" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.9b01498"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Heather Hobbs</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heather Hobbs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 07939 610784. E-mail: <a href="/cdn-cgi/l/email-protection#09616c687d616c7b27712761666b6b7a496e7a62276a6664"><span class="__cf_email__" data-cfemail="49212c283d212c3b67316721262b2b3a092e3a22672a2624">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Hobbs">Heather Hobbs</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8474-9016" title="Orcid link">http://orcid.org/0000-0001-8474-9016</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gianpaolo Bravi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gianpaolo Bravi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gianpaolo++Bravi">Gianpaolo Bravi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ian Campbell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ian Campbell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Campbell">Ian Campbell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maire Convery</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maire Convery</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maire++Convery">Maire Convery</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hannah Davies</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hannah Davies</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hannah++Davies">Hannah Davies</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Graham Inglis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graham Inglis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graham++Inglis">Graham Inglis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandeep Pal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandeep Pal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandeep++Pal">Sandeep Pal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simon Peace</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simon Peace</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Peace">Simon Peace</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joanna Redmond</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanna Redmond</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanna++Redmond">Joanna Redmond</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Declan Summers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Declan Summers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Declan++Summers">Declan Summers</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00348&amp;href=/doi/10.1021%2Facs.jmedchem.9b00348" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6972–6984</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 8, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 February 2019</li><li><span class="item_label"><b>Published</b> online</span>8 July 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 August 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00348" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00348</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6972%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHeather%2BHobbs%252C%2BGianpaolo%2BBravi%252C%2BIan%2BCampbell%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D15%26contentID%3Dacs.jmedchem.9b00348%26title%3DDiscovery%2Bof%2B3-Oxabicyclo%255B4.1.0%255Dheptane%252C%2Ba%2BNon-nitrogen%2BContaining%2BMorpholine%2BIsostere%252C%2Band%2BIts%2BApplication%2Bin%2BNovel%2BInhibitors%2Bof%2Bthe%2BPI3K-AKT-mTOR%2BPathway%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6984%26publicationDate%3DAugust%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00348"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4569</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00348" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Hobbs&quot;},{&quot;first_name&quot;:&quot;Gianpaolo&quot;,&quot;last_name&quot;:&quot;Bravi&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Campbell&quot;},{&quot;first_name&quot;:&quot;Maire&quot;,&quot;last_name&quot;:&quot;Convery&quot;},{&quot;first_name&quot;:&quot;Hannah&quot;,&quot;last_name&quot;:&quot;Davies&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;Inglis&quot;},{&quot;first_name&quot;:&quot;Sandeep&quot;,&quot;last_name&quot;:&quot;Pal&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Peace&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;Redmond&quot;},{&quot;first_name&quot;:&quot;Declan&quot;,&quot;last_name&quot;:&quot;Summers&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6972-6984&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00348&quot;},&quot;abstract&quot;:&quot;4-(Pyrimidin-4-yl)morpholines are privileged pharmacophores for PI3K and PIKKs inhibition by virtue of the morpholine oxygen, both forming the key hydrogen bonding interaction and conveying selectivity over the broader kinome. Key to the morpholine utility as a kinase hinge binder is its ability to adopt a coplanar conformation with an adjacent aromatic core favored by the morpholine nitrogen nonbonding pair of electrons interacting with the electron deficient pyrimidine π-system. Few selective morpholine replacements have been identified to date. Herein we describe the discovery of a potent non-nitrogen containing morpholine isostere with the ability to mimic this conformation and its application in a potent selective dual inhibitor of mTORC1 and mTORC2 (29b).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00348&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00348" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00348&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00348" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00348&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00348" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00348&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00348&amp;href=/doi/10.1021/acs.jmedchem.9b00348" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00348" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00348" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00348%26sid%3Dliteratum%253Aachs%26pmid%3D31283227%26genre%3Darticle%26aulast%3DHobbs%26date%3D2019%26atitle%3DDiscovery%2Bof%2B3-Oxabicyclo%255B4.1.0%255Dheptane%252C%2Ba%2BNon-nitrogen%2BContaining%2BMorpholine%2BIsostere%252C%2Band%2BIts%2BApplication%2Bin%2BNovel%2BInhibitors%2Bof%2Bthe%2BPI3K-AKT-mTOR%2BPathway%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D15%26spage%3D6972%26epage%3D6984%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/jmcmar.2019.62.issue-15/20190808/jmcmar.2019.62.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">4-(Pyrimidin-4-yl)morpholines are privileged pharmacophores for PI3K and PIKKs inhibition by virtue of the morpholine oxygen, both forming the key hydrogen bonding interaction and conveying selectivity over the broader kinome. Key to the morpholine utility as a kinase hinge binder is its ability to adopt a coplanar conformation with an adjacent aromatic core favored by the morpholine nitrogen nonbonding pair of electrons interacting with the electron deficient pyrimidine π-system. Few selective morpholine replacements have been identified to date. Herein we describe the discovery of a potent non-nitrogen containing morpholine isostere with the ability to mimic this conformation and its application in a potent selective dual inhibitor of mTORC1 and mTORC2 (<b>29b</b>).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The phospoinositide 3-kinase kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway has attracted much attention from the scientific community as a key regulator of diverse cellular processes including growth, proliferation, metabolism, differentiation, autophagy, survival, and cytoskeleton rearrangement.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The pathway is one of the most commonly dysregulated in cancer<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> and is also implicated in metabolic disorders and neurodegeneration.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Several ATP competitive and noncompetitive pathway inhibitors are already in the clinic,<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> and it is likely that much of the pharmaceutical industry is still active in this field.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17">(12−17)</a></div><div class="NLM_p">Morpholine acts as the hinge binder in the very first reported synthetic inhibitor of the PI3Ks, LY294002 (<b>1</b>)<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The X-ray cocrystal structures of <b>1</b>, and structurally related quercetin (<b>2</b>), with porcine PI3Kγ were published in 2000 and highlight the key hydrogen bonding interaction between the morpholine oxygen of <b>1</b> and Val882 which mimics the N1 interaction of the natural substrate, ATP.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Subsequent crystal structures, including dual PI3K-mTOR inhibitor PI-103 <b>3</b> bound to mTOR<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> further support the key morpholine-hinge hydrogen bond hypothesis and highlight the coplanarity of the morpholine and adjacent ring systems when binding to the respective active sites.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of LY294002 <b>1</b>, quercetin <b>2</b>, and PI-103 <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">4-(Pyrimidin-4-yl)morpholine (<b>A</b>) is a privileged pharmacophore for the PI3K-AKT-mTOR pathway<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> and is widely conserved across selective PI3K and PIKK inhibitors. Minimization of the dihedral angle CNcn (where C and N atoms belong to the aryl ring and the c and n atoms belonging to the aromatic ring) of 4-(pyrimidin-4-yl)morpholine (<b>A</b>) using density functional theory (DFT) and 6.31G** basis set in Jaguar<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> shows that the morpholine ring and the aryl ring are coplanar. This is due to stabilizing electronic overlap between the nitrogen lone pair and the aryl ring (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (left) Energy minimized structure of 4-(pyrimidin-4-yl)morpholine (<b>A</b>) using DFT. (right) Energy scanning plot of CNcn dihedral bond angle of <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Kinase inhibitors described to date possessing a morpholine hinge binder have shown exclusive selectivity for the lipid kinases<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and the adjacent electron deficient pyrimidine ring induces coplanarity, orienting the morpholine oxygen loan pair in the optimal vector for formation of the key hydrogen bonding interaction. Replacements for the morpholine ring are rare and limited largely to heteroaromatic rings or dihydropyran,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> both of which conserve the coplanar geometry. However, the combination of multiple aromatic rings has significant implications for “drug like” properties<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> and simple, planar structures are often associated with poor physicochemical profiles and toxicity while increasing carbon bond saturation (Fsp<sup>3</sup>), and structural complexity is correlated with improved solubility and success of compounds progressing into the clinic.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> The dihydropyran (DHP) hinge binder retains cross-kinome selectivity but has not been widely utilized in the literature, presumably due to its reduced Fsp<sup>3</sup> character, poor solubility profile, and potential reactivity. Limited examples of the fully saturated tetrahydropyran (THP) exist in the literature,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> but despite retaining the key oxygen, the inability of the THP to adopt a low energy coplanar conformation means the THP analogues are invariably less active than their unsaturated or morpholine analogues due to the conformational energy penalty to form the key hydrogen bonding interaction.</div><div class="NLM_p last">Herein we report the discovery of a novel, stable, carbon linked saturated cyclic system with increased Fsp<sup>3</sup> and differentiated physicochemical profile with the potential to mimic the binding mode of morpholine. Full comparative matched molecular pairs were prepared and described to give clear and complete understanding of changing factors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A brainstorm approach to novel alternative carbon-linked morpholine isosteres with improved Fsp<sup>3</sup> led us to consider the potential for 3-oxabicyclo[4.1.0]heptane (cyclopropyl pyran or CPP) to adopt a coplanar conformation with a pyrimidine core given that cyclopropyl carbon–carbon bonds are known to form stabilizing interactions with adjacent π-systems.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32−34)</a> Energy minimization using molecular mechanics using the MMFF94X force field in MOE<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> showed good structural overlap between morpholine pyrimidine (<b>A</b>) and dihydropyran (DHP) pyrimidine (<b>B</b>), however, tetrahydropyran (THP) pyrimidine (<b>C</b>) and 3-oxabicyclo[4.1.0]heptane pyrimidine (<b>D</b>) were both predicted to adopt preferred orthogonal geometries (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dihydropyran pyrimidine (<b>B</b>), tetrahydropyran pyrimidine (<b>C</b>), and CPP pyrimidine (<b>D</b>). Energy minimized structures using MMFF94X force field in MOE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similarly, investigation of the Cambridge crystallographic database also suggested that most cyclopropyl-aromatic combinations afford orthogonal geometry (e.g., CSD code ULIXIX); however, the structures exemplified in the crystallography database are predominantly cyclopropyl-phenyl combinations. Prior to discarding this option, rigorous quantum mechanical calculations using density functional theory (DFT) and the 6.31G** basis set in Jaguar<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> were undertaken which predicted a <i>coplanar</i> conformation for CPP (D) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dihedral scanning plots for various pyrimidine fragments using DFT/6-31G**.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The data in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> supports the hypothesis documented in the literature<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> that the dihydropyran (<b>9</b>) is a reasonable replacement for the morpholine (<b>5</b>) and 3-<i>S</i>-methylmorpholine (<b>6</b>) across a range of common lipid and lipid-like kinases with only a slight loss in affinity. The tetrahydropyran (<b>11</b>) loses significant affinity, in line with the hypothesis that is can only form the key oxygen hydrogen bound by adopting a less energetically favorable conformation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Assay Data for Tool Compounds <b>5</b>–<b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">hinge</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα pIC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PI3Kδ pIC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">mTOR pIC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">pAKT pIC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Fsp<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">chrom log <i>P</i><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">morpholine</td><td class="colsep0 rowsep0" align="center"><i>m</i>-phenol</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="center">5.9</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">107</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">DHP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" align="char" char=".">5. 5</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">THP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="center">4.5</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="center">4.8</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">102</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="center"><3<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">123</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="center">5.1</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">141</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="10" align="left">      </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">morpholine</td><td class="colsep0 rowsep0" align="center">Et urea</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="center">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">2. 7</td><td class="colsep0 rowsep0" align="char" char=".">109</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="center">6.1</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">DHP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="center">5.8</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">127</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="center">6.1</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">125</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Mean value of at least two repeat measurements per data point (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf" class="ext-link">Supporting Information</a> for details).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Chrom log <i>P</i> is the lipophilicity of the compound in its neutral state measured using reversed phase column chromatography (50 mm × 2 mm, 3 μM, Gemini NX C18, Phenomenex, UK) with fast acetonitrile gradient at starting mobile phase of pHs 2, 7.4, and 10.5. Chrom log <i>P</i> values are derived directly from the gradient retention times by using a calibration line obtained for standard compounds.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Kinetic solubility assay: 5 μL of 10 mM DMSO stock solution diluted to 100 μl with pH 7.4 phosphate buffered saline, equilibrated for 1 h at room temperature, and filtered through Millipore Multiscreen<sub>HTS</sub>-PCF filter plates and quantified by a charged aerosol detector.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Data from high concentration screen (1 mmol initial concentration).</p></div></div></div><div class="NLM_p">The CPP (<b>12</b>) is a chiral molecule and exists as two isomers, (<b>12a</b>) (3-(4-((1<i>R</i>,6<i>S</i>)-1-methyl-3-oxabicyclo[4.1.0]heptan-6-yl)pyrimidin-2-yl)phenol) and (<b>12b</b>) (3-(4-((1<i>S</i>,6<i>R</i>)-1-methyl-3-oxabicyclo[4.1.0]heptan-6-yl)pyrimidin-2-yl)phenol).</div><div class="NLM_p">The absolute stereochemistry of <b>12a</b> and <b>12b</b> are inferred from the small molecule crystal structure of <b>12b</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf" class="ext-link">Supporting Information</a>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> which has negative optical rotation. All subsequent. cyclopropyl pyrans reported here are assigned relative to <b>12b</b> by their optical rotation. Compounds with negative optical rotation are assumed 1<i>S</i>,6<i>R</i>.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) QM predicted structure using DFT/6-31G**. (b) Small molecule crystal structure of <b>12b</b> (CCDC 1864315, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf" class="ext-link">Supporting Information</a>). (c) A potential binding mode of <b>12b</b> which is consistent with a low occupancy cocrystal structure in PI3Kδ (not deposited).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The PI3K and mTOR kinase affinities and cellular efficacy (pAKT) of the more potent 1<i>S</i>,6<i>R</i> CPP isomer (<b>12b</b>) are broadly similar to the dihydropyran (<b>9</b>) although less potent and with lower lipophilic ligand efficiency, due to its increased lipophilicity, than the 3<i>S</i>-methylmorpholine (<b>6</b>), supporting the hypothesis that the 3-oxabicyclo[4.1.0]heptane motif can not only adopt a coplanar geometry with the adjacent pyrimidine ring but also is an active bioisostere for morpholine. The small molecule crystal structure of <b>12b</b> confirms coplanarity in the solid phase and the visible electron density in a low occupancy cocrystal structure of <b>12b</b> in PI3Kδ (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c, not deposited in PDB due to low occupancy, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf" class="ext-link">Supporting Information</a>) is consistent with a favorable low energy coplanar binding conformation and the ability of the CPP pyrimidine motif to sit close to the hinge in the active site.</div><div class="NLM_p">The emerging utility of mTOR inhibitors in diseases including a variety of cancers, thrombosis, fibrosis, and diabetes,<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41 ref42 ref43">(37−43)</a> along with a marked prevalence for morpholine pyrimidines among the selective inhibitors in the literature, led us to apply our discovery to the development of potent selective 3-oxabicyclo[4.1.0]heptane (CPP) mTOR inhibitors. Compounds with a classical mTOR ethyl urea back pocket, such as <b>7</b>, <b>8</b>, and <b>9</b>, illustrate the 10–30-fold increased affinity of such molecules for the mTOR protein and improved selectivity over the closely structurally related PI3K isoforms. It is postulated that this increased affinity is due to the additional hydrogen bonding interactions between the urea moiety and the protein back pocket region. Gratifyingly, this increased affinity for mTOR is conserved in the CPP molecules, with <b>13b</b> demonstrating a full log unit of increased affinity over <b>12b</b> and similar potency to the morpholine (<b>7</b>), 3<i>S</i>-methylmorpholine (<b>8</b>), and dihydropyran (<b>10</b>) (with similar caveats to <b>12b</b> with respect to ligand efficiency and lipophilicity). Furthermore, the selectivity of the 1<i>S</i>,6<i>R</i> analogue (<b>12b</b>) was improved by virtue of its reduced affinity for the class I PI3Ks. The CPP isomers (<b>13a</b> and <b>13b</b>), with considerably increased lipophilicities over the morpholines (<b>7</b>) and (<b>8</b>), might be expected to exhibit a dramatic drop in aqueous solubility. While the data shown are kinetic solubility values, a significant drop in solubility is not apparent.</div><div class="NLM_p">PI3KK research in the recent literature that caught our attention are the publications by AstraZeneca highlighting development of AZD3147 a dual mTORC1 mTORC2 inhibitor<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and the closely related AZ20, a selective ATR inhibitor.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The authors postulate that increasing the “nonplanarity” in the hinge region by incorporation of the 3(<i>S</i>)-methylmorpholine has a positive impact on cellular efficacy and solubility due to disruption of hydrogen bonding networks, disruption of the crystal packing, and an increased twist between the morpholine and pyrimidine rings. Disrupting planarity by alkylation of the methylene linker also had a positive impact on cellular potency but results in a significant increase lipophilicity. We were interested in the impact of the CPP in this series and the interplay between potency, lipophilicity, hydrogen bonding, and solubility. To this end compounds <b>14</b>, <b>15</b>, <b>21</b>, <b>22a</b>, <b>22b</b>, <b>23a</b>, and <b>23b</b> were synthesized (<a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) as benchmarks for us to assess the impact of our CPP replacements in the sulphone series and are not included in our subsequent selectivity analysis as they incorporate a classical nonselective kinase back pocket, however, these compounds confirm the general utility of the CPP replacement.</div><div class="NLM_p">While 1<i>S</i>,6<i>R</i> CPP <b>16b</b> shows a significant 5-fold drop in affinity over the 3<i>S</i>-methylmorpholine (<b>14</b>), their cellular efficacies (as determined by pAKT pIC<sub>50</sub>s: 5.5 vs 5.6) are almost identical, supporting hypothesis of a positive impact of increasing nonplanarity (or Fsp<sup>3</sup>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). It should be noted that the CPP isomers are also more lipophilic than the 3<i>S</i>-methylmorpholine (3.66 vs 3.33, respectively), and this increased lipophilicity will also have a positive effect on permeability (also true for the 3<i>S</i>-methylmorpholine vs morpholine matched pairs), however, the increased lipophilicity should logically have a negative impact on aqueous solubility which is not consistently apparent in our data. On average, the CPP substituent solubility is broadly similar to the 3<i>S</i>-methylmorpholine which in AstraZeneca’s hands were routinely 3-fold more soluble than the parent morpholines.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical Assay Data for Tool Compounds <b>14</b>–<b>27</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0013.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">hinge</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">mTOR pIC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">pAKT pIC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα pIC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PI3Kδ pIC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Fsp<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">chrom log <i>P</i><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>m</i>-phenol</td><td class="colsep0 rowsep0" align="center">6.7</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">DHP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">5.9</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">5.8</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">      </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><5.4<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">morpholine</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Et urea</td><td class="colsep0 rowsep0" align="center">7.3</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7,1</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">212</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">6.1</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">    </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7.3</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">6.6</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">6.9</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">      </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">glycinamide</td><td class="colsep0 rowsep0" align="center">7.7</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7.1</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">167</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7.4</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">158</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">Me morpholine</td><td class="colsep0 rowsep0" align="center">Me</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">8.0</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">198</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="center">1<i>R</i>,6<i>S</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7.3</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">257</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27b</b></td><td class="colsep0 rowsep0" align="center">1<i>S</i>,6<i>R</i> CPP</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7.6</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char="."><4.5</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">217</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Mean value of at least two repeat measurements per data point.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Chrom log <i>P</i> is the lipophilicity of the compound in its neutral state measured using reversed phase column chromatography (50 mm × 2 mm, 3 μM, Gemini NX C18, Phenomenex, UK) with fast acetonitrile gradient at starting mobile phase of pHs 2, 7.4, and 10.5. Chrom log <i>P</i> values are derived directly from the gradient retention times by using a calibration line obtained for standard compounds.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Kinetic solubility assay: 5 μL of 10 mM DMSO stock solution diluted to 100 μl with pH 7.4 phosphate buffered saline, equilibrated for 1 h at room temperature and filtered through Millipore Multiscreen<sub>HTS</sub>-PCF filter plates and quantified by a charged aerosol detector.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Compound <b>23a</b> tested inactive on two test occasions and positive on two test occasions (pIC<sub>50</sub> 7.0 and 7.2), considering the other matched pair data we suspect that the active data points are due to a technical error.</p></div></div></div><div class="NLM_p">Compounds <b>16</b>–<b>20</b> and <b>24</b>–<b>27</b> incorporating mTOR selective back pockets show the 1<i>S</i>,6<i>R</i> CPPs (<b>24b</b><b>25b</b>, <b>26b</b>, and <b>27b</b>) and are broadly equipotent with their morpholine (<b>18</b>) and 3<i>S</i>-methylmorpholine analogues (<b>16</b>, <b>17</b>, <b>19</b>, and <b>20</b>) but marginally more selective against the PI3K isoforms (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). Whereas the parent morpholine (<b>18</b>) shows limited cellular efficacy, the CPP analogues (<b>24b</b> and <b>25b</b>) are equiefficacious with the 3<i>S</i>-methylmorpholines (<b>16</b> and <b>17</b>). It should be noted that compounds <b>22a</b> and <b>22b</b> do not appear to follow the general trend of the 1<i>S</i>,6<i>R</i> isomer (<b>22b</b>) being the more potent. In this matched pair, the isomers are broadly equipotent. Our only explanation for this is a subtle change in binding pose facilitated by the small and nonselective phenol back pocket.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MMP comparisons of morpholine, 3<i>S</i>-methylmorpholine, and 1<i>S</i>,6<i>R</i> CPP analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In line with AstraZeneca’s findings, increasing the lipophilicity sulphone linker region with the dimethylated analogues resulted in increased cellular efficacy relative to the parent methylenes (<b>17</b> vs <b>16</b> and <b>20</b> vs <b>19</b>), which is evident in the 1<i>S</i>,6<i>R</i> CCP methylmorpholine matched pairs as a lower average drop off from mTOR to pAKT pIC<sub>50</sub>s. A preliminary analysis of the effect of the CPP on aqueous solubility suggests a variable effect that is broadly positive in the polar <i>m</i>-phenol and glycinamide back pockets, whereas with the highly planar urea back pocket the negative effect of increased lipophilicity dominates.</div><div class="NLM_p">Finally, we synthesized one of the more potent analogues from the AstraZeneca paper<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> alongside the two CPP analogues (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Compound <b>28</b> was synthesized as described in the literature using the modified palladium cross coupling conditions used as standard in our laboratories.</div><div class="NLM_p">1-(2-Hydroxyethyl)-3-(4-(4-((1<i>S</i>,6<i>R</i>)-1-methyl-3-oxabicyclo[4.1.0]heptan-6-yl)-6-(2-(methyl-sulfonyl)propan-2-yl)pyrimidin-2-yl)phenyl)thiourea <b>29b</b> is a single-digit nanomolar, a selective mTOR inhibitor with excellent selectivity over closely related kinases. <b>29b</b> compares favorably to the literature compound <b>28</b> with respect to mTOR affinity, efficacy, PI3K isoform selectivity, and aqueous solubility (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical Assay Data for Nanomolar mTOR Inhibitors <b>28</b>, <b>29</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">mTOR pIC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">pAKT pIC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PI3Kα pIC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">PI3Kδ pIC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Fsp<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">chrom log <i>P</i><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">solubility (μg/mL)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29a</b></td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">173</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Mean value of at least two repeat measurements per data point.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Chrom log <i>P</i> is the lipophilicity of the compound in its neutral state measured using reversed phase column chromatography (50 mm × 2 mm 3 μM Gemini NX C18, Phenomenex, UK) with fast acetonitrile gradient at starting mobile phase of pHs 2, 7.4, and 10.5. Chrom log <i>P</i> values are derived directly from the gradient retention times by using a calibration line obtained for standard compounds.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">kinetic solubility assay: 5 μL of 10 mM DMSO stock solution diluted to 100 μl with pH7.4 phosphate buffered saline, equilibrated for 1 h at room temperature and filtered through Millipore Multiscreen<sub>HTS</sub>-PCF filter plates and quantified by a charged aerosol detector.</p></div></div></div><div class="NLM_p">To examine the potential of the CPP morpholine replacement to have an impact in a clinical setting, we further profiled compounds <b>8</b>, <b>13a</b>, <b>13b</b>, <b>28</b>, and <b>29b</b>.</div><div class="NLM_p">The metabolic stability of matched pair compounds were assessed in human and rat microsomes to determine the relative stability of the CPP with the <i>m</i>-phenol (<b>13a</b> and <b>13b</b>) and the urea back pockets (<b>29b</b>) compared to the 3<i>S</i>-methylmorpholine (<b>8</b> and <b>28</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). All three <i>m</i>-phenol compounds showed moderate clearance profiles in human, whereas in rat the CPP containing compounds were readily turned over. Compounds <b>28</b> and <b>29b</b> were assessed in both human and rat microsomes and hepatocytes. Compound <b>28</b> was found to be a relatively low clearance compound, although it is moderately cleared in rat hepatocytes. Compound <b>29b</b> however is rapidly eliminated in both species in line with its increased lipophilicity. This data suggests no measurable difference between the two CPP isomers but a specific metabolic liability with the cyclopropyl pyran substituent in rats.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Metabolic Stability Data for Morpholine and CPP Matched Molecular Pairs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0015.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p last">As an exemplar of the CPP series, compound <b>27a</b> was profiled across a range of 17 kinases closely related to mTOR (ATM, ATR, CSNK2A1, CSNK2A2, PIK3C2A, PIK3C2B, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R4, PI4KA, PI4KB, PI4K2B, PRKDC [DNAPK], RIOK2) in a chemoproteomics kinobead screening assay and showed greater than 100-fold selectivity against each with the exception of PIK3CB (55-fold selectivity). Other cyclopropylpyrans, not reported here, showed marked ATM and ATR potency.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>5</b>–<b>8</b> were synthesized by precedented chemistry<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> according to the route outlined in <a class="ref internalNav" href="#sch1a" aria-label="Scheme 1">Scheme 1</a>a. The reaction of morpholine or 3<i>S</i>-methylmorpholine with 2,4-dichloropyrimidine and Hunig’s base proceeds selectively at room temperature to give intermediates <b>A</b> and <b>B</b> in good yield. Installation of the nonselective <i>m</i>-phenol and mTOR selective back pockets via Suzuki–Miyaura cross coupling<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> with the relevant pinacol boronic esters afforded tool compounds <b>5</b>, <b>6</b>, <b>7</b>, and <b>8</b> in good yields.</div><figure id="sch1a" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0007.jpeg" id="GRAPHIC-d7e2642-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) General Synthesis of Parent Morpholines <b>5</b>, <b>6</b>, <b>7</b>, and <b>8</b>; (b) General Synthesis of Dihydropyrans <b>9</b> & <b>10</b>, Terahydropyran <b>11</b>, and Cyclopropylpyrans <b>12</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch1a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) (<i>S</i>)-3-methylmorpholine, DIPEA rt; (b) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h; (c) Pd/C 5%, CH<sub>3</sub>CO<sub>2</sub>H, HCl/Zn 50 °C, 4 h, * chiral SFC; (d) Me<sub>3</sub>SO, NaH, DMSO, 65 °C, 4 h.</p></p></figure><div class="NLM_p">Similarly, palladium-mediated cross coupling furnished dihydropyran compounds intermediate <b>C</b> and subsequently <b>9</b> and <b>10</b> in good yields. Compound <b>9</b> was reduced with hydrogen over a palladium on carbon catalyst to afford the tetrahydropyran <b>11</b>. The synthesis of <b>12</b> and <b>13</b> were affected by a Johnson–Corey–Chaykovski cyclopropanation of <b>9</b> and <b>10</b> respectively in moderate yields. Interestingly Simmons–Smith cyclopropanation afforded none of the desired products. Simmons–Smith cyclopropanation is effective with electron-rich systems, and compounds <b>9</b> and <b>10</b> are both electron deficient by virtue of the neighboring pyrimidine, hence favoring the Johnson–Corey–Chaykovski cyclopropanation. Compounds <b>12</b> and <b>13</b> were subsequently separated into their single enantiomers <b>12a</b>, <b>12b</b>, <b>13a</b>, and <b>13b</b> by chiral SFC.</div><div class="NLM_p">The synthesis of 3-[4-(methanesulfonylmethyl)- and 3-[4-(2-methanesulfonylpropan-2-yl)-6-[(3<i>S</i>)-3-methylmorpholin-4-yl]pyrimidines is highlighted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> utilizing literature intermediates <b>D</b> and <b>E</b><sup><b>44</b></sup> and palladium cross coupling conditions favored in-house to furnish the <i>m</i>-phenols <b>14</b> and <b>15</b>, <i>p</i>-phenyl ethyl ureas <b>16</b> and <b>17</b>, and <i>p</i>-phenyl glycinamides <b>19</b> and <b>20</b>. 1-Ethyl-3-(4-(4-((methylsulfonyl)methyl)-6-morpholinopyrimidin-2-yl)phenyl)urea (<b>18</b>) was synthesized as described as previously<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> using the modified palladium cross coupling conditions used as standard in our laboratories.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of Compounds <b>14</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h.</p></p></figure><div class="NLM_p">The synthesis of 3-oxabicyclo[4.1.0]heptanes <b>22</b>, <b>23</b>, <b>24</b>, <b>25</b>, <b>26</b>, and <b>27</b> was improved over the two-step synthesis of tool compounds <b>12</b> and <b>13</b> by the initial synthesis of the 3-oxabicyclo[4.1.0]heptane pinacol boronic ester, intermediate <b>F</b>, and subsequent activation by conversion to the potassium 3-oxabicyclo[4.1.0]heptan-6-yltrifluoroborate intermediate <b>G</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Palladium mediated cross couplings with intermediate <b>G</b> produced consistently better yields than coupling directly with intermediate <b>F</b>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Intermediate <b>G</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Et<sub>2</sub>Zn, CH<sub>2</sub>Cll, fluorobenzene, −5 °C, multiple additions, rt 16 h; (b) KF/H<sub>2</sub>O, MeCN/MeOH, 2(2<i>R</i>,3<i>R</i>)-2,3-dihydroxysuccinic acid, THF rt.</p></p></figure><div class="NLM_p">The synthesis of 6-((methylsulfonyl)methyl)pyrimidine and 6-(2-(methylsulfonyl)propan-2-yl)pyrimidine compounds <b>21</b>–<b>27</b>, highlighted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, proceeds via the synthesis of known intermediate <b>H</b><sup><b>44</b></sup>. Suzuki–Miyaura cross-coupling chemistry, already described, furnished intermediate <b>I</b> and conditions optimized specifically for the coupling of intermediate <b>G</b> were utilized to deliver intermediate <b>J</b> in a single coupling step from the aryl chloride. Intermediate <b>I</b> was coupled with 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol to afford compound <b>21</b>.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Compounds <b>21</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h; (b) intermediate <b>G</b>, PdCl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, toluene:water 10:1, 110 °C, 15 h; * Chiral separation</p></p></figure><div class="NLM_p">Intermediate <b>J</b> was reacted with methyl iodide in the presence of sodium <i>tert</i>-butoxide to give the dimethylated intermediate <b>K</b>. Having established that the separate enantiomers were stable to the palladium-mediated cross-coupling conditions, intermediates <b>J</b> and <b>K</b> were separated by chiral SFC to afford intermediates <b>L</b>, <b>M</b>, <b>N</b>, and <b>O</b> prior to palladium-cross coupling to furnish compounds <b>22</b>, <b>23</b>, <b>24</b>, <b>25</b>, <b>26</b>, and <b>27</b>.</div><div class="NLM_p">The synthesis of sub nanomolar mTOR inhibitors <b>29a</b> and <b>29b</b> is described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Intermediates <b>N</b> and <b>O</b> were coupled using our standard palladium cross-coupling conditions to afford intermediates <b>P</b> and <b>Q</b> in moderate yields. Conversion of the aniline intermediates to the thioureas proceeded via a two-step, one-pot process involving initial formation of the thioisocyanates with di(imidazol-1-yl)methanethione followed by addition of ethanolamine to afford <b>29a</b> and <b>29b</b> in excellent yields.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>29a</b> and <b>29b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h; (b) 1,1′-thiocarbonyldiimidazole, DCM rt 4 h then ethanolamine 0 °C to rt 18 h.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Herein we have outlined the discovery of 3-oxabicyclo[4.1.0]heptane and demonstrated the use of in-depth quantum mechanical calculations to predict the low energy coplanar conformation of the cyclopropyl pyran attached to a pyrimidine ring. The anticipated coplanar geometry was confirmed through a small molecule crystal structure of compound <b>12b</b> and further supported by maintenance of potency compared with morpholine analogues. A preliminary cocrystal structure of <b>12b</b> in PI3Kδ supported our hypothesis of coplanarity in the active site and is consistent with maintenance of the key hydrogen bonding interaction, found in <b>PI-103</b>, that is common to all known morpholine based PI3K and PIKK inhibitors. We have performed a very thorough matched molecular pair analysis and provided a substantial data set illustrating that the incorporation of this novel moiety has increased FSp<sup>3</sup> character while removing an embedded aniline and therefore reducing the risk of genotoxic metabolites being formed in vivo without a detrimental effect on solubility.</div><div class="NLM_p">Following clear selectivity signals from our data set, we subsequently applied our discovery to a published series of selective mTOR inhibitors and showed that the cyclopropyl pyran analogue <b>29b</b> retains mTOR affinity and cellular efficacy with an improved selectivity over the class I PI3K isoforms and similar solubility profile when compared to the published 3<i>S</i>-methylmorpholine analogue <b>28</b>.</div><div class="NLM_p">The tractability of the single enantiomers of the CPP remains a synthetic challenge, and efforts toward a homochiral synthesis in house have, to date, proved unsuccessful with all single enantiomers described herein being isolated by chiral chromatography. In addition, the disconnect between the metabolic profile of the CPPs in rat and human has the potential to cause significant problems in obtaining rodent safety cover and predicting human PK and dose using traditional allometric scaling techniques; however, such problems could be overcome using modern techniques such as PB/PK modeling. The CPP matched molecular pairs have failed to address the metabolic clearance typically associated with the 3<i>S</i>-methylmorpholine with consistently elevated clearance profiles, in good agreement with the increased lipophilicity of the CPP substituent.</div><div class="NLM_p last">The replacement of <i>N</i>-aryl saturated heterocycles with fused cyclopropanes extends well beyond the lipid kinase field and, in principle, provides an alternative approach to control conformation besides the use of an aryl nitrogen. A full investigation into the steric and electronic requirements to obtain coplanar geometry has been undertaken and will be reported in due course.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44652" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44652" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p last">All solvents and reagents, unless otherwise stated, were commercially available from regular suppliers such as Sigma-Aldrich and Fluorochem and were used as purchased without further purification. When necessary, organic phases were filtered through ISOLUTE phase separator hydrophobic frits, which contain a membrane which is selectively permeable to organic solutions to remove traces of water. Intermediates were purified by flash column chromatography on Redisep Rf flash columns using an Isco Combi Flash Rf+ companion or similar eluting with increasing percentages of ethyl acetate in cyclohexane. Compounds for biological testing were purified either by mass-directed HPLC on C18 5 μm 30 mm × 150 mm XSelect CSH columns using decreasingly polar mixtures of acetonitrile in water with either a formic acid or ammonium carbonate modifier or by preparative HPLC on a Reveleris prep using C18 5 μm 30 mm × 100 mm Waters Xbridge columns using decreasingly polar mixtures of acetonitrile in water with an ammonium carbonate modifier or C18 5 μm 30 mm × 100 mm Waters Sunfire columns using decreasingly polar mixtures of acetonitrile in water with a formic acid or modifier. The purity of samples was assessed by NMR and HPLC and mass spectroscopy and are consistent with the proposed structures. The purity of compounds for biological testing were assessed by NMR, HPLC, and mass spectroscopy techniques and were ≥95% unless otherwise quoted. LCMS analysis was carried out on a Waters Acquity UPLC instrument equipped with a BEH column (50 mm × 2.1 mm, 1.7 μm packing diameter) and Waters Micromass ZQ MS using alternate-scan positive and negative electrospray. Analytes were detected as a summed UV wavelength of 210–350 nm. Samples were eluted with using decreasingly polar mixtures of acetonitrile in water with either a formic acid or ammonium carbonate modifier. Electrospray mass spectral data was obtained using a Waters ZQ/LC/mass spectrometer. Proton and carbon nuclear magnetic resonance (<sup>1</sup>H NMR and <sup>13</sup>C NMR) spectra were recorded in deuterated solvents at ambient temperature on a Bruker AVI (400 MHz), or Bruker AVII+ (600 MHz) spectrometer (with cryoprobe). Chemical shifts δ are reported in parts per million (ppm) relative to tetramethylsilane and are internally referenced to the residual solvent peak. Coupling constants (<i>J</i>) are given in hertz to the nearest 0.1 Hz. The following abbreviations have been used: s, singlet; d, doublet; t, triplet; q quartet; br, broad; and m, multiplet. High-resolution mass spectra were recorded on a Waters XEVO G2-XS quadrupole time-of-flight mass spectrometer, with analytes separated on an Acquity UPLC CSH C<sub>18</sub> column (100 mm × 2.1 mm, 1.7 μm packing diameter). LC conditions were 0.8 mL/min flow rate, 50 °C, injection volume 0.2 μL, using a gradient elution with (A) H<sub>2</sub>O containing 0.1% (v/v) formic acid and (B) acetonitrile containing 0.1% (v/v) formic acid. Gradient conditions were initially 3% B, increasing linearly to 100% B over 8.5 min, remaining at 100% B for 0.5 min then decreasing linearly to 3% B over 0.5 min followed by an equilibration period of 0.5 min prior to the next injection.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Method A</h3><div class="NLM_p last">The appropriate chloropyrimidine or dichloropyrimidine (1 equiv) was treated with the appropriate 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.8–1.2 equiv), PdCl<sub>2</sub>(dppf) (0.08 equiv), and potassium carbonate (2 equiv) and the mixture suspended in degassed 2-propanol:water 5:1. The reaction mixture was bubbled through with nitrogen for 1 min prior to heating at 110 °C for 2 h. The reaction mixture was filtered through Celite and eluted with EtOAc. The eluent was washed with water, filtered through a hydrophobic frit, and concentrated by blow down. Intermediate compounds were purified by normal phase column chromatography, and final compounds were purified by mass directed HPLC.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Method B</h3><div class="NLM_p last">Relevant 2-chloro-pyrimidine (1 equiv) was treated with <i>tert</i>-butyl methyl(2-oxo-2-((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)amino)ethyl)carbamate (1.2 equiv), PdCl<sub>2</sub>(dppf) (0.08 equiv), and potassium carbonate (2 equiv) and suspended in degassed 2-propanol:water 5:1. The reaction mixture was bubbled through with nitrogen for 1 min prior to heating at 110 °C for 2 h. The reaction mixture was filtered through Celite and eluted with EtOAc. The eluent was washed with water, filtered through a hydrophobic frit, and concentrated by blow down. The sample was resuspended in DCM and treated with TFA (∼10 equiv) and allowed to stand for 1 h prior to concentration by low down and purification by mass directed HPLC.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Method C</h3><div class="NLM_p last">Sodium hydride (2 equiv) was treated with trimethyloxosulfonium chloride (2 equiv) under a nitrogen atmosphere. Anhydrous DMSO (2 mL/mmol) was added dropwise and the reaction mixture stirred for 20 min. A solution of relevant dihydro-2<i>H</i>-pyran-4-yl)pyrimidine (1 equiv) in anhydrous DMSO (2 mL/mmol) was added and the reaction mixture stirred at 65 °C for 4 h. The reaction mixture was partitioned between EtOAc and water and the aqueous phase extracted three times with EtOAc. The combined organic phase was concentrated in vacuo and purified by column chromatography and recrystallization from toluene.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Method D</h3><div class="NLM_p last">A solution of relevant aniline (1 equiv) in dichloromethane at 0 °C was treated portion wise with 1,1′-thiocarbonyldiimidazole (2 equiv), and the mixture was stirred at ambient temperature for 4 h. The mixture was recooled to 0 °C, and ethanolamine (10 equiv) was added. The mixture was stirred at ambient temperature for 18 h. The reaction mixture was concentrated in vacuo and the residue purified by mass-directed HPLC.</div></div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-(2-Chloropyrimidin-4-yl)morpholine (Intermediate <b>A</b>)</h3><div class="NLM_p last">To a clear, colorless solution of morpholine (0.871 mL, 10.00 mmol) and DIPEA (3.49 mL, 20.00 mmol) in anhydrous <i>N</i>,<i>N</i>-dimethylformamide (DMF) (13 mL) was added 2,4-dichloropyrimidine (1.490 g, 10 mmol) dropwise, and the resulting colorless solution was stirred at 20 °C for 1 h prior to concentration in vacuo. The crude product was purified by column chromatography to afford 4-(2-chloropyrimidin-4-yl)morpholine (1.401 g, 7.02 mmol, 70% yield) as an amorphous white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.07 (d, <i>J</i> = 6.06 Hz, 1H), 6.39 (d, <i>J</i> = 6.06 Hz, 1H), 3.74–3.82 (m, 4H), 3.62- 3.67 (m, 4H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 200.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (3<i>S</i>)-4-(2-Chloropyrimidin-4-yl)-3-methylmorpholine (Intermediate <b>B</b>)</h3><div class="NLM_p last">A suspension of 2,4-dichloropyrimidine (500 mg, 3.36 mmol) in acetonitrile (6.7 mL) in a microwave vial was treated with DIPEA (1759 μL, 10.07 mmol) and (<i>S</i>)-3-methylmorpholine (381 μL, 3.36 mmol). The vial was sealed and stirred at ambient temperature for 19.5 h prior to addition of further (<i>S</i>)-3-methylmorpholine (38.1 μL, 0.336 mmol). The reaction mixture was stirred at ambient temperature for a further 2 h. The reaction mixture was partitioned between EtOAc (50 mL) and water (50 mL). The aqueous phase was extracted with further EtOAc (2 × 20 mL), and the combined organic phase was filtered through a hydrophobic frit and concentrated in vacuo. The residue was purified by column chromatography to afford (3<i>S</i>)-4-(2-chloropyrimidin-4-yl)-3-methylmorpholine (483 mg, 67% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.19 (d, <i>J</i> = 6.8 Hz, 3 H) 3.16 (td, <i>J</i> = 12.9, 3.9 Hz, 1 H) 3.42 (td, <i>J</i> = 11.9, 3.1 Hz, 1 H) 3.57 (dd, <i>J</i> = 11.6, 3.2 Hz, 1 H) 3.70 (d, <i>J</i> = 11.6 Hz, 1 H) 3.92 (dd, <i>J</i> = 11.6, 3.9 Hz, 1 H) 3.98 (br d, <i>J</i> = 13.0 Hz, 1 H) 4.33 (br s, 1 H) 6.79 (d, <i>J</i> = 6.2 Hz, 1 H) 8.10 (d, <i>J</i> = 6.2 Hz, 1 H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 214.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Chloro-4-(3,6-dihydro-2<i>H</i>-pyran-4-yl)pyrimidine (Intermediate <b>C</b>)</h3><div class="NLM_p last">From general method A. Yield 6.4%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.57 (d, <i>J</i> = 5.14 Hz, 1H), 7.28 (d, <i>J</i> = 5.14 Hz, 1H), 7.26 (d, <i>J</i> = 5.14 Hz, 1H), 7.10 (m, 1H), 4.42 (q, <i>J</i> = 2.93 Hz, 2H), 3.95 (t, <i>J</i> = 5.38 Hz, 2H), 2.59 (m, 2H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 197.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4,4,5,5-Tetramethyl-2-{3-oxabicyclo[4.1.0]heptan-6-yl}-1,3,2-dioxaborolane (Intermediate <b>F</b>)</h3><div class="NLM_p last">From general method A. A solution of 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1050 mg, 5 mmol) in fluorobenzene (10 mL) was cooled to −5 °C and was treated slowly with diethylzinc in hexanes (25.00 mL, 25.00 mmol) over 2 min. The mixture was stirred at −5 °C for 5 min prior to treating with a solution of chloroiodomethane (8819 mg, 50.0 mmol) in fluorobenzene (5 mL) dropwise over 5 min. The mixture was stirred at −5 °C for 10 min prior to three subsequent additions of diethylzinc and chloroiodomethane in the same manner. The reaction mixture was allowed to warm to room temperature and stirred for 16 h. The suspension was partitioned between aqueous NH<sub>4</sub>Cl (75 mL) and diethyl ether (2 × 50 mL) and then dried over MgSO<sub>4</sub>. The extract was evaporated onto florisil and purified by column chromatography to give 2-(3-oxabicyclo[4.1.0]heptan-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (485 mg, 2.164 mmol, 43.3% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 4.02 (d, <i>J</i> = 11.25 Hz, 1H), 3.85 (dd, <i>J</i> = 3.42, 11.25 Hz, 1H), 3.61 (ddd, <i>J</i> = 2.45, 6.36, 11.25 Hz, 1H), 3.17 (dt, <i>J</i> = 4.89, 11.25 Hz, 1H), 2.00–2.08 (m, 1H), 1.62–1.73 (m, 1H), 1.24 (s, 6H), 1.08 (br dd, <i>J</i> = 3.18, 5.62 Hz, 1H), 0.96 (dd, <i>J</i> = 2.93, 8.31 Hz, 1H), 0.66 (dd, <i>J</i> = 3.18, 5.62 Hz, 1H).</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Potassium Trifluoro({3-oxabicyclo[4.1.0]heptan-6-yl})boranuide (Intermediate <b>G</b>)</h3><div class="NLM_p last">2-(3-Oxabicyclo[4.1.0]heptan-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (5 g, 22.31 mmol) was dissolved in anhydrous acetonitrile (55 mL) and anhydrous MeOH (55 mL) under a nitrogen atmosphere. Aqueous potassium fluoride (5.2 g, 90 mmol) in water (20 mL) was added, and the suspension was stirred at room temperature under nitrogen for 10 min. (2<i>R</i>,3<i>R</i>)-2,3-Dihydroxysuccinic acid (6.70 g, 44.6 mmol) was added followed by THF (2.5 mL). The reaction mixture was stirred for 1.25 h and left standing overnight, after which the precipitate filtered off and washed with acetonitrile. The filtrate was concentrated in vacuo and azeotroped with toluene (3 × 50 mL) and triturated with diethyl ether (3 × 30 mL) to give potassium trifluoro({3-oxabicyclo[4.1.0]heptan-6-yl})boranuide 4.83 g (106% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 4.02 (d, <i>J</i> = 11.25 Hz, 1H), 3.85 (dd, <i>J</i> = 3.42, 11.25 Hz, 1H), 3.61 (ddd, <i>J</i> = 2.45, 6.36, 11.25 Hz, 1H), 3.17 (dt, <i>J</i> = 4.89, 11.25 Hz, 1H), 1.86–2.11 (m, 1H), 1.58–1.85 (m, 1H), 1.20–1.29 (m, 9H), 1.03–1.16 (m, 1H), 0.96 (dd, <i>J</i> = 2.93, 8.31 Hz, 1H), 0.66 (dd, <i>J</i> = 3.18, 5.62 Hz, 1H).</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Chloro-4-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-6-(methanesulfonylmethyl)pyrimidine (Intermediate <b>I</b>)</h3><div class="NLM_p last">From general method A. Isolated as a mixture of 2,4-bis(3,6-dihydro-2<i>H</i>-pyran-4-yl)6((methylsulfonyl)methyl) pyrimidine with 2-chloro-4-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-6-((methylsulfonyl)methyl)pyrimidine and used crude in the synthesis of compound <b>21</b>.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Chloro-4-(methanesulfonylmethyl)-6-{3-oxabicyclo[4.1.0]heptan-6-yl}pyrimidine (Intermediate <b>J</b>)</h3><div class="NLM_p last">2,4-Dichloro-6-((methylsulfonyl)methyl)pyrimidine (200 mg, 0.830 mmol), (3-oxabicyclo[4.1.0]heptan-6-yl)trifluoro-l4-borane, potassium salt (203 mg, 0.995 mmol), PdCl<sub>2</sub>(dppf) (60.7 mg, 0.083 mmol), and cesium carbonate (541 mg, 1.659 mmol) were suspended in toluene (2000 μL):water (200 μL), and the resulting mixture was degassed under a flow of nitrogen, sealed, and heated to 110 °C with stirring for 15 h. The reaction mixture was cooled to room temperature and treated with EtOAc (5 mL), and the mixture was filtered through Celite and eluted with EtOAc (3 × 5 mL). The filtrate was evaporated in vacuo and purified by column chromatography (98.8 mg, 0.326 mmol, 39.3% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 7.29 (s, 1H), 4.32 (s, 2H), 3.91–4.03 (m, 2H), 3.69 (ddd, 1H, <i>J</i> = 11.6 Hz, <i>J</i> = 5.7 Hz, <i>J</i> = 4.4 Hz), 3.42 (ddd, 1H, <i>J</i> = 11.7 Hz, <i>J</i> = 9.3 Hz, <i>J</i> = 5.1 Hz), 3.03 (s, 3H), 2.56 (dt, 1H, <i>J</i> = 13.9 Hz, <i>J</i> = 4.6 Hz), 2.09 (ddd, 1H, <i>J</i> = 14.2 Hz, <i>J</i> = 9.0 Hz, <i>J</i> = 5.9 Hz), 1.87–2.01 (m, 1H), 1.53 (dd, 1H, <i>J</i> = 9.2 Hz, <i>J</i> = 4.0 Hz), 1.33 (dd, 1H, <i>J</i> = 6.7 Hz, <i>J</i> = 4.3 Hz). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 303. Intermediate <b>J</b> was purified by chiral SFC for chiral separation to afford intermediate <b>K</b>.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Chloro-4-(methanesulfonylmethyl)-6-[(1<i>S</i>, 6<i>R</i>)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidine (Intermediate <b>K</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 7.61 (s, 1H), 4.68 (s, 2H), 3.78–3.97 (m, 2H), 3.55–3.62 (m, 1H), 3.32–3.41 (m, 1H), 3.11 (s, 3H), 2.44–2.57 (m, 1H), 1.96 (ddd, <i>J</i> = 5.70, 8.82, 14.20 Hz, 1H), 1.73–1.86 (m, 1H), 1.42 (dd, <i>J</i> = 3.95, 9.21 Hz, 1H), 1.25 (dd, <i>J</i> = 4.17, 6.80 Hz, 1H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 303; [α]<sub>D</sub><sup>20</sup> = −67.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Chloro-4-(methanesulfonylmethyl)-6-[(1<i>R</i>,6<i>S</i>)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidine (Intermediate <b>L</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 7.61 (s, 1H), 4.68 (s, 2H), 3.80–3.96 (m, 2H), 3.52–3.63 (m, 1H), 3.31–3.40 (m, 1H), 3.11 (s, 3H), 2.45–2.55 (m, 1H), 1.96 (ddd, <i>J</i> = 5.70, 8.82, 14.20 Hz, 1H), 1.73–1.86 (m, 1H), 1.42 (dd, <i>J</i> = 4.06, 9.32 Hz, 1H), 1.25 (dd, <i>J</i> = 4.17, 6.80 Hz, 1H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 303; [α]<sub>D</sub><sup>20</sup> = 72.</div></div><div id="sec5_5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Chloro-4-(2-methanesulfonylpropan-2-yl)-6-{3-oxabicyclo[4.1.0]heptan-6-yl}pyrimidine (Intermediate <b>M</b>)</h3><div class="NLM_p last">To a solution of 4-(3-oxabicyclo[4.1.0]heptan-6-yl)-2-chloro-6-((methylsulfonyl)methyl)pyrimidine (300 mg, 0.991 mmol) in anhydrous tetrahydrofuran (THF, 4 mL) was added sodium 2-methylpropan-2-olate 2 M in THF (1.486 mL, 2.97 mmol) followed by dropwise addition of iodomethane (0.155 mL, 2.477 mmol). The resulting mixture was stirred at ambient temperature for 5 h. The reaction mixture was quenched with saturated ammonium chloride (10 mL) and extracted with DCM (2 × 10 mL). The organic phase was concentrated in vacuo and purified by column chromatography to afford 2-chloro-4-(2-methanesulfonylpropan-2-yl)-6-{3-oxabicyclo[4.1.0]heptan-6-yl}pyrimidine (328 mg, 0.985 mmol, 99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 7.42 (s, 1H), 3.99 (d, <i>J</i> = 2.93 Hz, 2H), 3.70 (ddd, <i>J</i> = 4.40, 5.75, 11.62 Hz, 1H), 3.44 (ddd, <i>J</i> = 5.26, 9.23, 11.68 Hz, 1H), 2.91 (s, 3H), 2.56 (td, <i>J</i> = 4.86, 14.00 Hz, 1H), 2.05–2.19 (m, 2H), 1.92–1.99 (m, 1H), 1.84–1.89 (m, 7H), 1.48–1.55 (m, 1H), 1.25–1.36 (m, 2H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 328. Intermediate <b>M</b> was purified by chiral SFC for chiral separation to afford intermediatea <b>N</b> and <b>O</b>.</div></div><div id="sec5_5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Chloro-4-(2-methanesulfonylpropan-2-yl)-6-[(1<i>R</i>,6<i>S</i>)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidine (Intermediate <b>N</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 7.42 (s, 1H), 3.99 (d, <i>J</i> = 2.69 Hz, 2H), 3.70 (ddd, <i>J</i> = 4.40, 5.87, 11.74 Hz, 1H), 3.44 (ddd, <i>J</i> = 5.14, 9.29, 11.74 Hz, 1H), 2.91 (s, 3H), 2.56 (td, <i>J</i> = 4.71, 14.06 Hz, 1H), 2.12 (ddd, <i>J</i> = 5.87, 8.93, 14.31 Hz, 1H), 1.95 (br d, <i>J</i> = 2.69 Hz, 1H), 1.87 (s, 6H), 1.52 (dd, <i>J</i> = 4.16, 9.29 Hz, 1H), 1.32 (dd, <i>J</i> = 4.28, 6.72 Hz, 1H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 331; [α]<sub>D</sub><sup>20</sup> = −72.</div></div><div id="sec5_5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Chloro-4-(2-methanesulfonylpropan-2-yl)-6-[(1<i>S</i>,6<i>R</i>)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidine (Intermediate <b>O</b>)</h3><div class="NLM_p last">Yield 66%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 7.42 (s, 1H), 3.99 (d, <i>J</i> = 2.69 Hz, 2H), 3.70 (ddd, <i>J</i> = 4.40, 5.87, 11.74 Hz, 1H), 3.44 (ddd, <i>J</i> = 5.26, 9.23, 11.68 Hz, 1H), 2.91 (s, 3H), 2.56 (td, <i>J</i> = 4.77, 13.94 Hz, 1H), 2.12 (ddd, <i>J</i> = 5.87, 8.99, 14.24 Hz, 1H), 1.95 (br d, <i>J</i> = 2.69 Hz, 1H), 1.87 (s, 6H), 1.52 (dd, <i>J</i> = 4.16, 9.29 Hz, 1H), 1.32 (dd, <i>J</i> = 4.28, 6.72 Hz, 1H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 331. [α]<sub>D</sub><sup>20</sup> = 78.</div></div><div id="sec5_5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-[4-(2-Methanesulfonylpropan-2-yl)-6-[(1<i>R</i>,6<i>S</i>)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]aniline (Intermediate <b>P</b>)</h3><div class="NLM_p last">From intermediate <b>N</b>, general method A. Yield 43%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 7.99–8.20 (d, <i>J</i> = 8.80 Hz, 2H), 7.25 (s, 1H), 6.63 (d, <i>J</i> = 8.80 Hz, 2H), 5.65 (s, 2H), 3.79–4.04 (m, 2H), 3.51–3.71 (m, 1H), 3.38 (ddd, <i>J</i> = 5.26, 8.77, 11.62 Hz, 1H), 2.97 (s, 3H), 2.61–2.77 (dt, <i>J</i> = 5.12, 14.09 Hz,1H), 2.00 (ddd, <i>J</i> = 5.59, 8.60, 14.09 Hz, 1H), 1.88–1.95 (m, 1H), 1.45 (dd, <i>J</i> = 3.73, 9.21 Hz, 1H), 1.15 (dd, <i>J</i> = 3.84, 6.47 Hz, 1H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 388; [α]<sub>D</sub><sup>20</sup> = −78.</div></div><div id="sec5_5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-[4-(2-Methanesulfonylpropan-2-yl)-6-[(1<i>S</i>,6<i>R</i>)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]aniline (Intermediate <b>Q</b>)</h3><div class="NLM_p last">From intermediate <b>O</b>, general method A. Yield 47%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 8.04–8.18 (d, <i>J</i> = 8.80 Hz, 2H), 7.25 (s, 1H), 6.63 (d, <i>J</i> = 8.80 Hz, 2H), 5.65 (s, 2H), 3.78–4.01 (m, 2H), 3.53–3.65 (m, 1H), 3.38 (ddd, <i>J</i> = 5.15, 8.66, 11.62 Hz, 1H), 2.97 (s, 3H), 2.66 (td, <i>J</i> = 4.96, 13.98 Hz, 1H), 2.00 (ddd, <i>J</i> = 5.59, 8.66, 14.03 Hz, 1H), 1.87–1.95 (m, 1H), 1.45 (dd, <i>J</i> = 3.73, 9.21 Hz, 1H), 1.15 (dd, <i>J</i> = 3.84, 6.47 Hz, 1H). ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> = 388; [α]<sub>D</sub><sup>20</sup> = 67.</div></div><div id="sec5_5_14_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-[4-(3,6-Dihydro-2<i>H</i>-pyran-4-yl)pyrimidin-2-yl]phenol (<b>9</b>)</h3><div class="NLM_p last">From intermediate <b>C</b>, general method A. Yield 67%. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ ppm 8.74 (d, <i>J</i> = 5.4 Hz, 1H), 8.07 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 8.00 (dd, <i>J</i> = 2.4, 1.5 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 7.22 (d, <i>J</i> = 5.4 Hz, 1H), 7.08 (dt, <i>J</i> = 2.9, 1.5 Hz, 1H), 7.00 (ddd, <i>J</i> = 8.1, 2.6, 0.9 Hz, 1H), 5.95–6.59 (m, 1H), 4.46 (q, <i>J</i> = 2.7 Hz, 2H), 4.00 (t, <i>J</i> = 5.5 Hz, 2H), 2.67–2.74 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ ppm 163.6, 163.3, 157.4, 156.2, 139.3, 133.1, 130.4, 129.9, 120.6, 118.0, 115.0, 113.2, 65.8, 64.3, 25.1. HRMS-ESI (<i>m</i>/<i>z</i>): calcd for C<sub>15</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub> 255.1133; found [M + H]<sup>+</sup> 255.1121.</div></div><div id="sec5_5_14_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(4-{3-Oxabicyclo[4.1.0]heptan-6-yl}pyrimidin-2-yl)phenol (<b>12</b>)</h3><div class="NLM_p last">From compound <b>7</b>, general method C. Yield 17%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 8.66 (d, <i>J</i> = 5.56 Hz, 1H), 8.03 (d, <i>J</i> = 7.83 Hz, 1H), 7.90–7.96 (m, 1H), 7.37 (t, <i>J</i> = 7.96 Hz, 1H), 7.11 (d, <i>J</i> = 5.56 Hz, 1H), 6.98 (dd, <i>J</i> = 2.27, 7.58 Hz, 1H), 4.05 (d, <i>J</i> = 2.78 Hz, 2H), 3.67–3.81 (m, 1H), 3.50 (ddd, <i>J</i> = 5.05, 9.09, 11.62 Hz, 1H), 2.71 (td, <i>J</i> = 4.80, 13.89 Hz, 1H), 2.15 (ddd, <i>J</i> = 5.68, 8.91, 14.21 Hz, 1H), 1.99 (tdd, <i>J</i> = 2.91, 6.22, 9.19 Hz, 1H), 1.56 (dd, <i>J</i> = 4.04, 9.35 Hz, 1H), 1.26 (dd, <i>J</i> = 4.04, 6.57 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ ppm 173.2, 163.3, 156.6, 156.0, 139.4, 129.8, 120.6, 117.8, 114.8, 114.2, 65.6, 64.0, 25.2, 23.2, 23.1, 22. HRMS-ESI (<i>m</i>/<i>z</i>): calcd for C<sub>16</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub> 269.1290; found [M + H]<sup>+</sup> 269.1276. The two enantiomers were separated by chiral HPLC on Chiralpak IC 250 mm × 20 mm eluting with heptane:EtOH:Isopropylamine 90:10:0.2 to give 3-{4-[(1<i>R</i>,6<i>S</i>)-3-oxabicyclo[4.1.0] heptan-6-yl]pyrimidin-2-yl}phenol (<b>12a</b>), [α]<sub>D</sub><sup>20</sup> = −100, and 3-{4-[(1<i>S</i>,6<i>R</i>)-3-oxabicyclo[4.1.0] heptan-6-yl]pyrimidin-2-yl}phenol (<b>12b</b>), [α]<sub>D</sub><sup>20</sup> = 70.</div></div><div id="sec5_5_14_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-(2-Hydroxyethyl)-1-{4-[4-(2-methanesulfonylpropan-2-yl)-6-[(1<i>S</i>,6<i>R</i>)-3-oxabicyclo[4.1.0] heptan-6-yl]pyrimidin-2-yl]phenylthiourea (<b>29b</b>)</h3><div class="NLM_p last">From intermediate P, general method D. Yield 73%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.75–9.97 (m, 1H), 8.35 (d, <i>J</i> = 8.80 Hz, 2H), 7.91 (br s, 1H), 7.69 (d, <i>J</i> = 8.80 Hz, 2H), 4.82 (br s, 1H), 3.92–3.99 (m, 1H), 3.84–3.91 (m, 1H), 3.54–3.67 (m, 4H), 3.41 (ddd, <i>J</i> = 5.32, 8.71, 11.65 Hz, 1H), 2.99 (s, 3H), 2.71 (td, <i>J</i> = 4.95, 13.94 Hz, 1H), 1.93–2.09 (m, 2H), 1.84 (s, 6H), 1.52 (dd, <i>J</i> = 4.03, 9.17 Hz, 1H), 1.21 (dd, <i>J</i> = 4.03, 6.24 Hz, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 180.7, 174.3, 166.1, 162.0, 142.6, 132.6, 128.8, 122.2, 122.1, 113.1, 67.0, 65.1, 63.5, 59.6, 47.0, 36.5, 25.1, 23.5, 23.4, 22.8, 21.0. HRMS-ESI (<i>m</i>/<i>z</i>): calcd for C<sub>23</sub>H<sub>31</sub>N<sub>4</sub>O<sub>4</sub>S<sub>2</sub> 491.1787; found [M + H]<sup>+</sup> 491.1787; [α]<sub>D</sub><sup>20</sup> = 42.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00348" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00348" class="ext-link">10.1021/acs.jmedchem.9b00348</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data for the small molecule crystal structure of <b>9b</b>; a low occupancy cocrystal structure of <b>12b</b>; protocols for the PI3K, mTOR, and Akt assays and experimental data for the remaining novel compounds <b>5</b>–<b>29</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formular strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf">jm9b00348_si_001.pdf (419.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_002.csv">jm9b00348_si_002.csv (3.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00348" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Hobbs</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8474-9016" title="Orcid link">http://orcid.org/0000-0001-8474-9016</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#761e1317021e1304580e581e191414053611051d5815191b"><span class="__cf_email__" data-cfemail="dbb3bebaafb3bea9f5a3f5b3b4b9b9a89bbca8b0f5b8b4b6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianpaolo Bravi</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span>Present Address:
                        Dotmatics, The Old Monastery, Windhill, Bishops Stortford CM23 2ND, UK</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Campbell</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maire Convery</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannah Davies</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham Inglis</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandeep Pal</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Peace</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna Redmond</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Declan Summers</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span>Present Address:
                        Costello Medical Consulting Ltd, Jupiter House 10, Cambridge CB1 2JD, UK</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4187-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Alan Kennedy, Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street Glasgow, G1 1XL, U.K. for the small molecule crystal structure of <b>12b</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">mTORC1</td><td class="NLM_def"><p class="first last">mTOR complex1</p></td></tr><tr><td class="NLM_term">mTORC2</td><td class="NLM_def"><p class="first last">mTOR complex 2</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PIKK</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase-related kinases</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">Molecular Operating Environment</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoracetic acid</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectroscopy</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high pressure liquid chromatography.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yap, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2008.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-412&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynaudauthor=J.+S.+de+Bonoauthor=P.+Workman&title=Targeting+the+PI3K%E2%80%93AKT%E2%80%93mTOR+pathway%3A+progress%2C+pitfalls%2C+and+promises&doi=10.1016%2Fj.coph.2008.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0ljp6d5VookkHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K%25E2%2580%2593AKT%25E2%2580%2593mTOR%2520pathway%253A%2520progress%252C%2520pitfalls%252C%2520and%2520promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D412%26doi%3D10.1016%2Fj.coph.2008.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1038/nrd2926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer&doi=10.1038%2Fnrd2926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0ljp6d5VookkHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644%26doi%3D10.1038%2Fnrd2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meric-Bernstam, F.</span></span> <span> </span><span class="NLM_article-title">Targeting the PI3K pathway in cancer: are we making headway?</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2018.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnrclinonc.2018.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29508857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVyjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=273-291&author=F.+Jankuauthor=T.+A.+Yapauthor=F.+Meric-Bernstam&title=Targeting+the+PI3K+pathway+in+cancer%3A+are+we+making+headway%3F&doi=10.1038%2Fnrclinonc.2018.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K pathway in cancer: are we making headway?</span></div><div class="casAuthors">Janku, Filip; Yap, Timothy A.; Meric-Bernstam, Funda</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">273-291</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The PI3K-AKT-mTOR pathway is one of the most frequently dysregulated pathways in cancer and, consequently, more than 40 compds. that target key components of this signalling network have been tested in clin. trials involving patients with a range of different cancers.  The clin. development of many of these agents, however, has not advanced to late-phase randomized trials, and the antitumor activity of those that have been evaluated in comparative prospective studies has typically been limited, or toxicities were found to be prohibitive.  Nevertheless, the mTOR inhibitors temsirolimus and everolimus and the PI3K inhibitors idelalisib and copanlisib have been approved by the FDA for clin. use in the treatment of a no. of different cancers.  Novel compds. with greater potency and selectivity, as well as improved therapeutic indexes owing to reduced risks of toxicity, are clearly required.  In addn., biomarkers that are predictive of a response, such as PIK3CA mutations for inhibitors of the PI3K catalytic subunit α isoform, must be identified and anal. and clin. validated.  Finally, considering that oncogenic activation of the PI3K-AKT-mTOR pathway often occurs alongside pro-tumorigenic aberrations in other signalling networks, rational combinations are also needed to optimize the effectiveness of treatment.  Herein, we review the current experience with anticancer therapies that target the PI3K-AKT-mTOR pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbPxYBT6FMIbVg90H21EOLACvtfcHk0ljp6d5VookkHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVyjsLY%253D&md5=73e00e3137c598e3a88ecf6a3d180b8c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2018.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2018.28%26sid%3Dliteratum%253Aachs%26aulast%3DJanku%26aufirst%3DF.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DMeric-Bernstam%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520PI3K%2520pathway%2520in%2520cancer%253A%2520are%2520we%2520making%2520headway%253F%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D15%26spage%3D273%26epage%3D291%26doi%3D10.1038%2Fnrclinonc.2018.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regad, T.</span></span> <span> </span><span class="NLM_article-title">Targeting RTK signaling pathways in cancer</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1758</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.3390/cancers7030860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.3390%2Fcancers7030860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=26404379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1758-1784&author=T.+Regad&title=Targeting+RTK+signaling+pathways+in+cancer&doi=10.3390%2Fcancers7030860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RTK signaling pathways in cancer</span></div><div class="casAuthors">Regad, Tarik</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1758-1784</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation, differentiation and survival.  The induction of these pathways depends on Receptor Tyrosine Kinases (RTKs) that are activated upon ligand binding.  In cancer, constitutive and aberrant activations of components of those pathways result in increased proliferation, survival and metastasis.  For instance, mutations affecting RTKs, Ras, B-Raf, PI3K and AKT are common in perpetuating the malignancy of several types of cancers and from different tissue origins.  Therefore, these signaling pathways became prime targets for cancer therapy.  This review aims to provide an overview about the most frequently encountered mutations, the pathogenesis that results from such mutations and the known therapeutic strategies developed to counteract their aberrant functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjg0xbtTp_DLVg90H21EOLACvtfcHk0lh4k3nHZ8JuIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVKhs74%253D&md5=69915108fbea525b049fea614ee8e210</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3390%2Fcancers7030860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers7030860%26sid%3Dliteratum%253Aachs%26aulast%3DRegad%26aufirst%3DT.%26atitle%3DTargeting%2520RTK%2520signaling%2520pathways%2520in%2520cancer%26jtitle%3DCancers%26date%3D2015%26volume%3D7%26spage%3D1758%26epage%3D1784%26doi%3D10.3390%2Fcancers7030860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haring, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, R.</span></span> <span> </span><span class="NLM_article-title">How insulin receptor substrate proteins regulate the metabolic capacity of the liver - implications for health and disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1316</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.2174/092986708784534956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.2174%2F092986708784534956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=18537611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1316-1329&author=L.+Fritscheauthor=C.+Weigertauthor=H.-U.+Haringauthor=R.+Lehmann&title=How+insulin+receptor+substrate+proteins+regulate+the+metabolic+capacity+of+the+liver+-+implications+for+health+and+disease&doi=10.2174%2F092986708784534956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How insulin receptor substrate proteins regulate the metabolic capacity of the liver - implications for health and disease</span></div><div class="casAuthors">Fritsche, Louise; Weigert, Cora; Haering, Hans-Ulrich; Lehmann, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1316-1329</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The liver plays a key role in glucose homeostasis, lipid and energy metab.  Its function is primarily controlled by the anabolic hormone insulin and its counterparts glucagon, catecholamines and glucocorticoids.  Dysregulation of this homeostatic system is a major cause for development of the metabolic syndrome and type 2 diabetes mellitus.  The features of the underlying dynamic mol. network that coordinates systemic nutrient homeostasis are less clear.  But recently, considerable progress has been made in elucidating mol. pathways and potential factors involved in the regulation of energy and lipid metab. and affected in diabetic states.  In this review we will focus on important stations in the complex network of mols. that control the balance between glucose prodn., glucose utilization and regulation of lipid metab.  Special attention will be paid to the insulin receptor substrate (IRS) proteins with the two major isoforms IRS-1 and IRS-2 as a crit. node in hepatic insulin signaling.  IRS proteins act as docking mols. to connect tyrosine kinase receptor activation to essential downstream kinase cascades, including activation of the PI-3 kinase or MAPK cascade.  IRS-1 and IRS-2 are complementary key players in the regulation of hepatic insulin signaling and expression of genes involved in gluconeogenesis, glycogen synthesis and lipid metab.  The function of IRS proteins is regulated by their expression levels and posttranslational modifications.  This regulation within the dynamic mol. network that coordinates systemic nutrient homeostasis will be outlined in detail under the following conditions: after feeding, during fasting and during exercise.  Dysfunction of IRS proteins initially leads to post-prandial hyperglycemia, increased hepatic glucose prodn., and dysregulated lipid synthesis and is discussed as major pathophysiol. mechanism for the development of insulin resistance and type 2 diabetes mellitus.  Understanding the mol. regulation and the pathophysiol. modifications of IRS proteins is crucial in order to identify new sites for potential intervention to treat or prevent hepatic insulin resistance and type 2 diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDYj3XCArV_7Vg90H21EOLACvtfcHk0lh4k3nHZ8JuIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyhsrk%253D&md5=8bef4cd0e1e27d34affb3085c2432d4a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F092986708784534956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784534956%26sid%3Dliteratum%253Aachs%26aulast%3DFritsche%26aufirst%3DL.%26aulast%3DWeigert%26aufirst%3DC.%26aulast%3DHaring%26aufirst%3DH.-U.%26aulast%3DLehmann%26aufirst%3DR.%26atitle%3DHow%2520insulin%2520receptor%2520substrate%2520proteins%2520regulate%2520the%2520metabolic%2520capacity%2520of%2520the%2520liver%2520-%2520implications%2520for%2520health%2520and%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D1316%26epage%3D1329%26doi%3D10.2174%2F092986708784534956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heras-Sandoval, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila-Muñoz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C.</span></span> <span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase/mTor pathway as a therapeutic target for brain aging and neurodegeneration</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.3390/ph4081070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.3390%2Fph4081070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2gurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=1070-1087&author=D.+Heras-Sandovalauthor=E.+Avila-Mu%C3%B1ozauthor=C.+Arias&title=The+phosphatidylinositol+3-kinase%2FmTor+pathway+as+a+therapeutic+target+for+brain+aging+and+neurodegeneration&doi=10.3390%2Fph4081070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-kinase/mTor pathway as a therapeutic target for brain aging and neurodegeneration</span></div><div class="casAuthors">Heras-Sandoval, David; Avila-Munoz, Evangelina; Arias, Clorinda</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1070-1087</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Many pathol. conditions are assocd. with phosphatidylinositol 3-kinase (PI3K) dysfunction, providing an incentive for the study of the effects of PI3K modulation in different aspects of diabetes, cancer, and aging.  The PI3K/AKT/mTOR pathway is a key transducer of brain metabolic and mitogenic signals involved in neuronal proliferation, differentiation, and survival.  In several models of neurodegenerative diseases assocd. with aging, the PI3K/AKT pathway has been found to be dysregulated, suggesting that two or more initiating events may trigger disease formation in an age-related manner.  The search for chem. compds. able to modulate the activity of the PI3K/AKT/mTOR pathway is emerging as a potential therapeutic strategy for the treatment and/or prevention of some metabolic defects assocd. with brain aging.  In the current review, we summarize some of the crit. actions of PI3K in brain function as well as the evidence of its involvement in aging and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79ZB5FimxHbVg90H21EOLACvtfcHk0lh4k3nHZ8JuIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2gurnN&md5=be49cfdcc2fd34f4ac23dfc13788f289</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3390%2Fph4081070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph4081070%26sid%3Dliteratum%253Aachs%26aulast%3DHeras-Sandoval%26aufirst%3DD.%26aulast%3DAvila-Mu%25C3%25B1oz%26aufirst%3DE.%26aulast%3DArias%26aufirst%3DC.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase%252FmTor%2520pathway%2520as%2520a%2520therapeutic%2520target%2520for%2520brain%2520aging%2520and%2520neurodegeneration%26jtitle%3DPharmaceuticals%26date%3D2011%26volume%3D4%26spage%3D1070%26epage%3D1087%26doi%3D10.3390%2Fph4081070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heras-Sandoval, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Rojas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Damián, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza-Chaverri, J.</span></span> <span> </span><span class="NLM_article-title">The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2694</span>– <span class="NLM_lpage">2701</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2014.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.cellsig.2014.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=25173700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Squ7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=2694-2701&author=D.+Heras-Sandovalauthor=J.+M.+P%C3%A9rez-Rojasauthor=J.+Hern%C3%A1ndez-Dami%C3%A1nauthor=J.+Pedraza-Chaverri&title=The+role+of+PI3K%2FAKT%2FmTOR+pathway+in+the+modulation+of+autophagy+and+the+clearance+of+protein+aggregates+in+neurodegeneration&doi=10.1016%2Fj.cellsig.2014.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</span></div><div class="casAuthors">Heras-Sandoval, David; Perez-Rojas, Jazmin M.; Hernandez-Damian, Jacqueline; Pedraza-Chaverri, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2694-2701</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Disruption of autophagy plays an import role in neurodegenerative disorders, where deficient elimination of abnormal and toxic protein aggregates promotes cellular stress, failure and death.  Therefore, induction of autophagy has been proposed as a reasonable strategy to help neurons clear abnormal protein aggregates and survive.  The kinase mammalian target of rapamycin (mTOR) is a major regulator of the autophagic process and is regulated by starvation, growth factors, and cellular stressors.  Upstream of mTOR the survival PI3K/AKT pathway modulates mTOR activity that is also altered in neurodegenerative diseases of Alzheimer and Parkinson.  Nevertheless, the interplay between the PI3K/AKT/mTOR pathway and the autophagic process is complex and a more detailed examn. of tissue from patients suffering neurodegenerative diseases and of animal and cellular models is needed.  In the present work we review the recent findings on the role of the PI3K/AKT/mTOR pathway in the modulation of the autophagic process in neuronal protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYRkhLYeGjRbVg90H21EOLACvtfcHk0lhvQV-hmFBsbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Squ7rF&md5=35f98407f6f41639e29500260a3ff91f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2014.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2014.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DHeras-Sandoval%26aufirst%3DD.%26aulast%3DP%25C3%25A9rez-Rojas%26aufirst%3DJ.%2BM.%26aulast%3DHern%25C3%25A1ndez-Dami%25C3%25A1n%26aufirst%3DJ.%26aulast%3DPedraza-Chaverri%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520PI3K%252FAKT%252FmTOR%2520pathway%2520in%2520the%2520modulation%2520of%2520autophagy%2520and%2520the%2520clearance%2520of%2520protein%2520aggregates%2520in%2520neurodegeneration%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D2694%26epage%3D2701%26doi%3D10.1016%2Fj.cellsig.2014.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sul, H. S.</span></span> <span> </span><span class="NLM_article-title">Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.coph.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=20817607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVals7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=684-691&author=R.+H.+F.+Wongauthor=H.+S.+Sul&title=Insulin+signaling+in+fatty+acid+and+fat+synthesis%3A+a+transcriptional+perspective&doi=10.1016%2Fj.coph.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective</span></div><div class="casAuthors">Wong, Roger H. F.; Sul, Hei Sook</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">684-691</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Transcription of enzymes involved in FA and TAG synthesis is coordinately induced in lipogenic tissues by feeding and insulin treatment.  The three major transcription factors involved are USF, SREBP-1c, and LXRα.  New insights into the insulin-signaling pathway(s) that control(s) lipogenic gene transcription via these factors have recently been revealed.  Dephosphorylation/activation of DNA-PK by PP1 causes phosphorylation of USF that in turn recruits P/CAF to be acetylated for transcriptional activation.  SREBP-1c can be induced by mTORC1, bifurcating lipogenesis from AKT-activated gluconeogenesis.  LXRα may serve as a glucose sensor and, along with ChREBP, may activate lipogenic genes in the fed state.  Dysregulation of FA and TAG metab. often contributes to metabolic diseases such as obesity, diabetes, and cardiovascular diseases.  Transcription factors and signaling mols. involved in transcriptional activation of FA and TAG synthesis represent attractive targets for the prevention and treatment of metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogRKm8XQTvcLVg90H21EOLACvtfcHk0lhvQV-hmFBsbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVals7rO&md5=685fb366eeb911d8ae0c76af214bd1aa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BH.%2BF.%26aulast%3DSul%26aufirst%3DH.%2BS.%26atitle%3DInsulin%2520signaling%2520in%2520fatty%2520acid%2520and%2520fat%2520synthesis%253A%2520a%2520transcriptional%2520perspective%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D684%26epage%3D691%26doi%3D10.1016%2Fj.coph.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span> <span> </span><span class="NLM_article-title">Comparison of FDA approved kinase targets to clinical trial ones: Insights from their system profiles and drug-target interaction networks</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1155/2016/2509385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1155%2F2016%2F2509385" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1-9&author=J.+Xuauthor=P.+Wangauthor=H.+Yangauthor=J.+Zhouauthor=Y.+Liauthor=X.+Liauthor=W.+Xueauthor=C.+Yuauthor=Y.+Tianauthor=F.+Zhu&title=Comparison+of+FDA+approved+kinase+targets+to+clinical+trial+ones%3A+Insights+from+their+system+profiles+and+drug-target+interaction+networks&doi=10.1155%2F2016%2F2509385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2016%2F2509385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F2509385%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DF.%26atitle%3DComparison%2520of%2520FDA%2520approved%2520kinase%2520targets%2520to%2520clinical%2520trial%2520ones%253A%2520Insights%2520from%2520their%2520system%2520profiles%2520and%2520drug-target%2520interaction%2520networks%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D9%26doi%3D10.1155%2F2016%2F2509385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.ctrv.2017.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=28779636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WgtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=93-101&author=F.+Janku&title=Phosphoinositide+3-kinase+%28PI3K%29+pathway+inhibitors+in+solid+tumors%3A+From+laboratory+to+patients&doi=10.1016%2Fj.ctrv.2017.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients</span></div><div class="casAuthors">Janku, Filip</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The phosphoinositide 3-kinase (PI3K) pathway is an intracellular signaling pathway that has regulatory roles in cell survival, proliferation, and differentiation, and a crit. role in tumorigenesis.  In cancer, multiple studies have investigated the therapeutic targeting of the PI3K pathway, and multiple inhibitors targeting PI3K and its isoforms, protein kinase B/AKT, mammalian target of rapamycin (mTOR), and other pathway proteins have been developed.  For the treatment of solid tumors, only allosteric mTOR inhibitors, such as everolimus and temsirolimus, are currently approved for clin. use.  This review describes the PI3K inhibitors that have progressed from the lab. to late-stage clin. trials, and discusses the challenges that have prevented other compds. from doing the same.  Challenges to the therapeutic effectiveness of some PI3K inhibitors include the absence of reliable and effective biomarkers, their limited efficacy as single agents, insufficient development of rational therapeutic combinations, the use of schedules with a variety of off-target effects, and suboptimal therapeutic exposures.  Therefore, with regard to PI3K inhibitors currently in late-stage clin. trials, the identification of appropriate biomarkers of efficacy and the development of optimal combination regimens and dosing schedules are likely to be important for graduation into clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQhlVdFU8NPrVg90H21EOLACvtfcHk0liqkqYMXqbjlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WgtbrJ&md5=5b60a21296fea87bffc4e691f9e5c7be</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DJanku%26aufirst%3DF.%26atitle%3DPhosphoinositide%25203-kinase%2520%2528PI3K%2529%2520pathway%2520inhibitors%2520in%2520solid%2520tumors%253A%2520From%2520laboratory%2520to%2520patients%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2017%26volume%3D59%26spage%3D93%26epage%3D101%26doi%3D10.1016%2Fj.ctrv.2017.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polanska, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delpuech, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinidad, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michopoulos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaghan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polanski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellston, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avivar-Valderas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumberbatch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchlow, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, S. T.</span></span> <span> </span><span class="NLM_article-title">Inhibiting PI3Kβ with AZD8186 regulates key metabolic pathways in PTEN-null tumors</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7584</span>– <span class="NLM_lpage">7595</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-17-0676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1158%2F1078-0432.CCR-17-0676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=28972046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=7584-7595&author=J.+T.+Lynchauthor=U.+M.+Polanskaauthor=O.+Delpuechauthor=U.+Hancoxauthor=A.+G.+Trinidadauthor=F.+Michopoulosauthor=C.+Lenaghanauthor=R.+McEwenauthor=J.+Bradfordauthor=R.+Polanskiauthor=R.+Ellstonauthor=A.+Avivar-Valderasauthor=J.+Pillingauthor=A.+Staniszewskaauthor=M.+Cumberbatchauthor=S.+E.+Critchlowauthor=F.+Cruzaleguiauthor=S.+T.+Barry&title=Inhibiting+PI3K%CE%B2+with+AZD8186+regulates+key+metabolic+pathways+in+PTEN-null+tumors&doi=10.1158%2F1078-0432.CCR-17-0676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors</span></div><div class="casAuthors">Lynch, James T.; Polanska, Urszula M.; Delpuech, Oona; Hancox, Urs; Trinidad, Antonio G.; Michopoulos, Filippos; Lenaghan, Carol; McEwen, Robert; Bradford, James; Polanski, Radek; Ellston, Rebecca; Avivar-Valderas, Alvaro; Pilling, James; Staniszewska, Anna; Cumberbatch, Marie; Critchlow, Susan E.; Cruzalegui, Francisco; Barry, Simon T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7584-7595</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: PTEN-null tumors become dependent on the PI3Kβ isoform and can be targeted by mols. such as the selective PI3Kβ inhibitor AZD8186.  However, beyond the modulation of the canonical PI3K pathway, the consequences of inhibiting PI3Kβ are poorly defined.  Exptl. Design: To det. the broader impact of AZD8186 in PTEN-null tumors, we performed a genome-wide RNA-seq anal. of PTEN-null triple-neg. breast tumor xenografts treated with AZD8186.  Mechanistic consequences of AZD8186 treatment were examd. across a no. of PTEN-null cell lines and tumor models.  Results: AZD8186 treatment resulted in modification of transcript and protein biomarkers assocd. with cell metab.  We obsd. downregulation of cholesterol biosynthesis genes and upregulation of markers assocd. with metabolic stress.  Downregulation of cholesterol biosynthesis proteins, such as HMGCS1, occurred in PTEN-null cell lines and tumor xenografts sensitive to AZD8186.  Therapeutic inhibition of PI3Kβ also upregulated PDHK4 and increased PDH phosphorylation, indicative of reduced carbon flux into the TCA cycle.  Consistent with this, metabolomic anal. revealed a no. of changes in key carbon pathways, nucleotide, and amino acid biosynthesis.  Conclusions: This study identifies novel mechanistic biomarkers of PI3Kβ inhibition in PTEN-null tumors supporting the concept that targeting PI3Kβ may exploit a metabolic dependency that contributes to therapeutic benefit in inducing cell stress.  Considering these addnl. pathways will guide biomarker and combination strategies for this class of agents.  Clin Cancer Res; 23(24); 7584-95. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpxd85DV7hRrVg90H21EOLACvtfcHk0liqkqYMXqbjlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtLfP&md5=d48605426588d3abec1d11d7581b1c0a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-0676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-0676%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BT.%26aulast%3DPolanska%26aufirst%3DU.%2BM.%26aulast%3DDelpuech%26aufirst%3DO.%26aulast%3DHancox%26aufirst%3DU.%26aulast%3DTrinidad%26aufirst%3DA.%2BG.%26aulast%3DMichopoulos%26aufirst%3DF.%26aulast%3DLenaghan%26aufirst%3DC.%26aulast%3DMcEwen%26aufirst%3DR.%26aulast%3DBradford%26aufirst%3DJ.%26aulast%3DPolanski%26aufirst%3DR.%26aulast%3DEllston%26aufirst%3DR.%26aulast%3DAvivar-Valderas%26aufirst%3DA.%26aulast%3DPilling%26aufirst%3DJ.%26aulast%3DStaniszewska%26aufirst%3DA.%26aulast%3DCumberbatch%26aufirst%3DM.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26atitle%3DInhibiting%2520PI3K%25CE%25B2%2520with%2520AZD8186%2520regulates%2520key%2520metabolic%2520pathways%2520in%2520PTEN-null%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D7584%26epage%3D7595%26doi%3D10.1158%2F1078-0432.CCR-17-0676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Evolution of a novel, orally bioavailable series of PI3Kδ inhibitors from an inhaled lead for the treatment of respiratory disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7239</span>– <span class="NLM_lpage">7251</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyitLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7239-7251&author=A.+Amourauthor=N.+Bartonauthor=A.+W.+J.+Cooperauthor=G.+Inglisauthor=C.+Jamiesonauthor=C.+N.+Luscombeauthor=J.+Morrellauthor=S.+Peaceauthor=D.+Perezauthor=P.+Rowlandauthor=C.+Tameauthor=S.+Uddinauthor=G.+Vitulliauthor=N.+Wellaway&title=Evolution+of+a+novel%2C+orally+bioavailable+series+of+PI3K%CE%B4+inhibitors+from+an+inhaled+lead+for+the+treatment+of+respiratory+disease&doi=10.1021%2Facs.jmedchem.6b00799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease</span></div><div class="casAuthors">Amour, Augustin; Barton, Nick; Cooper, Anthony W. J.; Inglis, Graham; Jamieson, Craig; Luscombe, Christopher N.; Morrell, Josie; Peace, Simon; Perez, David; Rowland, Paul; Tame, Christopher J.; Uddin, Sorif; Vitulli, Giovanni; Wellaway, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7239-7251</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a novel oral series of PI3Kδ inhibitors with promising selectivity and excellent in vivo characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKbdEJSHwYD7Vg90H21EOLACvtfcHk0lgkkLgc5MaxAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyitLnN&md5=ab4641778d1c80f0dd9551d6d75ff4ef</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00799%26sid%3Dliteratum%253Aachs%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTame%26aufirst%3DC.%26aulast%3DUddin%26aufirst%3DS.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DEvolution%2520of%2520a%2520novel%252C%2520orally%2520bioavailable%2520series%2520of%2520PI3K%25CE%25B4%2520inhibitors%2520from%2520an%2520inhaled%2520lead%2520for%2520the%2520treatment%2520of%2520respiratory%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7239%26epage%3D7251%26doi%3D10.1021%2Facs.jmedchem.6b00799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Correction to evolution of a novel, orally bioavailable series of PI3Kδ inhibitors from an inhaled lead for the treatment of respiratory disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8148</span>– <span class="NLM_lpage">8148</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOnt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8148-8148&author=A.+Amourauthor=N.+Bartonauthor=A.+W.+J.+Cooperauthor=G.+Inglisauthor=C.+Jamiesonauthor=C.+N.+Luscombeauthor=J.+Morrellauthor=S.+Peaceauthor=D.+Perezauthor=P.+Rowlandauthor=C.+J.+Tameauthor=S.+Uddinauthor=G.+Vitulliauthor=N.+Wellaway&title=Correction+to+evolution+of+a+novel%2C+orally+bioavailable+series+of+PI3K%CE%B4+inhibitors+from+an+inhaled+lead+for+the+treatment+of+respiratory+disease&doi=10.1021%2Facs.jmedchem.6b01157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease [Erratum to document cited in CA165:218406]</span></div><div class="casAuthors">Amour, Augustin; Barton, Nick; Cooper, Anthony W. J.; Inglis, Graham; Jamieson, Craig; Luscombe, Christopher N.; Morrell, Josie; Peace, Simon; Perez, David; Rowland, Paul; Tame, Christopher J.; Uddin, Sorif; Vitulli, Giovanni; Wellaway, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8148</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the author listings an author name was not correct; Christopher J. Tame name is provided correctly.  On page 7239 the central structure in the abstr. graphic is incorrect; a cor. abstr. graphic is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIn6ht38qRz7Vg90H21EOLACvtfcHk0lgkkLgc5MaxAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOnt7fM&md5=ba1fce1922cdfdb777390f03423af0fa</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01157%26sid%3Dliteratum%253Aachs%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTame%26aufirst%3DC.%2BJ.%26aulast%3DUddin%26aufirst%3DS.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DCorrection%2520to%2520evolution%2520of%2520a%2520novel%252C%2520orally%2520bioavailable%2520series%2520of%2520PI3K%25CE%25B4%2520inhibitors%2520from%2520an%2520inhaled%2520lead%2520for%2520the%2520treatment%2520of%2520respiratory%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8148%26epage%3D8148%26doi%3D10.1021%2Facs.jmedchem.6b01157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lopez
de Turiso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campuzano, I. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duquette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vissinga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whoriskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and in vivo evaluation of the potent and selective PI3Kδ inhibitors 2-((1<i>S</i>)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1<i>S</i>)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7252</span>– <span class="NLM_lpage">7267</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00827</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKmsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7252-7267&author=F.+Gonzalez-Lopez%0Ade+Turisoauthor=X.+Haoauthor=Y.+Shinauthor=M.+Buiauthor=I.+D.+G.+Campuzanoauthor=M.+Cardozoauthor=M.+C.+Dunnauthor=J.+Duquetteauthor=B.+Fisherauthor=R.+S.+Fotiauthor=K.+Henneauthor=X.+Heauthor=Y.-L.+Huauthor=R.+C.+Kellyauthor=M.+G.+Johnsonauthor=B.+S.+Lucasauthor=J.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=T.+San+Miguelauthor=D.+Mohnauthor=T.+Tranauthor=C.+Vissingaauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=X.+Zhangauthor=T.+D.+Cushing&title=Discovery+and+in+vivo+evaluation+of+the+potent+and+selective+PI3K%CE%B4+inhibitors+2-%28%281S%29-1-%28%286-amino-5-cyano-4-pyrimidinyl%29amino%29ethyl%29-6-fluoro-N-methyl-3-%282-pyridinyl%29-4-quinolinecarboxamide+%28AM-0687%29+and+2-%28%281S%29-1-%28%286-amino-5-cyano-4-pyrimidinyl%29amino%29ethyl%29-5-fluoro-N-methyl-3-%282-pyridinyl%29-4-quinolinecarboxamide+%28AM-1430%29&doi=10.1021%2Facs.jmedchem.6b00827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)</span></div><div class="casAuthors">Gonzalez-Lopez de Turiso, Felix; Hao, Xiaolin; Shin, Youngsook; Bui, Minna; Campuzano, Iain D. G.; Cardozo, Mario; Dunn, Michelle C.; Duquette, Jason; Fisher, Benjamin; Foti, Robert S.; Henne, Kirk; He, Xiao; Hu, Yi-Ling; Kelly, Ron C.; Johnson, Michael G.; Lucas, Brian S.; McCarter, John; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; San Miguel, Tisha; Mohn, Deanna; Tran, Thuy; Vissinga, Christine; Wannberg, Sharon; Whittington, Douglas A.; Whoriskey, John; Yu, Gang; Zalameda, Leeanne; Zhang, Xuxia; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7252-7267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of the potency and pharmacokinetic profile of the lead 2,3,4-trisubstituted quinoline led to the discovery of two potent, selective, and orally bioavailable PI3Kδ inhibitors, I (AM-0687) and II (AM-1430).  On the basis of their improved profile, these analogs were selected for in vivo pharmacodynamic (PD) and efficacy expts. in animal models of inflammation.  The in vivo PD studies, which were carried out in a mouse pAKT inhibition animal model, confirmed the obsd. potency of I and II in biochem. and cellular assays.  Efficacy expts. in a keyhole limpet hemocyanin model in rats demonstrated that administration of either I or II resulted in a strong dose-dependent redn. of IgG and IgM specific antibodies.  The excellent in vitro and in vivo profiles of these analogs make them suitable for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTy9A921V9wLVg90H21EOLACvtfcHk0lhYDRp4KtfGsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKmsrjJ&md5=f22bac738698c31ea80bef504fc117ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00827%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DBui%26aufirst%3DM.%26aulast%3DCampuzano%26aufirst%3DI.%2BD.%2BG.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DM.%2BC.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DLucas%26aufirst%3DB.%2BS.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DVissinga%26aufirst%3DC.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%2520and%2520in%2520vivo%2520evaluation%2520of%2520the%2520potent%2520and%2520selective%2520PI3K%25CE%25B4%2520inhibitors%25202-%2528%25281S%2529-1-%2528%25286-amino-5-cyano-4-pyrimidinyl%2529amino%2529ethyl%2529-6-fluoro-N-methyl-3-%25282-pyridinyl%2529-4-quinolinecarboxamide%2520%2528AM-0687%2529%2520and%25202-%2528%25281S%2529-1-%2528%25286-amino-5-cyano-4-pyrimidinyl%2529amino%2529ethyl%2529-5-fluoro-N-methyl-3-%25282-pyridinyl%2529-4-quinolinecarboxamide%2520%2528AM-1430%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7252%26epage%3D7267%26doi%3D10.1021%2Facs.jmedchem.6b00827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClory, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, A.</span></span> <span> </span><span class="NLM_article-title">The discovery and process chemistry development of GDC-0084, a brain penetrating inhibitor of PI3K and mTOR</span>. <i>ACS Symp. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1239</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1021/bk-2016-1239.ch006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bk-2016-1239.ch006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1239&publication_year=2016&pages=147-173&author=T.+P.+Heffronauthor=A.+McCloryauthor=A.+Stumpf&title=The+discovery+and+process+chemistry+development+of+GDC-0084%2C+a+brain+penetrating+inhibitor+of+PI3K+and+mTOR&doi=10.1021%2Fbk-2016-1239.ch006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and process chemistry development of GDC-0084, a brain penetrating inhibitor of PI3K and mTOR</span></div><div class="casAuthors">Heffron, Timothy P.; McClory, Andrew; Stumpf, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">ACS Symposium Series</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1239</span>
        (<span class="NLM_cas:issue">Comprehensive Accounts of Pharmaceutical Research and Development: From Discovery to Late-Stage Process Development, Volume 1</span>),
    <span class="NLM_cas:pages">147-173</span>CODEN:
                <span class="NLM_cas:coden">ACSMC8</span>;
        ISSN:<span class="NLM_cas:issn">0097-6156</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant signaling of the PI3K pathway has been implicated in the majority of cases of glioblastoma multiforme (GBM),a malignant brain tumor with an assocd. poor prognosis.In order for a PI3K/mTOR inhibitor to inhibit PI3K pathway signaling where GBM tumors reside, such mols. must be capable of penetrating the blood-brain barrier (BBB).  This chapter describes the medicinal chem. efforts that led to the discovery of GDC-0084, a BBB penetrating inhibitor of PI3K and mTOR, followed by the process chem. development that enabled its advancement to clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9WQRHVlURdrVg90H21EOLACvtfcHk0lhYDRp4KtfGsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislWmu7o%253D&md5=5a72c7a3576ec2bc840902befdd6c862</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbk-2016-1239.ch006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbk-2016-1239.ch006%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DMcClory%26aufirst%3DA.%26aulast%3DStumpf%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520and%2520process%2520chemistry%2520development%2520of%2520GDC-0084%252C%2520a%2520brain%2520penetrating%2520inhibitor%2520of%2520PI3K%2520and%2520mTOR%26jtitle%3DACS%2520Symp.%2520Ser.%26date%3D2016%26volume%3D1239%26spage%3D147%26epage%3D173%26doi%3D10.1021%2Fbk-2016-1239.ch006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchomel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duquette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vissinga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whoriskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span> <span> </span><span class="NLM_article-title">Discovery, optimization, and in vivo evaluation of benzimidazole derivatives AM-8508 and AM-9635 as potent and selective PI3Kδ inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01651</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=431-447&author=Y.+Shinauthor=J.+Suchomelauthor=M.+Cardozoauthor=J.+Duquetteauthor=X.+Heauthor=K.+Henneauthor=Y.-L.+Huauthor=R.+C.+Kellyauthor=J.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=T.+San+Miguelauthor=D.+Mohnauthor=T.+Tranauthor=C.+Vissingaauthor=S.+Wongauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=X.+Zhangauthor=T.+D.+Cushing&title=Discovery%2C+optimization%2C+and+in+vivo+evaluation+of+benzimidazole+derivatives+AM-8508+and+AM-9635+as+potent+and+selective+PI3K%CE%B4+inhibitors&doi=10.1021%2Facs.jmedchem.5b01651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors</span></div><div class="casAuthors">Shin, Youngsook; Suchomel, Julia; Cardozo, Mario; Duquette, Jason; He, Xiao; Henne, Kirk; Hu, Yi-Ling; Kelly, Ron C.; McCarter, John; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; San Miguel, Tisha; Mohn, Deanna; Tran, Thuy; Vissinga, Christine; Wong, Simon; Wannberg, Sharon; Whittington, Douglas A.; Whoriskey, John; Yu, Gang; Zalameda, Leeanne; Zhang, Xuxia; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">431-447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead optimization efforts resulted in the discovery of two potent, selective, and orally bioavailable PI3Kδ inhibitors, 1 (AM-8508) and 2 (AM-9635), with good pharmacokinetic properties.  The compds. inhibit B cell receptor (BCR)-mediated AKT phosphorylation (pAKT) in PI3Kδ-dependent in vitro cell based assays.  These compds. which share a benzimidazole bicycle are effective when administered in vivo at unbound concns. consistent with their in vitro cell potency as a consequence of improved unbound drug concn. with lower unbound clearance.  Furthermore, the compds. demonstrated efficacy in a Keyhole Limpet Hemocyanin (KLH) study in rats, where the blockade of PI3Kδ activity by inhibitors 1 and 2 led to effective inhibition of antigen-specific IgG and IgM formation after immunization with KLH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr81OyYoamY1rVg90H21EOLACvtfcHk0lhOmx043KTuKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP&md5=258ce4cf8c13cf799f342ebab3137264</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01651%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSuchomel%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DVissinga%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%252C%2520optimization%252C%2520and%2520in%2520vivo%2520evaluation%2520of%2520benzimidazole%2520derivatives%2520AM-8508%2520and%2520AM-9635%2520as%2520potent%2520and%2520selective%2520PI3K%25CE%25B4%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D431%26epage%3D447%26doi%3D10.1021%2Facs.jmedchem.5b01651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunsire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriskantharajah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montembault, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leemereise, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinanes-Garcia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsten, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessel, E. M.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2017.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.pupt.2017.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=28823947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKnsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=69-77&author=A.+Cahnauthor=J.+N.+Hamblinauthor=M.+Beggauthor=R.+Wilsonauthor=L.+Dunsireauthor=S.+Sriskantharajahauthor=M.+Montembaultauthor=C.+N.+Leemereiseauthor=L.+Galinanes-Garciaauthor=H.+Watzauthor=A.+M.+Kirstenauthor=R.+Fuhrauthor=E.+M.+Hessel&title=Safety%2C+pharmacokinetics+and+dose-response+characteristics+of+GSK2269557%2C+an+inhaled+PI3K%CE%B4+inhibitor+under+development+for+the+treatment+of+COPD&doi=10.1016%2Fj.pupt.2017.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD</span></div><div class="casAuthors">Cahn, A.; Hamblin, J. N.; Begg, M.; Wilson, R.; Dunsire, L.; Sriskantharajah, S.; Montembault, M.; Leemereise, C. N.; Galinanes-Garcia, L.; Watz, H.; Kirsten, A. M.; Fuhr, R.; Hessel, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-77</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">While current therapies reduce symptoms in chronic obstructive pulmonary disease (COPD) patients, substantial unmet need remains and novel treatments are highly desired.  Phosphoinositide 3-kinase δ (PI3Kδ) is a lipid kinase specifically expressed in leukocytes and involved in their recruitment and activation.  This study evaluated the safety, pharmacokinetics (PK) and dose-response characteristics of inhaled GSK2269557, a PI3Kδ inhibitor, in moderate-to-severe COPD patients with stable disease.  In this randomised, double-blind, placebo controlled, parallel group study, patients received once daily inhaled treatment with GSK2269557 1000 μg or placebo for 14 days (Part A, primary aim safety, N = 28 patients).  In part B of the study (primary aim pharmacodynamic dose-response, N = 36 patients), GSK2269557 100, 200, 500, 700, 1000, 2000 μg or placebo was given for 14 days.  In both Part A and B, GSK2269557 was added to the usual maintenance therapy.  Safety, PK assessments and induced sputum collection for cytokine anal. were conducted at baseline and after 7 and 14 days of treatment.  Adverse events (AEs) were monitored throughout.In Part A, mean age was 61.7 years (SD 6.7), 29% were females, and mean FEV1% predicted was 59.7% (SD 11.4)2.  In Part B, mean age was 63.3 years (SD 6.3), 44% were females, and mean FEV1% predicted was 56.5% (SD 11.5)2.  GSK2269557 was well tolerated in both parts of the study; the most commonly reported AEs were cough and headache, with cough being reported with a greater incidence in the GSK2269557 groups vs. placebo (Part A: 19% vs. 14% and Part B: range of 0-80% for different doses vs. 0% on placebo).  No drug-related serious AEs or clin. significant changes in any other safety parameters were reported.  GSK2269557 was rapidly absorbed into plasma following all doses with a max. peak at approx. 2 h.  Following repeat administration, accumulation in plasma was approx. 2-3 fold from Day 1 to Day 7.  At Day 14, relative to placebo, sputum interleukin (IL)-8 and IL-6 levels were reduced on av. by 32% and 29% resp. after inhalation of GSK2269557 1000 μg in Part A.  In Part B, although inhibition of both IL-8 and IL-6 levels was obsd., the levels were variable and there was insufficient evidence to support a monotonic dose-response.  In this study, inhaled GSK2269557 had an acceptable safety profile for progression into larger studies in COPD patients.  Moreover, inhalation of GSK2269557 resulted in suppression of sputum IL-8 and IL-6 levels, consistent with the known anti-inflammatory activity of a PI3Kδ inhibitor.  Inhibition of inflammatory cytokines in the airway compartment may contribute to the potential therapeutic benefit of a PI3Kδ inhibitor in chronically inflamed COPD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLev2M055yDLVg90H21EOLACvtfcHk0lhOmx043KTuKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKnsb7M&md5=bf5733fdf1e02f3804724f1a523c758b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2017.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2017.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DCahn%26aufirst%3DA.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DBegg%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DDunsire%26aufirst%3DL.%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DMontembault%26aufirst%3DM.%26aulast%3DLeemereise%26aufirst%3DC.%2BN.%26aulast%3DGalinanes-Garcia%26aufirst%3DL.%26aulast%3DWatz%26aufirst%3DH.%26aulast%3DKirsten%26aufirst%3DA.%2BM.%26aulast%3DFuhr%26aufirst%3DR.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520dose-response%2520characteristics%2520of%2520GSK2269557%252C%2520an%2520inhaled%2520PI3K%25CE%25B4%2520inhibitor%2520under%2520development%2520for%2520the%2520treatment%2520of%2520COPD%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2017%26volume%3D46%26spage%3D69%26epage%3D77%26doi%3D10.1016%2Fj.pupt.2017.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlahos, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matter, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. F.</span></span> <span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">5241</span>– <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0lhOmx043KTuKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gharbi, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghir, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timms, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterfield, M. D.</span></span> <span> </span><span class="NLM_article-title">Exploring the specificity of the PI3K family inhibitor LY294002</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>404</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1042/BJ20061489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1042%2FBJ20061489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=17302559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1ansr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=404&publication_year=2007&pages=15-21&author=S.+I.+Gharbiauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworthauthor=T.+Hancoxauthor=N.+Saghirauthor=J.+F.+Timmsauthor=M.+D.+Waterfield&title=Exploring+the+specificity+of+the+PI3K+family+inhibitor+LY294002&doi=10.1042%2FBJ20061489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the specificity of the PI3K family inhibitor LY294002</span></div><div class="casAuthors">Gharbi, Severine I.; Zvelebil, Marketa J.; Shuttleworth, Stephen J.; Hancox, Tim; Saghir, Nahid; Timms, John F.; Waterfield, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">404</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The PI3Ks (phosphatidylinositol 3-kinases) regulate cellular signalling networks that are involved in processes linked to the survival, growth, proliferation, metab. and specialized differentiated functions of cells.  The subversion of this network is common in cancer and has also been linked to disorders of inflammation.  The elucidation of the physiol. function of PI3K has come from pharmacol. studies, which use the enzyme inhibitors Wortmannin and LY294002, and from PI3K genetic knockout models of the effects of loss of PI3K function.  Several reports have shown that LY294002 is not exclusively selective for the PI3Ks, and could in fact act on other lipid kinases and addnl. apparently unrelated proteins.  Since this inhibitor still remains a drug of choice in numerous PI3K studies (over 500 in the last year), it is important to establish the precise specificity of this compd.  We report here the use of a chem. proteomic strategy in which an analog of LY294002, PI828, was immobilized onto epoxy-activated Sepharose beads.  This affinity material was then used as a bait to fish-out potential protein targets from cellular exts.  Proteins with high affinity for immobilized PI828 were sepd. by one-dimensional gel electrophoresis and identified by liq. chromatog.-tandem MS.  The present study reveals that LY294002 not only binds to class I PI3Ks and other PI3K-related kinases, but also to novel targets seemingly unrelated to the PI3K family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1XNfuEAyf97Vg90H21EOLACvtfcHk0lgoUUCeE0uQoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1ansr8%253D&md5=02996a8077f221689b6a6da0b111d3ae</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1042%2FBJ20061489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061489%26sid%3Dliteratum%253Aachs%26aulast%3DGharbi%26aufirst%3DS.%2BI.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DTimms%26aufirst%3DJ.%2BF.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DExploring%2520the%2520specificity%2520of%2520the%2520PI3K%2520family%2520inhibitor%2520LY294002%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D404%26spage%3D15%26epage%3D21%26doi%3D10.1042%2FBJ20061489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perisic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span> <span> </span><span class="NLM_article-title">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(05)00089-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2FS1097-2765%2805%2900089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=11090628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=909-919&author=E.+H.+Walkerauthor=M.+E.+Pacoldauthor=O.+Perisicauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=M.+P.+Wymannauthor=R.+L.+Williams&title=Structural+determinants+of+phosphoinositide+3-kinase+inhibition+by+wortmannin%2C+LY294002%2C+quercetin%2C+myricetin%2C+and+staurosporine&doi=10.1016%2FS1097-2765%2805%2900089-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span></div><div class="casAuthors">Walker, Edward H.; Pacold, Michael E.; Perisic, Olga; Stephens, Len; Hawkins, Philip T.; Wymann, Matthias P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The specific phosphoinositide 3-kinase (P13K) inhibitors wortmannin and LY294002 have been invaluable tools for elucidating the roles of these enzymes in signal transduction pathways.  The X-ray crystallog. structures of P13K bound to these lipid kinase inhibitors and to the broad-spectrum protein kinase inhibitors quercetin, myricetin, and staurosporine reveal how these compds. fit into the ATP binding pocket.  With a nanomolar IC50, wortmannin most closely fits and fills the active site and induces a conformational change in the catalytic domain.  Surprisingly, LY294002 and the lead compd. on which it was designed, quercetin, as well as the closely related flavonoid myricetin bind P13K in remarkably different orientations that are related to each other by 1800 rotations.  Staurosporine/P13K interactions are reminiscent of low-affinity protein kinase/staurosporine complexes.  These results provide a rich basis for development of isoform-specific P13K inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgIbTky2xQmbVg90H21EOLACvtfcHk0lgoUUCeE0uQoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D&md5=5dd92f9b48c437e43c0023fdff10c1ac</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900089-4%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%2BH.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructural%2520determinants%2520of%2520phosphoinositide%25203-kinase%2520inhibition%2520by%2520wortmannin%252C%2520LY294002%252C%2520quercetin%252C%2520myricetin%252C%2520and%2520staurosporine%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D909%26epage%3D919%26doi%3D10.1016%2FS1097-2765%2805%2900089-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudge, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koos, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidialingam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">mTOR kinase structure, mechanism and regulation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>497</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1038/nature12122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnature12122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=23636326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFyns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=217-224&author=H.+Yangauthor=D.+G.+Rudgeauthor=J.+D.+Koosauthor=B.+Vaidialingamauthor=H.+J.+Yangauthor=N.+P.+Pavletich&title=mTOR+kinase+structure%2C+mechanism+and+regulation&doi=10.1038%2Fnature12122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR kinase structure, mechanism and regulation</span></div><div class="casAuthors">Yang, Haijuan; Rudge, Derek G.; Koos, Joseph D.; Vaidialingam, Bhamini; Yang, Hyo J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7448</span>),
    <span class="NLM_cas:pages">217-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer.  Here we report co-crystal structures of a complex of truncated mTOR and mammalian lethal with SEC13 protein 8 (mLST8) with an ATP transition state mimic (MgF3-) and with ATP-site inhibitors (Torin2, PP242, and PI-103).  The structures reveal an intrinsically active kinase conformation, with catalytic residues and a catalytic mechanism remarkably similar to canonical protein kinases.  The active site is highly recessed owing to the FKBP12-rapamycin-binding (FRB) domain and an inhibitory helix protruding from the catalytic cleft.  MTOR-activating mutations map to the structural framework that holds these elements in place, indicating that the kinase is controlled by restricted access.  In vitro biochem. shows that the FRB domain acts as a gatekeeper, with its rapamycin-binding site interacting with substrates to grant them access to the restricted active site.  Rapamycin-FKBP12 inhibits the kinase by directly blocking substrate recruitment and by further restricting active-site access.  The structures also reveal active-site residues and conformational changes that underlie inhibitor potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjvPQtdm6yCbVg90H21EOLACvtfcHk0ljNmO8vOsVORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFyns7k%253D&md5=07809555fbdf2004819a7f2da5727baf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnature12122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12122%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DRudge%26aufirst%3DD.%2BG.%26aulast%3DKoos%26aufirst%3DJ.%2BD.%26aulast%3DVaidialingam%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DmTOR%2520kinase%2520structure%252C%2520mechanism%2520and%2520regulation%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D217%26epage%3D224%26doi%3D10.1038%2Fnature12122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döring, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drückes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köppler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbauer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1021/jm501557a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501557a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=443-456&author=F.+Muthauthor=M.+G%C3%BCntherauthor=S.+M.+Bauerauthor=E.+D%C3%B6ringauthor=S.+Fischerauthor=J.+Maierauthor=P.+Dr%C3%BCckesauthor=J.+K%C3%B6pplerauthor=J.+Trappeauthor=U.+Rothbauerauthor=P.+Kochauthor=S.+A.+Laufer&title=Tetra-substituted+pyridinylimidazoles+as+dual+inhibitors+of+p38%CE%B1+mitogen-activated+protein+kinase+and+c-Jun+N-terminal+kinase+3+for+potential+treatment+of+neurodegenerative+diseases&doi=10.1021%2Fjm501557a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases</span></div><div class="casAuthors">Muth, Felix; Guenther, Marcel; Bauer, Silke M.; Doering, Eva; Fischer, Sabine; Maier, Julia; Drueckes, Peter; Koeppler, Juergen; Trappe, Joerg; Rothbauer, Ulrich; Koch, Pierre; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">443-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tetra-substituted imidazoles were designed as dual inhibitors of c-Jun N-terminal kinase (JNK) 3 and p38α mitogen-activated protein (MAP) kinase.  A library of 45 derivs. was prepd. and evaluated in a kinase activity assay for their ability to inhibit both kinases, JNK3 and p38α MAP kinase.  Dual inhibitors with IC50 values down to the low double-digit nanomolar range at both enzymes were identified.  The best balanced dual JNK3/p38α MAP kinase inhibitors are I (IC50: JNK3, 18 nM; p38α, 30 nM) and II (IC50: JNK3, 26 nM; p38α, 34 nM) featuring both excellent soly. and metabolic stability.  They may serve as useful tool compds. for preclin. proof-of-principle studies in order to validate the synergistic role of both kinases in the progression of Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNwp_1AD67j7Vg90H21EOLACvtfcHk0ljNmO8vOsVORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ&md5=3b17ce2ed0396efcee28302d6f6910e7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm501557a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501557a%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DF.%26aulast%3DG%25C3%25BCnther%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DD%25C3%25B6ring%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DK%25C3%25B6ppler%26aufirst%3DJ.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRothbauer%26aufirst%3DU.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTetra-substituted%2520pyridinylimidazoles%2520as%2520dual%2520inhibitors%2520of%2520p38%25CE%25B1%2520mitogen-activated%2520protein%2520kinase%2520and%2520c-Jun%2520N-terminal%2520kinase%25203%2520for%2520potential%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D443%26epage%3D456%26doi%3D10.1021%2Fjm501557a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6746</span>– <span class="NLM_lpage">6754</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.bmc.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=25468038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=6746-6754&author=W.+Zhuauthor=C.+Sunauthor=S.+Xuauthor=C.+Wuauthor=J.+Wuauthor=M.+Xuauthor=H.+Zhaoauthor=L.+Chenauthor=W.+Zengauthor=P.+Zheng&title=Design%2C+synthesis%2C+anticancer+activity+and+docking+studies+of+novel+4-morpholino-7%2C8-dihydro-5H-thiopyrano%5B4%2C3-d%5Dpyrimidine+derivatives+as+mTOR+inhibitors&doi=10.1016%2Fj.bmc.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors</span></div><div class="casAuthors">Zhu, Wufu; Sun, Chengyu; Xu, Shan; Wu, Chunjiang; Wu, Jielian; Xu, Mengze; Zhao, He; Chen, Le; Zeng, Weipeng; Zheng, Pengwu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6746-6754</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivs. were designed, synthesized and their chem. structures were confirmed by 1H NMR, 13C NMR, MS and HRMS spectrum.  All the compds. were evaluated for the inhibitory activity against mTOR kinase at 10 μM level.  Five selected compds. were further evaluated for the inhibitory activity against PI3Kα at 10 μM level, and the IC50 values against mTOR kinase and two cancer cell lines.  Twelve of the target compds. exhibited moderate antitumor activities.  The most promising compd. I showed strong antitumor activities against mTOR kinase, H460 and PC-3 cell lines with IC50 values of 0.80 ± 0.15 μM, 7.43 ± 1.45 μM and 11.90 ± 0.94 μM, which were 1.28 to 1.71-fold more active than BMCL-200908069-1 (1.37 ± 0.07 μM, 9.52 ± 0.29 μM, 16.27 ± 0.54 μM), resp.  Structure-activity relationships (SARs) and docking studies indicated that the thiopyrano[4,3-d]pyrimidine scaffolds exerted little effect on antitumor activities of target compds.  Substitutions of the aryl group at the C-4 position had a significant impact on the antitumor activities, and 4-OH substitution produced the best potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQBsC6aipUe7Vg90H21EOLACvtfcHk0ljNmO8vOsVORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7zL&md5=bcf5b31e7aa3c7c4e87c8b8944e253d0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DDesign%252C%2520synthesis%252C%2520anticancer%2520activity%2520and%2520docking%2520studies%2520of%2520novel%25204-morpholino-7%252C8-dihydro-5H-thiopyrano%255B4%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D6746%26epage%3D6754%26doi%3D10.1016%2Fj.bmc.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, A.</span></span> <span> </span><span class="NLM_article-title">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5114</span>– <span class="NLM_lpage">5117</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.bmcl.2012.05.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=22765900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5114-5117&author=K.+K.-C.+Liuauthor=S.+Baileyauthor=D.+M.+Dinhauthor=H.+Lamauthor=C.+Liauthor=P.+A.+Wellsauthor=M.-J.+Yinauthor=A.+Zou&title=Conformationally-restricted+cyclic+sulfones+as+potent+and+selective+mTOR+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2012.05.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Liu, Kevin K.-C.; Bailey, Simon; Dinh, Dac M.; Lam, Hieu; Li, Chunze; Wells, Peter A.; Yin, Min-Jean; Zou, Aihua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5114-5117</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel conformationally-restricted mTOR kinase inhibitors with cyclic sulfone scaffold were designed.  Synthesis and structure-activity relationship (SAR) studies are described with emphasis on optimization of the mTOR potency and selectivity against class I PI3Kα kinase.  PF-05139962 I was identified with excellent mTOR biochem. inhibition, cellular potency, kinase selectivity and in vitro ADME properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmuwjN05w_4LVg90H21EOLACvtfcHk0lheRu7kaSGxyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D&md5=c1abe951c4d17f22a2301004eff55d91</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.104%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.-C.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DZou%26aufirst%3DA.%26atitle%3DConformationally-restricted%2520cyclic%2520sulfones%2520as%2520potent%2520and%2520selective%2520mTOR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5114%26epage%3D5117%26doi%3D10.1016%2Fj.bmcl.2012.05.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bochevarov, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braden, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halls, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences</span>. <i>Int. J. Quantum Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2142</span>, <span class="refDoi"> DOI: 10.1002/qua.24481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1002%2Fqua.24481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCqs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=2110-2142&author=A.+D.+Bochevarovauthor=E.+Harderauthor=T.+F.+Hughesauthor=J.+R.+Greenwoodauthor=D.+A.+Bradenauthor=D.+M.+Philippauthor=D.+Rinaldoauthor=M.+D.+Hallsauthor=J.+Zhangauthor=R.+A.+Friesner&title=Jaguar%3A+A+high-performance+quantum+chemistry+software+program+with+strengths+in+life+and+materials+sciences&doi=10.1002%2Fqua.24481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences</span></div><div class="casAuthors">Bochevarov, Art D.; Harder, Edward; Hughes, Thomas F.; Greenwood, Jeremy R.; Braden, Dale A.; Philipp, Dean M.; Rinaldo, David; Halls, Mathew D.; Zhang, Jing; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Quantum Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2110-2142</span>CODEN:
                <span class="NLM_cas:coden">IJQCB2</span>;
        ISSN:<span class="NLM_cas:issn">0020-7608</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Jaguar is an ab initio quantum chem. program that specializes in fast electronic structure predictions for mol. systems of medium and large size.  Jaguar focuses on computational methods with reasonable computational scaling with the size of the system, such as d. functional theory (DFT) and local second-order Moller-Plesset perturbation theory.  The favorable scaling of the methods and the high efficiency of the program make it possible to conduct routine computations involving several thousand MOs.  This performance is achieved through a utilization of the pseudospectral approxn. and several levels of parallelization.  The speed advantages are beneficial for applying Jaguar in biomol. computational modeling.  Addnl., owing to its superior wave function guess for transition-metal-contg. systems, Jaguar finds applications in inorg. and bioinorg. chem.  The emphasis on larger systems and transition metal elements paves the way toward developing Jaguar for its use in materials science modeling.  The article describes the historical and new features of Jaguar, such as improved parallelization of many modules, innovations in ab initio pKa prediction, and new semiempirical corrections for nondynamic correlation errors in DFT.  Jaguar applications in drug discovery, materials science, force field parameterization, and other areas of computational research are reviewed.  Timing benchmarks and other results obtained from the most recent Jaguar code are provided.  The article concludes with a discussion of challenges and directions for future development of the program. © 2013 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt_0dnCf0Yq7Vg90H21EOLACvtfcHk0lgdHAJncOltpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCqs7%252FP&md5=2fc119bb9e0501e55d7292f7735c24ea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fqua.24481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqua.24481%26sid%3Dliteratum%253Aachs%26aulast%3DBochevarov%26aufirst%3DA.%2BD.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DHughes%26aufirst%3DT.%2BF.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DBraden%26aufirst%3DD.%2BA.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRinaldo%26aufirst%3DD.%26aulast%3DHalls%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DJaguar%253A%2520A%2520high-performance%2520quantum%2520chemistry%2520software%2520program%2520with%2520strengths%2520in%2520life%2520and%2520materials%2520sciences%26jtitle%3DInt.%2520J.%2520Quantum%2520Chem.%26date%3D2013%26volume%3D113%26spage%3D2110%26epage%3D2142%26doi%3D10.1002%2Fqua.24481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodny, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: Importance of the morpholine ring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1021/jm501026z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501026z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=41-71&author=M.+Andrsauthor=J.+Korabecnyauthor=D.+Junauthor=Z.+Hodnyauthor=J.+Bartekauthor=K.+Kuca&title=Phosphatidylinositol+3-kinase+%28PI3K%29+and+phosphatidylinositol+3-kinase-related+kinase+%28PIKK%29+inhibitors%3A+Importance+of+the+morpholine+ring&doi=10.1021%2Fjm501026z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring</span></div><div class="casAuthors">Andrs, Martin; Korabecny, Jan; Jun, Daniel; Hodny, Zdenek; Bartek, Jiri; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-71</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein kinases (PIKKs) are two related families of kinases that play key roles in regulation of cell proliferation, metab., migration, survival, and responses to diverse stresses including DNA damage.  To design novel efficient strategies for treatment of cancer and other diseases, these kinases have been extensively studied.  Despite their different nature, these two kinase families have related origin and share very similar kinase domains.  Therefore, chem. inhibitors of these kinases usually carry analogous structural motifs.  The most common feature of these inhibitors is a crit. hydrogen bond to morpholine oxygen, initially present in the early nonspecific PI3K and PIKK inhibitor 3 (LY294002), which served as a valuable chem. tool for development of many addnl. PI3K and PIKK inhibitors.  While several PI3K pathway inhibitors have recently shown promising clin. responses, inhibitors of the DNA damage-related PIKKs remain thus far largely in preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPlvsq-HTebVg90H21EOLACvtfcHk0lgdHAJncOltpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzE&md5=a8c22f580691084554036dec7d0cc95b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501026z%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520%2528PI3K%2529%2520and%2520phosphatidylinositol%25203-kinase-related%2520kinase%2520%2528PIKK%2529%2520inhibitors%253A%2520Importance%2520of%2520the%2520morpholine%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D41%26epage%3D71%26doi%3D10.1021%2Fjm501026z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheijen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooijmans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toral-Barza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zask, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.bmcl.2009.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=19963384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=640-643&author=J.+Kaplanauthor=J.+C.+Verheijenauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+3%2C6-dihydro-2H-pyran+as+a+morpholine+replacement+in+6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+and+2-arylthieno%5B3%2C2-d%5Dpyrimidines%3A+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29&doi=10.1016%2Fj.bmcl.2009.11.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span></div><div class="casAuthors">Kaplan, Joshua; Verheijen, Jeroen C.; Brooijmans, Natasja; Toral-Barza, Lourdes; Hollander, Irwin; Yu, Ker; Zask, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">640-643</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The morpholine hinge-region binding group on a series of pyrazolopyrimidine and thienopyrimidine mammalian target of rapamycin (mTOR) inhibitors was replaced with 3,6-dihydro-2H-pyran (DHP), giving compds. of equiv. potency and selectivity vs. PI3K.  These results establish the DHP group as a hinge-region binding motif for the prepn. of highly potent and selective mTOR inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBTLsFT9FBubVg90H21EOLACvtfcHk0li7NqPiP2wupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE&md5=9398107e05207e302a8358103f31fb2f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25203%252C6-dihydro-2H-pyran%2520as%2520a%2520morpholine%2520replacement%2520in%25206-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520and%25202-arylthieno%255B3%252C2-d%255Dpyrimidines%253A%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D640%26epage%3D643%26doi%3D10.1016%2Fj.bmcl.2009.11.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0li7NqPiP2wupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Physicochemical descriptors of aromatic character and their use in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7215</span>, <span class="refDoi"> DOI: 10.1021/jm500515d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500515d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7206-7215&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=Physicochemical+descriptors+of+aromatic+character+and+their+use+in+drug+discovery&doi=10.1021%2Fjm500515d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical Descriptors of Aromatic Character and Their Use in Drug Discovery</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7206-7215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Published physicochem. descriptors of mols. that convey aromaticity-related character are reviewed in the context of drug design and discovery.  Studies that have employed arom. descriptors are discussed, and several descriptors are compared and contrasted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogc1vxNtUQl7Vg90H21EOLACvtfcHk0li7NqPiP2wupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wmsbw%253D&md5=7aca9f7309bb5dd806aeb4c2b4ff8eab</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm500515d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500515d%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DPhysicochemical%2520descriptors%2520of%2520aromatic%2520character%2520and%2520their%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7206%26epage%3D7215%26doi%3D10.1021%2Fjm500515d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhu8wjMv_mVPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland 2: complexity and promiscuity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1039/c2md20347b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1039%2Fc2md20347b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=515-519&author=F.+Lovering&title=Escape+from+Flatland+2%3A+complexity+and+promiscuity&doi=10.1039%2Fc2md20347b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland 2: complexity and promiscuity</span></div><div class="casAuthors">Lovering, Frank</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-519</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Toxicity plays a major role in attrition in the clinic and promiscuity has been linked to toxicity.  A no. of mol. descriptors have been identified that contribute to promiscuity including ionization and logP.  In this study we report on the relationship between complexity, as measured by two descriptors [fraction sp3 (Fsp3) where Fsp3 = (no. of sp3 hybridized carbons/total carbon count) and chiral carbon count], and promiscuity as well as Cyp450 inhibition.  We find that increasing complexity reduces promiscuity and Cyp450 inhibition.  As an understanding of key property descriptors has helped the pharmaceutical industry to address some of the deficiencies of compds. as pertains to bioavailability, awareness of the descriptors that impact promiscuity should allow us to better address toxicity in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJfDH0430P-bVg90H21EOLACvtfcHk0lhu8wjMv_mVPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D&md5=c03d3b99da22a684cbbbb00fb1633342</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fc2md20347b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20347b%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26atitle%3DEscape%2520from%2520Flatland%25202%253A%2520complexity%2520and%2520promiscuity%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D515%26epage%3D519%26doi%3D10.1039%2Fc2md20347b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. J.</span></span> <span> </span><span class="NLM_article-title">Protonated cyclopropanes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/cr60260a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr60260a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADyaF1MXkvFSnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1969&pages=543-550&author=C.+J.+Collins&title=Protonated+cyclopropanes&doi=10.1021%2Fcr60260a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Protonated cyclopropanes</span></div><div class="casAuthors">Collins, Clair Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-50</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review and interpretation of the data with 33 references.  The existence of protonated cyclopropane intermediates is confirmed.  None of the data demands either a methyl-bridged ion or a face-protonated structure; some expts. require an edge-protonated intermediate.  In the case of the norbornyl cation, the face-protonated structure is excluded, and also the edge-protonated intermediates, at least as the sole cations involved in promoting hydride shift.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpikTawTqWZ3LVg90H21EOLACvtfcHk0lhu8wjMv_mVPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvFSnsbY%253D&md5=35628ed28b78a212d822244ae039280f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr60260a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60260a004%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DC.%2BJ.%26atitle%3DProtonated%2520cyclopropanes%26jtitle%3DChem.%2520Rev.%26date%3D1969%26volume%3D69%26spage%3D543%26epage%3D550%26doi%3D10.1021%2Fcr60260a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorko, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hencher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. H.</span></span> <span> </span><span class="NLM_article-title">The molecular structure of trimethylenecyclopropane</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2425</span>– <span class="NLM_lpage">2434</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)82515-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2FS0040-4020%2801%2982515-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADyaF1cXptVOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1968&pages=2425-2434&author=E.+A.+Dorkoauthor=J.+L.+Hencherauthor=S.+H.+Bauer&title=The+molecular+structure+of+trimethylenecyclopropane&doi=10.1016%2FS0040-4020%2801%2982515-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular structure of trimethylenecyclopropane</span></div><div class="casAuthors">Dorko, Ernest A.; Hencher, J. L.; Bauer, Simon Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2425-34</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The mol. structure of trimethylenecyclopropane has been detd. from electron diffraction data obtained on the vapor.  Planarity of the mol. was assumed and shrinkages were calcd. from the evaluated nonbonded C-C distances.  The geometric parameters calcd. by least sqs. from the mol. intensity are: C:C = 1.343 ± 0.02; C-C = 1.453 ± 0.02; C-H = 1.108 ± 0.015 A.; angle CCH = 121.8 ± 2°.  The calcd. shrinkages are: δC1C6 = 0.009; δC2C6 = 0.028 A.  The uncertainties quoted for the distances are twice the calcd. standard deviations.  A variation of Walsh's model for the bonding in cyclopropane is proposed, to account for reported differences in bond lengths between trimethylenecyclopropane and several related mols.  The structural data suggest that delocalization is present in these 3-member rings.  30 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpScVMRaYKgy7Vg90H21EOLACvtfcHk0lhyd3TPQ4IErA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXptVOjtQ%253D%253D&md5=08f0c6cb1bfe037792fca98b7cf82401</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2982515-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252982515-1%26sid%3Dliteratum%253Aachs%26aulast%3DDorko%26aufirst%3DE.%2BA.%26aulast%3DHencher%26aufirst%3DJ.%2BL.%26aulast%3DBauer%26aufirst%3DS.%2BH.%26atitle%3DThe%2520molecular%2520structure%2520of%2520trimethylenecyclopropane%26jtitle%3DTetrahedron%26date%3D1968%26volume%3D24%26spage%3D2425%26epage%3D2434%26doi%3D10.1016%2FS0040-4020%2801%2982515-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Meijere, A.</span></span> <span> </span><span class="NLM_article-title">Bonding properties of cyclopropane and their chemical consequences</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1002/anie.197908093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1002%2Fanie.197908093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=809-826&author=A.+de%0AMeijere&title=Bonding+properties+of+cyclopropane+and+their+chemical+consequences&doi=10.1002%2Fanie.197908093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fanie.197908093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197908093%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMeijere%26aufirst%3DA.%26atitle%3DBonding%2520properties%2520of%2520cyclopropane%2520and%2520their%2520chemical%2520consequences%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1979%26volume%3D18%26spage%3D809%26epage%3D826%26doi%3D10.1002%2Fanie.197908093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span> <i>Molecular Operating
Environment (MOE)</i>; <span class="NLM_publisher-name">Chemical Computing Group,
University of Sherbrooke</span>: <span class="NLM_publisher-loc">1010 Sherbooke
St. West, Suite #910, Montreal, QC,
Canada, H3A 2R7</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment+%28MOE%29%3B+Chemical+Computing+Group%2C%0AUniversity+of+Sherbrooke%3A+1010+Sherbooke%0ASt.+West%2C+Suite+%23910%2C+Montreal%2C+QC%2C%0ACanada%2C+H3A+2R7%2C+2019."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%252C%250AUniversity%2520of%2520Sherbrooke%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span>; <span class="NLM_string-name">Hobbs, H.</span>; <span class="NLM_string-name">Jamieson, C.</span>; <span class="NLM_string-name">Kennedy, A. R.</span>; <span class="NLM_string-name">Pal, S.</span>; <span class="NLM_string-name">Peace, S.</span>; <span class="NLM_string-name">Pogany, P.</span>; <span class="NLM_string-name">Upton, R.</span>; <span class="NLM_string-name">Summers, D.</span></span> <span> </span><span class="NLM_article-title">A theoretical and experimental investigation into the conformational bias of aryl cyclopropylpyrans, novel biosteres for <i>N</i>-aryl morpholines</span>, <span class="NLM_year">2018</span>, manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+A.+Convery&author=H.+Hobbs&author=C.+Jamieson&author=A.+R.+Kennedy&author=S.+Pal&author=S.+Peace&author=P.+Pogany&author=R.+Upton&author=D.+Summers&title=A+theoretical+and+experimental+investigation+into+the+conformational+bias+of+aryl+cyclopropylpyrans%2C+novel+biosteres+for+N-aryl+morpholines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DConvery%26aufirst%3DM.%2BA.%26atitle%3DA%2520theoretical%2520and%2520experimental%2520investigation%2520into%2520the%2520conformational%2520bias%2520of%2520aryl%2520cyclopropylpyrans%252C%2520novel%2520biosteres%2520for%2520N-aryl%2520morpholines%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smerdon, S. J.</span></span> <span> </span><span class="NLM_article-title">A year in structural signaling: mTOR—The PIKK of the bunch?</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">pe6</span>– <span class="NLM_lpage">pe6</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2005174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1126%2Fscisignal.2005174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=24595107" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=pe6-pe6&author=S.+J.+Smerdon&title=A+year+in+structural+signaling%3A+mTOR%E2%80%94The+PIKK+of+the+bunch%3F&doi=10.1126%2Fscisignal.2005174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2005174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2005174%26sid%3Dliteratum%253Aachs%26aulast%3DSmerdon%26aufirst%3DS.%2BJ.%26atitle%3DA%2520year%2520in%2520structural%2520signaling%253A%2520mTOR%25E2%2580%2594The%2520PIKK%2520of%2520the%2520bunch%253F%26jtitle%3DSci.%2520Signaling%26date%3D2014%26volume%3D7%26spage%3Dpe6%26epage%3Dpe6%26doi%3D10.1126%2Fscisignal.2005174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. N.</span></span> <span> </span><span class="NLM_article-title">mTOR in aging, metabolism, and cancer</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2012.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.gde.2012.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=23317514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosF2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=53-62&author=M.+Cornuauthor=V.+Albertauthor=M.+N.+Hall&title=mTOR+in+aging%2C+metabolism%2C+and+cancer&doi=10.1016%2Fj.gde.2012.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR in aging, metabolism, and cancer</span></div><div class="casAuthors">Cornu, Marion; Albert, Verena; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The target of rapamycin (TOR) is a highly conserved serine/threonine kinase that is part of two structurally and functionally distinct complexes, TORC1 and TORC2.  In multicellular organisms, TOR regulates cell growth and metab. in response to nutrients, growth factors and cellular energy.  Deregulation of TOR signaling alters whole body metab. and causes age-related disease.  This review describes the most recent advances in TOR signaling with a particular focus on mammalian TOR (mTOR) in metabolic tissues vis-a-vis aging, obesity, type 2 diabetes, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgrTlg2UvYbVg90H21EOLACvtfcHk0lhyd3TPQ4IErA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosF2ntg%253D%253D&md5=674a12eb04fa17883aa593edc3ea5057</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2012.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2012.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCornu%26aufirst%3DM.%26aulast%3DAlbert%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DmTOR%2520in%2520aging%252C%2520metabolism%252C%2520and%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2013%26volume%3D23%26spage%3D53%26epage%3D62%26doi%3D10.1016%2Fj.gde.2012.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoncu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efeyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">mTOR: from growth signal integration to cancer, diabetes and ageing</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1038/nrm3025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnrm3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=21157483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=21-35&author=R.+Zoncuauthor=A.+Efeyanauthor=D.+M.+Sabatini&title=mTOR%3A+from+growth+signal+integration+to+cancer%2C+diabetes+and+ageing&doi=10.1038%2Fnrm3025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR: from growth signal integration to cancer, diabetes and ageing</span></div><div class="casAuthors">Zoncu, Roberto; Efeyan, Alejo; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-35</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors.  Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt.  In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfHzFJues0NLVg90H21EOLACvtfcHk0ljrGdvQcmpojQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK&md5=3631307dc34df2ecc2eb79900c10b74c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrm3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3025%26sid%3Dliteratum%253Aachs%26aulast%3DZoncu%26aufirst%3DR.%26aulast%3DEfeyan%26aufirst%3DA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DmTOR%253A%2520from%2520growth%2520signal%2520integration%2520to%2520cancer%252C%2520diabetes%2520and%2520ageing%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D21%26epage%3D35%26doi%3D10.1038%2Fnrm3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nho, R.</span></span> <span> </span><span class="NLM_article-title">The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">778</span>, <span class="refDoi"> DOI: 10.3390/ijms19030778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.3390%2Fijms19030778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOnt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=778&author=J.+Lawrenceauthor=R.+Nho&title=The+role+of+the+mammalian+target+of+rapamycin+%28mTOR%29+in+pulmonary+fibrosis&doi=10.3390%2Fijms19030778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis</span></div><div class="casAuthors">Lawrence, Jessica; Nho, Richard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">778/1-778/31</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)-dependent pathway is one of the most integral pathways linked to cell metab., proliferation, differentiation, and survival.  This pathway is dysregulated in a variety of diseases, including neoplasia, immune-mediated diseases, and fibroproliferative diseases such as pulmonary fibrosis.  The mTOR kinase is frequently referred to as the master regulator of this pathway.  Alterations in mTOR signaling are closely assocd. with dysregulation of autophagy, inflammation, and cell growth and survival, leading to the development of lung fibrosis.  Inhibitors of mTOR have been widely studied in cancer therapy, as they may sensitize cancer cells to radiation therapy.  Studies also suggest that mTOR inhibitors are promising modulators of fibroproliferative diseases such as idiopathic pulmonary fibrosis (IPF) and radiation-induced pulmonary fibrosis (RIPF).  Therefore, mTOR represents an attractive and unique therapeutic target in pulmonary fibrosis.  In this review, we discuss the pathol. role of mTOR kinase in pulmonary fibrosis and examine how mTOR inhibitors may mitigate fibrotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLdBqLwSUL7Vg90H21EOLACvtfcHk0ljrGdvQcmpojQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOnt7zE&md5=a4b2c61ccf4a181fd74c4f13d1c30596</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fijms19030778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19030778%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DJ.%26aulast%3DNho%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520in%2520pulmonary%2520fibrosis%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D778%26doi%3D10.3390%2Fijms19030778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holroyd, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michie, A. M.</span></span> <span> </span><span class="NLM_article-title">The role of mTOR-mediated signaling in the regulation of cellular migration</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2018.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.imlet.2018.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29408410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2018&pages=74-79&author=A.+K.+Holroydauthor=A.+M.+Michie&title=The+role+of+mTOR-mediated+signaling+in+the+regulation+of+cellular+migration&doi=10.1016%2Fj.imlet.2018.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mTOR-mediated signaling in the regulation of cellular migration</span></div><div class="casAuthors">Holroyd, Ailsa K.; Michie, Alison M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mechanistic target for rapamycin (mTOR) is a serine/threonine protein kinase that forms two distinct complexes mTORC1 and mTORC2, integrating mitogen and nutrient signals to regulate cell survival and proliferation; processes which are commonly deregulated in human cancers.  MTORC1 and mTORC2 have divergent mol. assocns. and cellular functions: mTORC1 regulates in mRNA translation and protein synthesis, while mTORC2 is involved in the regulation of cellular survival and metab.  Through AKT phosphorylation/activation, mTORC2 has also been reported to regulate cell migration.  Recent attention has focused on the aberrant activation of the PI3K/mTOR pathway in B cell malignancies and there is growing evidence for its involvement in disease pathogenesis, due to its location downstream of other established novel drug targets that intercept B cell receptor (BCR) signals.  Shared pharmacol. features of BCR signal inhibitors include a striking "lymphocyte redistribution" effect whereby patients experience a sharp increase in lymphocyte count on initiation of therapy followed by a steady decline.  Chronic lymphocytic leukemia (CLL) serves as a paradigm for migration studies as lymphocytes are among the most widely travelled cells in the body, a product of their role in immunol. surveillance.  The subversion of normal lymphocyte movement in CLL is being elucidated; this review aims to describe the migration impairment which occurs as part of the wider context of cancer cell migration defects, with a focus on the role of mTOR in mediating migration effects downstream of BCR ligation and other microenvironmental signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcvLP5NpDTYrVg90H21EOLACvtfcHk0ljrGdvQcmpojQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVeqsbg%253D&md5=1aeba89015fcf2e4e34a02169b1caab0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2018.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DHolroyd%26aufirst%3DA.%2BK.%26aulast%3DMichie%26aufirst%3DA.%2BM.%26atitle%3DThe%2520role%2520of%2520mTOR-mediated%2520signaling%2520in%2520the%2520regulation%2520of%2520cellular%2520migration%26jtitle%3DImmunol.%2520Lett.%26date%3D2018%26volume%3D196%26spage%3D74%26epage%3D79%26doi%3D10.1016%2Fj.imlet.2018.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quek, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavin, M. F</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. L</span></span> <span> </span><span class="NLM_article-title">PIKKing a way to regulate inflammation</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1111/imcb.1001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1111%2Fimcb.1001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29359354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2018&pages=8-20&author=H.+Quekauthor=Y.+C.+Limauthor=M.+F+Lavinauthor=T.+L+Roberts&title=PIKKing+a+way+to+regulate+inflammation&doi=10.1111%2Fimcb.1001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">PIKKing a way to regulate inflammation</span></div><div class="casAuthors">Quek, Hazel; Lim, Yi Chieh; Lavin, Martin F.; Roberts, Tara L.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-20</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">1440-1711</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Australia, Ltd.</span>)
        </div><div class="casAbstract">The phosphoinositide-3-kinase like kinases are a family of very large protein kinases.  These PI3-kinase like kinase (PIKK) proteins have well-established roles in detection and repair of damage to the genome, regulation of the transcriptome and cellular metab.  Recently there has emerged, evidence for links between these proteins and inflammation.  While some of these links come from an increased understanding of the impacts of damage to the cell on inflammatory responses, others suggest that PIKK proteins also have direct roles in regulation of immune responses.  Particularly evident is the link between DNA damage and innate immune response pathways.  Here, we review recent findings on the PIKK family of proteins and how they impact on inflammation, particularly activation of the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7h-dNfAS2U7Vg90H21EOLACvtfcHk0lgIYBKVAxCFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb8%253D&md5=d362c6dbf38cb62ee44a0fcb3b4830cc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fimcb.1001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimcb.1001%26sid%3Dliteratum%253Aachs%26aulast%3DQuek%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DY.%2BC.%26aulast%3DLavin%26aufirst%3DM.%2BF%26aulast%3DRoberts%26aufirst%3DT.%2BL%26atitle%3DPIKKing%2520a%2520way%2520to%2520regulate%2520inflammation%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2018%26volume%3D96%26spage%3D8%26epage%3D20%26doi%3D10.1111%2Fimcb.1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">Twenty-five years of mTOR: Uncovering the link from nutrients to growth</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">11818</span>– <span class="NLM_lpage">11825</span>, <span class="refDoi"> DOI: 10.1073/pnas.1716173114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1073%2Fpnas.1716173114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29078414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=11818-11825&author=D.+M.+Sabatini&title=Twenty-five+years+of+mTOR%3A+Uncovering+the+link+from+nutrients+to+growth&doi=10.1073%2Fpnas.1716173114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty-five years of mTOR: Uncovering the link from nutrients to growth</span></div><div class="casAuthors">Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11818-11825</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  In my PNAS Inaugural Article, I describe the development of the mTOR field, starting with efforts to understand the mechanism of action of the drug rapamycin, which ∼25 y ago led to the discovery of the mTOR protein kinase.  I focus on insights that we have contributed and on work that has been particularly influential to me, as well as provide some personal reflections and stories.  We now appreciate that, as part of two distinct complexes, mTORC1 and mTORC2, mTOR is the major regulator of growth (mass accumulation) in animals and is the key link between the availability of nutrients in the environment and the control of most anabolic and catabolic processes.  Nutrients signal to mTORC1 through the lysosome-assocd. Rag GTPases and their many regulators and assocd. cytosolic and lysosomal nutrient sensors.  MTOR signaling is deregulated in common diseases, like cancer and epilepsy, and mTORC1 is a well-validated modulator of aging in multiple model organisms.  There is significant excitement around using mTORC1 inhibitors to treat cancer and neurol. disease and, potentially, to improve healthspan and lifespan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDmRqhnDPEJrVg90H21EOLACvtfcHk0lgIYBKVAxCFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrsbfF&md5=feb38ce2f2314a76f8838828be4d38db</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1716173114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1716173114%26sid%3Dliteratum%253Aachs%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DTwenty-five%2520years%2520of%2520mTOR%253A%2520Uncovering%2520the%2520link%2520from%2520nutrients%2520to%2520growth%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D11818%26epage%3D11825%26doi%3D10.1073%2Fpnas.1716173114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeritt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culshaw, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3147: A potent, selective dual inhibitor of mTORC1 and mTORC2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2326</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1021/jm501778s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501778s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2326-2349&author=K.+G.+Pikeauthor=J.+Morrisauthor=L.+Rustonauthor=S.+L.+Passauthor=R.+Greenwoodauthor=E.+J.+Williamsauthor=J.+Demerittauthor=J.+D.+Culshawauthor=K.+Gillauthor=M.+Passauthor=M.+R.+V.+Finlayauthor=C.+J.+Goodauthor=C.+A.+Robertsauthor=G.+S.+Currieauthor=K.+Bladesauthor=J.+M.+Edenauthor=S.+E.+Pearson&title=Discovery+of+AZD3147%3A+A+potent%2C+selective+dual+inhibitor+of+mTORC1+and+mTORC2&doi=10.1021%2Fjm501778s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2</span></div><div class="casAuthors">Pike, Kurt G.; Morris, Jeff; Ruston, Linette; Pass, Sarah L.; Greenwood, Ryan; Williams, Emma J.; Demeritt, Julie; Culshaw, Janet D.; Gill, Kristy; Pass, Martin; Finlay, M. Raymond V.; Good, Catherine J.; Roberts, Craig A.; Currie, Gordon S.; Blades, Kevin; Eden, Jonathan M.; Pearson, Stuart E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2326-2349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High throughput screening followed by a lead generation campaign uncovered a novel series of urea contg. morpholinopyrimidine compds. which act as potent and selective dual inhibitors of mTORC1 and mTORC2.  The authors describe the continued compd. optimization campaign for this series, in particular focused on identifying compds. with improved cellular potency, improved aq. soly., and good stability in human hepatocyte incubations.  Knowledge from empirical SAR investigations was combined with an understanding of the mol. interactions in the crystal lattice to improve both cellular potency and soly., and the composite parameters of LLE and pIC50-pSoly. were used to assess compd. quality and progress.  Predictive models were employed to efficiently mine the attractive chem. space identified resulting in the discovery of I (AZD3147), an extremely potent and selective dual inhibitor of mTORC1 and mTORC2 with physicochem. and pharmacokinetic properties suitable for development as a potential clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVFrPEX3khBbVg90H21EOLACvtfcHk0lgIYBKVAxCFYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D&md5=92d9596bf3c160bcde73fd9c586d6b84</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm501778s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501778s%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DPass%26aufirst%3DS.%2BL.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DDemeritt%26aufirst%3DJ.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DGill%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DGood%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DPearson%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520AZD3147%253A%2520A%2520potent%252C%2520selective%2520dual%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2326%26epage%3D2349%26doi%3D10.1021%2Fjm501778s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foote, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odedra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suleman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thommes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadhurst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2125</span>– <span class="NLM_lpage">2138</span>, <span class="refDoi"> DOI: 10.1021/jm301859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2125-2138&author=K.+M.+Footeauthor=K.+Bladesauthor=A.+Croninauthor=S.+Filleryauthor=S.+S.+Guichardauthor=L.+Hassallauthor=I.+Hicksonauthor=X.+Jacqauthor=P.+J.+Jewsburyauthor=T.+M.+McGuireauthor=J.+W.+M.+Nissinkauthor=R.+Odedraauthor=K.+Pageauthor=P.+Perkinsauthor=A.+Sulemanauthor=K.+Tamauthor=P.+Thommesauthor=R.+Broadhurstauthor=C.+Wood&title=Discovery+of+4-%7B4-%5B%283R%29-3-methylmorpholin-4-yl%5D-6-%5B1-%28methylsulfonyl%29cyclopropyl%5Dpyrimidin-2-yl%7D-1H-indole+%28AZ20%29%3A+A+potent+and+selective+inhibitor+of+ATR+protein+kinase+with+monotherapy+in+vivo+antitumor+activity&doi=10.1021%2Fjm301859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity</span></div><div class="casAuthors">Foote, Kevin M.; Blades, Kevin; Cronin, Anna; Fillery, Shaun; Guichard, Sylvie S.; Hassall, Lorraine; Hickson, Ian; Jacq, Xavier; Jewsbury, Philip J.; McGuire, Thomas M.; Nissink, J. Willem M.; Odedra, Rajesh; Page, Ken; Perkins, Paula; Suleman, Abid; Tam, Kin; Thommes, Pia; Broadhurst, Rebecca; Wood, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2125-2138</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ATR is an attractive new anticancer drug target whose inhibitors have potential as chemo- or radiation sensitizers or as monotherapy in tumors addicted to particular DNA-repair pathways.  We describe the discovery and synthesis of a series of sulfonylmorpholinopyrimidines that show potent and selective ATR inhibition.  Optimization from a high quality screening hit within tight SAR space led to compd. I (AZ20) which inhibits ATR immunopptd. from HeLa nuclear exts. with an IC50 of 5 nM and ATR mediated phosphorylation of Chk1 in HT29 colorectal adenocarcinoma tumor cells with an IC50 of 50 nM.  Compd. I potently inhibits the growth of LoVo colorectal adenocarcinoma tumor cells in vitro and has high free exposure in mouse following moderate oral doses.  At well tolerated doses I leads to significant growth inhibition of LoVo xenografts grown in nude mice.  Compd. I is a useful compd. to explore ATR pharmacol. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpY5_RVxXl9LVg90H21EOLACvtfcHk0lje6D0rsclFiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsr0%253D&md5=60d2f6fe78e2b82695198b9cba930ae7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm301859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301859s%26sid%3Dliteratum%253Aachs%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DCronin%26aufirst%3DA.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DGuichard%26aufirst%3DS.%2BS.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSuleman%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DK.%26aulast%3DThommes%26aufirst%3DP.%26aulast%3DBroadhurst%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25204-%257B4-%255B%25283R%2529-3-methylmorpholin-4-yl%255D-6-%255B1-%2528methylsulfonyl%2529cyclopropyl%255Dpyrimidin-2-yl%257D-1H-indole%2520%2528AZ20%2529%253A%2520A%2520potent%2520and%2520selective%2520inhibitor%2520of%2520ATR%2520protein%2520kinase%2520with%2520monotherapy%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2125%26epage%3D2138%26doi%3D10.1021%2Fjm301859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3437</span>– <span class="NLM_lpage">3440</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)95429-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2FS0040-4039%2801%2995429-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1979&pages=3437-3440&author=N.+Miyauraauthor=K.+Yamadaauthor=A.+Suzuki&title=A+new+stereospecific+cross-coupling+by+the+palladium-catalyzed+reaction+of+1-alkenylboranes+with+1-alkenyl+or+1-alkynyl+halides&doi=10.1016%2FS0040-4039%2801%2995429-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2995429-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252995429-2%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DA%2520new%2520stereospecific%2520cross-coupling%2520by%2520the%2520palladium-catalyzed%2520reaction%2520of%25201-alkenylboranes%2520with%25201-alkenyl%2520or%25201-alkynyl%2520halides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1979%26volume%3D20%26spage%3D3437%26epage%3D3440%26doi%3D10.1016%2FS0040-4039%2801%2995429-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gujral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riyal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gahlot, V.</span></span> <span> </span><span class="NLM_article-title">Suzuki cross coupling reaction-a review</span>. <i>Indo Glob. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=351-367&author=S.+Gujralauthor=S.+Khatriauthor=P.+Riyalauthor=V.+Gahlot&title=Suzuki+cross+coupling+reaction-a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGujral%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DS.%26aulast%3DRiyal%26aufirst%3DP.%26aulast%3DGahlot%26aufirst%3DV.%26atitle%3DSuzuki%2520cross%2520coupling%2520reaction-a%2520review%26jtitle%3DIndo%2520Glob.%2520J.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D2%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elena Lenci, Lorenzo Calugi, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Occurrence of Morpholine in Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 378-390. <a href="https://doi.org/10.1021/acschemneuro.0c00729" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00729%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DOccurrence%252Bof%252BMorpholine%252Bin%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DLenci%26aufirst%3DElena%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13112020%26date%3D11012021%26date%3D18012021%26volume%3D12%26issue%3D3%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Nelson</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Whitehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Put a ring on it: application of small aliphatic rings in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 448-471. <a href="https://doi.org/10.1039/D0MD00370K" title="DOI URL">https://doi.org/10.1039/D0MD00370K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00370K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00370K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPut%252Ba%252Bring%252Bon%252Bit%25253A%252Bapplication%252Bof%252Bsmall%252Baliphatic%252Brings%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D448%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Yu</span>, <span class="hlFld-ContribAuthor ">Minghui  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhaoping  Pan</span>, <span class="hlFld-ContribAuthor ">Fengbo  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Guo</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel akt1 inhibitor induces autophagy associated death in hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112076. <a href="https://doi.org/10.1016/j.ejmech.2020.112076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bakt1%252Binhibitor%252Binduces%252Bautophagy%252Bassociated%252Bdeath%252Bin%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DYu%26aufirst%3DMeng%26date%3D2020%26volume%3D189%26spage%3D112076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of LY294002 <b>1</b>, quercetin <b>2</b>, and PI-103 <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (left) Energy minimized structure of 4-(pyrimidin-4-yl)morpholine (<b>A</b>) using DFT. (right) Energy scanning plot of CNcn dihedral bond angle of <b>A</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dihydropyran pyrimidine (<b>B</b>), tetrahydropyran pyrimidine (<b>C</b>), and CPP pyrimidine (<b>D</b>). Energy minimized structures using MMFF94X force field in MOE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dihedral scanning plots for various pyrimidine fragments using DFT/6-31G**.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) QM predicted structure using DFT/6-31G**. (b) Small molecule crystal structure of <b>12b</b> (CCDC 1864315, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf" class="ext-link">Supporting Information</a>). (c) A potential binding mode of <b>12b</b> which is consistent with a low occupancy cocrystal structure in PI3Kδ (not deposited).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. MMP comparisons of morpholine, 3<i>S</i>-methylmorpholine, and 1<i>S</i>,6<i>R</i> CPP analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1a" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0007.jpeg" id="rightTab-GRAPHIC-d7e2642-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a) General Synthesis of Parent Morpholines <b>5</b>, <b>6</b>, <b>7</b>, and <b>8</b>; (b) General Synthesis of Dihydropyrans <b>9</b> & <b>10</b>, Terahydropyran <b>11</b>, and Cyclopropylpyrans <b>12</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch1a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) (<i>S</i>)-3-methylmorpholine, DIPEA rt; (b) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h; (c) Pd/C 5%, CH<sub>3</sub>CO<sub>2</sub>H, HCl/Zn 50 °C, 4 h, * chiral SFC; (d) Me<sub>3</sub>SO, NaH, DMSO, 65 °C, 4 h.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthesis of Compounds <b>14</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Intermediate <b>G</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Et<sub>2</sub>Zn, CH<sub>2</sub>Cll, fluorobenzene, −5 °C, multiple additions, rt 16 h; (b) KF/H<sub>2</sub>O, MeCN/MeOH, 2(2<i>R</i>,3<i>R</i>)-2,3-dihydroxysuccinic acid, THF rt.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Synthesis of Compounds <b>21</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h; (b) intermediate <b>G</b>, PdCl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, toluene:water 10:1, 110 °C, 15 h; * Chiral separation</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/medium/jm-2019-00348p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>29a</b> and <b>29b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.9b00348/20190801/images/large/jm-2019-00348p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00348&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) borolane, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, 2-propanol:water 5:1, 110 °C, 2 h; (b) 1,1′-thiocarbonyldiimidazole, DCM rt 4 h then ethanolamine 0 °C to rt 18 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yap, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bono, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2008.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-412&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynaudauthor=J.+S.+de+Bonoauthor=P.+Workman&title=Targeting+the+PI3K%E2%80%93AKT%E2%80%93mTOR+pathway%3A+progress%2C+pitfalls%2C+and+promises&doi=10.1016%2Fj.coph.2008.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0lh5D8fx2q0Pgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K%25E2%2580%2593AKT%25E2%2580%2593mTOR%2520pathway%253A%2520progress%252C%2520pitfalls%252C%2520and%2520promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D412%26doi%3D10.1016%2Fj.coph.2008.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1038/nrd2926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer&doi=10.1038%2Fnrd2926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lgQglNrH7QwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644%26doi%3D10.1038%2Fnrd2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yap, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meric-Bernstam, F.</span></span> <span> </span><span class="NLM_article-title">Targeting the PI3K pathway in cancer: are we making headway?</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2018.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnrclinonc.2018.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29508857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVyjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=273-291&author=F.+Jankuauthor=T.+A.+Yapauthor=F.+Meric-Bernstam&title=Targeting+the+PI3K+pathway+in+cancer%3A+are+we+making+headway%3F&doi=10.1038%2Fnrclinonc.2018.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K pathway in cancer: are we making headway?</span></div><div class="casAuthors">Janku, Filip; Yap, Timothy A.; Meric-Bernstam, Funda</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">273-291</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The PI3K-AKT-mTOR pathway is one of the most frequently dysregulated pathways in cancer and, consequently, more than 40 compds. that target key components of this signalling network have been tested in clin. trials involving patients with a range of different cancers.  The clin. development of many of these agents, however, has not advanced to late-phase randomized trials, and the antitumor activity of those that have been evaluated in comparative prospective studies has typically been limited, or toxicities were found to be prohibitive.  Nevertheless, the mTOR inhibitors temsirolimus and everolimus and the PI3K inhibitors idelalisib and copanlisib have been approved by the FDA for clin. use in the treatment of a no. of different cancers.  Novel compds. with greater potency and selectivity, as well as improved therapeutic indexes owing to reduced risks of toxicity, are clearly required.  In addn., biomarkers that are predictive of a response, such as PIK3CA mutations for inhibitors of the PI3K catalytic subunit α isoform, must be identified and anal. and clin. validated.  Finally, considering that oncogenic activation of the PI3K-AKT-mTOR pathway often occurs alongside pro-tumorigenic aberrations in other signalling networks, rational combinations are also needed to optimize the effectiveness of treatment.  Herein, we review the current experience with anticancer therapies that target the PI3K-AKT-mTOR pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbPxYBT6FMIbVg90H21EOLACvtfcHk0lgQglNrH7QwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVyjsLY%253D&md5=73e00e3137c598e3a88ecf6a3d180b8c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2018.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2018.28%26sid%3Dliteratum%253Aachs%26aulast%3DJanku%26aufirst%3DF.%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DMeric-Bernstam%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520PI3K%2520pathway%2520in%2520cancer%253A%2520are%2520we%2520making%2520headway%253F%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D15%26spage%3D273%26epage%3D291%26doi%3D10.1038%2Fnrclinonc.2018.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Regad, T.</span></span> <span> </span><span class="NLM_article-title">Targeting RTK signaling pathways in cancer</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1758</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.3390/cancers7030860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.3390%2Fcancers7030860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=26404379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=1758-1784&author=T.+Regad&title=Targeting+RTK+signaling+pathways+in+cancer&doi=10.3390%2Fcancers7030860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RTK signaling pathways in cancer</span></div><div class="casAuthors">Regad, Tarik</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1758-1784</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation, differentiation and survival.  The induction of these pathways depends on Receptor Tyrosine Kinases (RTKs) that are activated upon ligand binding.  In cancer, constitutive and aberrant activations of components of those pathways result in increased proliferation, survival and metastasis.  For instance, mutations affecting RTKs, Ras, B-Raf, PI3K and AKT are common in perpetuating the malignancy of several types of cancers and from different tissue origins.  Therefore, these signaling pathways became prime targets for cancer therapy.  This review aims to provide an overview about the most frequently encountered mutations, the pathogenesis that results from such mutations and the known therapeutic strategies developed to counteract their aberrant functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjg0xbtTp_DLVg90H21EOLACvtfcHk0lgQglNrH7QwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVKhs74%253D&md5=69915108fbea525b049fea614ee8e210</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3390%2Fcancers7030860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers7030860%26sid%3Dliteratum%253Aachs%26aulast%3DRegad%26aufirst%3DT.%26atitle%3DTargeting%2520RTK%2520signaling%2520pathways%2520in%2520cancer%26jtitle%3DCancers%26date%3D2015%26volume%3D7%26spage%3D1758%26epage%3D1784%26doi%3D10.3390%2Fcancers7030860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haring, H.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, R.</span></span> <span> </span><span class="NLM_article-title">How insulin receptor substrate proteins regulate the metabolic capacity of the liver - implications for health and disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1316</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.2174/092986708784534956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.2174%2F092986708784534956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=18537611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1316-1329&author=L.+Fritscheauthor=C.+Weigertauthor=H.-U.+Haringauthor=R.+Lehmann&title=How+insulin+receptor+substrate+proteins+regulate+the+metabolic+capacity+of+the+liver+-+implications+for+health+and+disease&doi=10.2174%2F092986708784534956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">How insulin receptor substrate proteins regulate the metabolic capacity of the liver - implications for health and disease</span></div><div class="casAuthors">Fritsche, Louise; Weigert, Cora; Haering, Hans-Ulrich; Lehmann, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1316-1329</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The liver plays a key role in glucose homeostasis, lipid and energy metab.  Its function is primarily controlled by the anabolic hormone insulin and its counterparts glucagon, catecholamines and glucocorticoids.  Dysregulation of this homeostatic system is a major cause for development of the metabolic syndrome and type 2 diabetes mellitus.  The features of the underlying dynamic mol. network that coordinates systemic nutrient homeostasis are less clear.  But recently, considerable progress has been made in elucidating mol. pathways and potential factors involved in the regulation of energy and lipid metab. and affected in diabetic states.  In this review we will focus on important stations in the complex network of mols. that control the balance between glucose prodn., glucose utilization and regulation of lipid metab.  Special attention will be paid to the insulin receptor substrate (IRS) proteins with the two major isoforms IRS-1 and IRS-2 as a crit. node in hepatic insulin signaling.  IRS proteins act as docking mols. to connect tyrosine kinase receptor activation to essential downstream kinase cascades, including activation of the PI-3 kinase or MAPK cascade.  IRS-1 and IRS-2 are complementary key players in the regulation of hepatic insulin signaling and expression of genes involved in gluconeogenesis, glycogen synthesis and lipid metab.  The function of IRS proteins is regulated by their expression levels and posttranslational modifications.  This regulation within the dynamic mol. network that coordinates systemic nutrient homeostasis will be outlined in detail under the following conditions: after feeding, during fasting and during exercise.  Dysfunction of IRS proteins initially leads to post-prandial hyperglycemia, increased hepatic glucose prodn., and dysregulated lipid synthesis and is discussed as major pathophysiol. mechanism for the development of insulin resistance and type 2 diabetes mellitus.  Understanding the mol. regulation and the pathophysiol. modifications of IRS proteins is crucial in order to identify new sites for potential intervention to treat or prevent hepatic insulin resistance and type 2 diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDYj3XCArV_7Vg90H21EOLACvtfcHk0lh1eU_IR25e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyhsrk%253D&md5=8bef4cd0e1e27d34affb3085c2432d4a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F092986708784534956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784534956%26sid%3Dliteratum%253Aachs%26aulast%3DFritsche%26aufirst%3DL.%26aulast%3DWeigert%26aufirst%3DC.%26aulast%3DHaring%26aufirst%3DH.-U.%26aulast%3DLehmann%26aufirst%3DR.%26atitle%3DHow%2520insulin%2520receptor%2520substrate%2520proteins%2520regulate%2520the%2520metabolic%2520capacity%2520of%2520the%2520liver%2520-%2520implications%2520for%2520health%2520and%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D1316%26epage%3D1329%26doi%3D10.2174%2F092986708784534956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heras-Sandoval, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila-Muñoz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arias, C.</span></span> <span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase/mTor pathway as a therapeutic target for brain aging and neurodegeneration</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1070</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.3390/ph4081070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.3390%2Fph4081070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2gurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=1070-1087&author=D.+Heras-Sandovalauthor=E.+Avila-Mu%C3%B1ozauthor=C.+Arias&title=The+phosphatidylinositol+3-kinase%2FmTor+pathway+as+a+therapeutic+target+for+brain+aging+and+neurodegeneration&doi=10.3390%2Fph4081070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-kinase/mTor pathway as a therapeutic target for brain aging and neurodegeneration</span></div><div class="casAuthors">Heras-Sandoval, David; Avila-Munoz, Evangelina; Arias, Clorinda</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1070-1087</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Many pathol. conditions are assocd. with phosphatidylinositol 3-kinase (PI3K) dysfunction, providing an incentive for the study of the effects of PI3K modulation in different aspects of diabetes, cancer, and aging.  The PI3K/AKT/mTOR pathway is a key transducer of brain metabolic and mitogenic signals involved in neuronal proliferation, differentiation, and survival.  In several models of neurodegenerative diseases assocd. with aging, the PI3K/AKT pathway has been found to be dysregulated, suggesting that two or more initiating events may trigger disease formation in an age-related manner.  The search for chem. compds. able to modulate the activity of the PI3K/AKT/mTOR pathway is emerging as a potential therapeutic strategy for the treatment and/or prevention of some metabolic defects assocd. with brain aging.  In the current review, we summarize some of the crit. actions of PI3K in brain function as well as the evidence of its involvement in aging and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq79ZB5FimxHbVg90H21EOLACvtfcHk0lh1eU_IR25e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2gurnN&md5=be49cfdcc2fd34f4ac23dfc13788f289</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.3390%2Fph4081070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph4081070%26sid%3Dliteratum%253Aachs%26aulast%3DHeras-Sandoval%26aufirst%3DD.%26aulast%3DAvila-Mu%25C3%25B1oz%26aufirst%3DE.%26aulast%3DArias%26aufirst%3DC.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase%252FmTor%2520pathway%2520as%2520a%2520therapeutic%2520target%2520for%2520brain%2520aging%2520and%2520neurodegeneration%26jtitle%3DPharmaceuticals%26date%3D2011%26volume%3D4%26spage%3D1070%26epage%3D1087%26doi%3D10.3390%2Fph4081070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heras-Sandoval, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Rojas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Damián, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza-Chaverri, J.</span></span> <span> </span><span class="NLM_article-title">The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2694</span>– <span class="NLM_lpage">2701</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2014.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.cellsig.2014.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=25173700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Squ7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=2694-2701&author=D.+Heras-Sandovalauthor=J.+M.+P%C3%A9rez-Rojasauthor=J.+Hern%C3%A1ndez-Dami%C3%A1nauthor=J.+Pedraza-Chaverri&title=The+role+of+PI3K%2FAKT%2FmTOR+pathway+in+the+modulation+of+autophagy+and+the+clearance+of+protein+aggregates+in+neurodegeneration&doi=10.1016%2Fj.cellsig.2014.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</span></div><div class="casAuthors">Heras-Sandoval, David; Perez-Rojas, Jazmin M.; Hernandez-Damian, Jacqueline; Pedraza-Chaverri, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2694-2701</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Disruption of autophagy plays an import role in neurodegenerative disorders, where deficient elimination of abnormal and toxic protein aggregates promotes cellular stress, failure and death.  Therefore, induction of autophagy has been proposed as a reasonable strategy to help neurons clear abnormal protein aggregates and survive.  The kinase mammalian target of rapamycin (mTOR) is a major regulator of the autophagic process and is regulated by starvation, growth factors, and cellular stressors.  Upstream of mTOR the survival PI3K/AKT pathway modulates mTOR activity that is also altered in neurodegenerative diseases of Alzheimer and Parkinson.  Nevertheless, the interplay between the PI3K/AKT/mTOR pathway and the autophagic process is complex and a more detailed examn. of tissue from patients suffering neurodegenerative diseases and of animal and cellular models is needed.  In the present work we review the recent findings on the role of the PI3K/AKT/mTOR pathway in the modulation of the autophagic process in neuronal protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYRkhLYeGjRbVg90H21EOLACvtfcHk0lh1eU_IR25e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Squ7rF&md5=35f98407f6f41639e29500260a3ff91f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2014.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2014.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DHeras-Sandoval%26aufirst%3DD.%26aulast%3DP%25C3%25A9rez-Rojas%26aufirst%3DJ.%2BM.%26aulast%3DHern%25C3%25A1ndez-Dami%25C3%25A1n%26aufirst%3DJ.%26aulast%3DPedraza-Chaverri%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520PI3K%252FAKT%252FmTOR%2520pathway%2520in%2520the%2520modulation%2520of%2520autophagy%2520and%2520the%2520clearance%2520of%2520protein%2520aggregates%2520in%2520neurodegeneration%26jtitle%3DCell.%2520Signalling%26date%3D2014%26volume%3D26%26spage%3D2694%26epage%3D2701%26doi%3D10.1016%2Fj.cellsig.2014.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sul, H. S.</span></span> <span> </span><span class="NLM_article-title">Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.coph.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=20817607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVals7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=684-691&author=R.+H.+F.+Wongauthor=H.+S.+Sul&title=Insulin+signaling+in+fatty+acid+and+fat+synthesis%3A+a+transcriptional+perspective&doi=10.1016%2Fj.coph.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective</span></div><div class="casAuthors">Wong, Roger H. F.; Sul, Hei Sook</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">684-691</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Transcription of enzymes involved in FA and TAG synthesis is coordinately induced in lipogenic tissues by feeding and insulin treatment.  The three major transcription factors involved are USF, SREBP-1c, and LXRα.  New insights into the insulin-signaling pathway(s) that control(s) lipogenic gene transcription via these factors have recently been revealed.  Dephosphorylation/activation of DNA-PK by PP1 causes phosphorylation of USF that in turn recruits P/CAF to be acetylated for transcriptional activation.  SREBP-1c can be induced by mTORC1, bifurcating lipogenesis from AKT-activated gluconeogenesis.  LXRα may serve as a glucose sensor and, along with ChREBP, may activate lipogenic genes in the fed state.  Dysregulation of FA and TAG metab. often contributes to metabolic diseases such as obesity, diabetes, and cardiovascular diseases.  Transcription factors and signaling mols. involved in transcriptional activation of FA and TAG synthesis represent attractive targets for the prevention and treatment of metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogRKm8XQTvcLVg90H21EOLACvtfcHk0lgzYG62OFUDoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVals7rO&md5=685fb366eeb911d8ae0c76af214bd1aa</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BH.%2BF.%26aulast%3DSul%26aufirst%3DH.%2BS.%26atitle%3DInsulin%2520signaling%2520in%2520fatty%2520acid%2520and%2520fat%2520synthesis%253A%2520a%2520transcriptional%2520perspective%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D684%26epage%3D691%26doi%3D10.1016%2Fj.coph.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span> <span> </span><span class="NLM_article-title">Comparison of FDA approved kinase targets to clinical trial ones: Insights from their system profiles and drug-target interaction networks</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2016</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1155/2016/2509385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1155%2F2016%2F2509385" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=1-9&author=J.+Xuauthor=P.+Wangauthor=H.+Yangauthor=J.+Zhouauthor=Y.+Liauthor=X.+Liauthor=W.+Xueauthor=C.+Yuauthor=Y.+Tianauthor=F.+Zhu&title=Comparison+of+FDA+approved+kinase+targets+to+clinical+trial+ones%3A+Insights+from+their+system+profiles+and+drug-target+interaction+networks&doi=10.1155%2F2016%2F2509385"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2016%2F2509385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F2509385%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXue%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DF.%26atitle%3DComparison%2520of%2520FDA%2520approved%2520kinase%2520targets%2520to%2520clinical%2520trial%2520ones%253A%2520Insights%2520from%2520their%2520system%2520profiles%2520and%2520drug-target%2520interaction%2520networks%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D9%26doi%3D10.1155%2F2016%2F2509385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janku, F.</span></span> <span> </span><span class="NLM_article-title">Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.ctrv.2017.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=28779636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WgtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=93-101&author=F.+Janku&title=Phosphoinositide+3-kinase+%28PI3K%29+pathway+inhibitors+in+solid+tumors%3A+From+laboratory+to+patients&doi=10.1016%2Fj.ctrv.2017.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoinositide 3-kinase (PI3K) pathway inhibitors in solid tumors: From laboratory to patients</span></div><div class="casAuthors">Janku, Filip</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-101</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The phosphoinositide 3-kinase (PI3K) pathway is an intracellular signaling pathway that has regulatory roles in cell survival, proliferation, and differentiation, and a crit. role in tumorigenesis.  In cancer, multiple studies have investigated the therapeutic targeting of the PI3K pathway, and multiple inhibitors targeting PI3K and its isoforms, protein kinase B/AKT, mammalian target of rapamycin (mTOR), and other pathway proteins have been developed.  For the treatment of solid tumors, only allosteric mTOR inhibitors, such as everolimus and temsirolimus, are currently approved for clin. use.  This review describes the PI3K inhibitors that have progressed from the lab. to late-stage clin. trials, and discusses the challenges that have prevented other compds. from doing the same.  Challenges to the therapeutic effectiveness of some PI3K inhibitors include the absence of reliable and effective biomarkers, their limited efficacy as single agents, insufficient development of rational therapeutic combinations, the use of schedules with a variety of off-target effects, and suboptimal therapeutic exposures.  Therefore, with regard to PI3K inhibitors currently in late-stage clin. trials, the identification of appropriate biomarkers of efficacy and the development of optimal combination regimens and dosing schedules are likely to be important for graduation into clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQhlVdFU8NPrVg90H21EOLACvtfcHk0lgzYG62OFUDoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WgtbrJ&md5=5b60a21296fea87bffc4e691f9e5c7be</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DJanku%26aufirst%3DF.%26atitle%3DPhosphoinositide%25203-kinase%2520%2528PI3K%2529%2520pathway%2520inhibitors%2520in%2520solid%2520tumors%253A%2520From%2520laboratory%2520to%2520patients%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2017%26volume%3D59%26spage%3D93%26epage%3D101%26doi%3D10.1016%2Fj.ctrv.2017.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polanska, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delpuech, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinidad, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michopoulos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaghan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polanski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellston, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avivar-Valderas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniszewska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumberbatch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchlow, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, S. T.</span></span> <span> </span><span class="NLM_article-title">Inhibiting PI3Kβ with AZD8186 regulates key metabolic pathways in PTEN-null tumors</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7584</span>– <span class="NLM_lpage">7595</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-17-0676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1158%2F1078-0432.CCR-17-0676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=28972046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=7584-7595&author=J.+T.+Lynchauthor=U.+M.+Polanskaauthor=O.+Delpuechauthor=U.+Hancoxauthor=A.+G.+Trinidadauthor=F.+Michopoulosauthor=C.+Lenaghanauthor=R.+McEwenauthor=J.+Bradfordauthor=R.+Polanskiauthor=R.+Ellstonauthor=A.+Avivar-Valderasauthor=J.+Pillingauthor=A.+Staniszewskaauthor=M.+Cumberbatchauthor=S.+E.+Critchlowauthor=F.+Cruzaleguiauthor=S.+T.+Barry&title=Inhibiting+PI3K%CE%B2+with+AZD8186+regulates+key+metabolic+pathways+in+PTEN-null+tumors&doi=10.1158%2F1078-0432.CCR-17-0676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors</span></div><div class="casAuthors">Lynch, James T.; Polanska, Urszula M.; Delpuech, Oona; Hancox, Urs; Trinidad, Antonio G.; Michopoulos, Filippos; Lenaghan, Carol; McEwen, Robert; Bradford, James; Polanski, Radek; Ellston, Rebecca; Avivar-Valderas, Alvaro; Pilling, James; Staniszewska, Anna; Cumberbatch, Marie; Critchlow, Susan E.; Cruzalegui, Francisco; Barry, Simon T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7584-7595</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: PTEN-null tumors become dependent on the PI3Kβ isoform and can be targeted by mols. such as the selective PI3Kβ inhibitor AZD8186.  However, beyond the modulation of the canonical PI3K pathway, the consequences of inhibiting PI3Kβ are poorly defined.  Exptl. Design: To det. the broader impact of AZD8186 in PTEN-null tumors, we performed a genome-wide RNA-seq anal. of PTEN-null triple-neg. breast tumor xenografts treated with AZD8186.  Mechanistic consequences of AZD8186 treatment were examd. across a no. of PTEN-null cell lines and tumor models.  Results: AZD8186 treatment resulted in modification of transcript and protein biomarkers assocd. with cell metab.  We obsd. downregulation of cholesterol biosynthesis genes and upregulation of markers assocd. with metabolic stress.  Downregulation of cholesterol biosynthesis proteins, such as HMGCS1, occurred in PTEN-null cell lines and tumor xenografts sensitive to AZD8186.  Therapeutic inhibition of PI3Kβ also upregulated PDHK4 and increased PDH phosphorylation, indicative of reduced carbon flux into the TCA cycle.  Consistent with this, metabolomic anal. revealed a no. of changes in key carbon pathways, nucleotide, and amino acid biosynthesis.  Conclusions: This study identifies novel mechanistic biomarkers of PI3Kβ inhibition in PTEN-null tumors supporting the concept that targeting PI3Kβ may exploit a metabolic dependency that contributes to therapeutic benefit in inducing cell stress.  Considering these addnl. pathways will guide biomarker and combination strategies for this class of agents.  Clin Cancer Res; 23(24); 7584-95. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpxd85DV7hRrVg90H21EOLACvtfcHk0lhKmgj6S2khgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtLfP&md5=d48605426588d3abec1d11d7581b1c0a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-0676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-0676%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DJ.%2BT.%26aulast%3DPolanska%26aufirst%3DU.%2BM.%26aulast%3DDelpuech%26aufirst%3DO.%26aulast%3DHancox%26aufirst%3DU.%26aulast%3DTrinidad%26aufirst%3DA.%2BG.%26aulast%3DMichopoulos%26aufirst%3DF.%26aulast%3DLenaghan%26aufirst%3DC.%26aulast%3DMcEwen%26aufirst%3DR.%26aulast%3DBradford%26aufirst%3DJ.%26aulast%3DPolanski%26aufirst%3DR.%26aulast%3DEllston%26aufirst%3DR.%26aulast%3DAvivar-Valderas%26aufirst%3DA.%26aulast%3DPilling%26aufirst%3DJ.%26aulast%3DStaniszewska%26aufirst%3DA.%26aulast%3DCumberbatch%26aufirst%3DM.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DBarry%26aufirst%3DS.%2BT.%26atitle%3DInhibiting%2520PI3K%25CE%25B2%2520with%2520AZD8186%2520regulates%2520key%2520metabolic%2520pathways%2520in%2520PTEN-null%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2017%26volume%3D23%26spage%3D7584%26epage%3D7595%26doi%3D10.1158%2F1078-0432.CCR-17-0676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Evolution of a novel, orally bioavailable series of PI3Kδ inhibitors from an inhaled lead for the treatment of respiratory disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7239</span>– <span class="NLM_lpage">7251</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyitLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7239-7251&author=A.+Amourauthor=N.+Bartonauthor=A.+W.+J.+Cooperauthor=G.+Inglisauthor=C.+Jamiesonauthor=C.+N.+Luscombeauthor=J.+Morrellauthor=S.+Peaceauthor=D.+Perezauthor=P.+Rowlandauthor=C.+Tameauthor=S.+Uddinauthor=G.+Vitulliauthor=N.+Wellaway&title=Evolution+of+a+novel%2C+orally+bioavailable+series+of+PI3K%CE%B4+inhibitors+from+an+inhaled+lead+for+the+treatment+of+respiratory+disease&doi=10.1021%2Facs.jmedchem.6b00799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease</span></div><div class="casAuthors">Amour, Augustin; Barton, Nick; Cooper, Anthony W. J.; Inglis, Graham; Jamieson, Craig; Luscombe, Christopher N.; Morrell, Josie; Peace, Simon; Perez, David; Rowland, Paul; Tame, Christopher J.; Uddin, Sorif; Vitulli, Giovanni; Wellaway, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7239-7251</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a novel oral series of PI3Kδ inhibitors with promising selectivity and excellent in vivo characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKbdEJSHwYD7Vg90H21EOLACvtfcHk0lhKmgj6S2khgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyitLnN&md5=ab4641778d1c80f0dd9551d6d75ff4ef</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00799%26sid%3Dliteratum%253Aachs%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTame%26aufirst%3DC.%26aulast%3DUddin%26aufirst%3DS.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DEvolution%2520of%2520a%2520novel%252C%2520orally%2520bioavailable%2520series%2520of%2520PI3K%25CE%25B4%2520inhibitors%2520from%2520an%2520inhaled%2520lead%2520for%2520the%2520treatment%2520of%2520respiratory%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7239%26epage%3D7251%26doi%3D10.1021%2Facs.jmedchem.6b00799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peace, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tame, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uddin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellaway, N.</span></span> <span> </span><span class="NLM_article-title">Correction to evolution of a novel, orally bioavailable series of PI3Kδ inhibitors from an inhaled lead for the treatment of respiratory disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8148</span>– <span class="NLM_lpage">8148</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOnt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8148-8148&author=A.+Amourauthor=N.+Bartonauthor=A.+W.+J.+Cooperauthor=G.+Inglisauthor=C.+Jamiesonauthor=C.+N.+Luscombeauthor=J.+Morrellauthor=S.+Peaceauthor=D.+Perezauthor=P.+Rowlandauthor=C.+J.+Tameauthor=S.+Uddinauthor=G.+Vitulliauthor=N.+Wellaway&title=Correction+to+evolution+of+a+novel%2C+orally+bioavailable+series+of+PI3K%CE%B4+inhibitors+from+an+inhaled+lead+for+the+treatment+of+respiratory+disease&doi=10.1021%2Facs.jmedchem.6b01157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease [Erratum to document cited in CA165:218406]</span></div><div class="casAuthors">Amour, Augustin; Barton, Nick; Cooper, Anthony W. J.; Inglis, Graham; Jamieson, Craig; Luscombe, Christopher N.; Morrell, Josie; Peace, Simon; Perez, David; Rowland, Paul; Tame, Christopher J.; Uddin, Sorif; Vitulli, Giovanni; Wellaway, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8148</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the author listings an author name was not correct; Christopher J. Tame name is provided correctly.  On page 7239 the central structure in the abstr. graphic is incorrect; a cor. abstr. graphic is given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIn6ht38qRz7Vg90H21EOLACvtfcHk0ljsJK1eg8ElRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOnt7fM&md5=ba1fce1922cdfdb777390f03423af0fa</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01157%26sid%3Dliteratum%253Aachs%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DInglis%26aufirst%3DG.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DMorrell%26aufirst%3DJ.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTame%26aufirst%3DC.%2BJ.%26aulast%3DUddin%26aufirst%3DS.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWellaway%26aufirst%3DN.%26atitle%3DCorrection%2520to%2520evolution%2520of%2520a%2520novel%252C%2520orally%2520bioavailable%2520series%2520of%2520PI3K%25CE%25B4%2520inhibitors%2520from%2520an%2520inhaled%2520lead%2520for%2520the%2520treatment%2520of%2520respiratory%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8148%26epage%3D8148%26doi%3D10.1021%2Facs.jmedchem.6b01157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Lopez
de Turiso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campuzano, I. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duquette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vissinga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whoriskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and in vivo evaluation of the potent and selective PI3Kδ inhibitors 2-((1<i>S</i>)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1<i>S</i>)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7252</span>– <span class="NLM_lpage">7267</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00827</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKmsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7252-7267&author=F.+Gonzalez-Lopez%0Ade+Turisoauthor=X.+Haoauthor=Y.+Shinauthor=M.+Buiauthor=I.+D.+G.+Campuzanoauthor=M.+Cardozoauthor=M.+C.+Dunnauthor=J.+Duquetteauthor=B.+Fisherauthor=R.+S.+Fotiauthor=K.+Henneauthor=X.+Heauthor=Y.-L.+Huauthor=R.+C.+Kellyauthor=M.+G.+Johnsonauthor=B.+S.+Lucasauthor=J.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=T.+San+Miguelauthor=D.+Mohnauthor=T.+Tranauthor=C.+Vissingaauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=X.+Zhangauthor=T.+D.+Cushing&title=Discovery+and+in+vivo+evaluation+of+the+potent+and+selective+PI3K%CE%B4+inhibitors+2-%28%281S%29-1-%28%286-amino-5-cyano-4-pyrimidinyl%29amino%29ethyl%29-6-fluoro-N-methyl-3-%282-pyridinyl%29-4-quinolinecarboxamide+%28AM-0687%29+and+2-%28%281S%29-1-%28%286-amino-5-cyano-4-pyrimidinyl%29amino%29ethyl%29-5-fluoro-N-methyl-3-%282-pyridinyl%29-4-quinolinecarboxamide+%28AM-1430%29&doi=10.1021%2Facs.jmedchem.6b00827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)</span></div><div class="casAuthors">Gonzalez-Lopez de Turiso, Felix; Hao, Xiaolin; Shin, Youngsook; Bui, Minna; Campuzano, Iain D. G.; Cardozo, Mario; Dunn, Michelle C.; Duquette, Jason; Fisher, Benjamin; Foti, Robert S.; Henne, Kirk; He, Xiao; Hu, Yi-Ling; Kelly, Ron C.; Johnson, Michael G.; Lucas, Brian S.; McCarter, John; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; San Miguel, Tisha; Mohn, Deanna; Tran, Thuy; Vissinga, Christine; Wannberg, Sharon; Whittington, Douglas A.; Whoriskey, John; Yu, Gang; Zalameda, Leeanne; Zhang, Xuxia; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7252-7267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of the potency and pharmacokinetic profile of the lead 2,3,4-trisubstituted quinoline led to the discovery of two potent, selective, and orally bioavailable PI3Kδ inhibitors, I (AM-0687) and II (AM-1430).  On the basis of their improved profile, these analogs were selected for in vivo pharmacodynamic (PD) and efficacy expts. in animal models of inflammation.  The in vivo PD studies, which were carried out in a mouse pAKT inhibition animal model, confirmed the obsd. potency of I and II in biochem. and cellular assays.  Efficacy expts. in a keyhole limpet hemocyanin model in rats demonstrated that administration of either I or II resulted in a strong dose-dependent redn. of IgG and IgM specific antibodies.  The excellent in vitro and in vivo profiles of these analogs make them suitable for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTy9A921V9wLVg90H21EOLACvtfcHk0ljUKTsRS4tRbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKmsrjJ&md5=f22bac738698c31ea80bef504fc117ed</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00827%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DBui%26aufirst%3DM.%26aulast%3DCampuzano%26aufirst%3DI.%2BD.%2BG.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DM.%2BC.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DLucas%26aufirst%3DB.%2BS.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DVissinga%26aufirst%3DC.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%2520and%2520in%2520vivo%2520evaluation%2520of%2520the%2520potent%2520and%2520selective%2520PI3K%25CE%25B4%2520inhibitors%25202-%2528%25281S%2529-1-%2528%25286-amino-5-cyano-4-pyrimidinyl%2529amino%2529ethyl%2529-6-fluoro-N-methyl-3-%25282-pyridinyl%2529-4-quinolinecarboxamide%2520%2528AM-0687%2529%2520and%25202-%2528%25281S%2529-1-%2528%25286-amino-5-cyano-4-pyrimidinyl%2529amino%2529ethyl%2529-5-fluoro-N-methyl-3-%25282-pyridinyl%2529-4-quinolinecarboxamide%2520%2528AM-1430%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7252%26epage%3D7267%26doi%3D10.1021%2Facs.jmedchem.6b00827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClory, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stumpf, A.</span></span> <span> </span><span class="NLM_article-title">The discovery and process chemistry development of GDC-0084, a brain penetrating inhibitor of PI3K and mTOR</span>. <i>ACS Symp. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1239</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1021/bk-2016-1239.ch006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bk-2016-1239.ch006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1239&publication_year=2016&pages=147-173&author=T.+P.+Heffronauthor=A.+McCloryauthor=A.+Stumpf&title=The+discovery+and+process+chemistry+development+of+GDC-0084%2C+a+brain+penetrating+inhibitor+of+PI3K+and+mTOR&doi=10.1021%2Fbk-2016-1239.ch006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and process chemistry development of GDC-0084, a brain penetrating inhibitor of PI3K and mTOR</span></div><div class="casAuthors">Heffron, Timothy P.; McClory, Andrew; Stumpf, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">ACS Symposium Series</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1239</span>
        (<span class="NLM_cas:issue">Comprehensive Accounts of Pharmaceutical Research and Development: From Discovery to Late-Stage Process Development, Volume 1</span>),
    <span class="NLM_cas:pages">147-173</span>CODEN:
                <span class="NLM_cas:coden">ACSMC8</span>;
        ISSN:<span class="NLM_cas:issn">0097-6156</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant signaling of the PI3K pathway has been implicated in the majority of cases of glioblastoma multiforme (GBM),a malignant brain tumor with an assocd. poor prognosis.In order for a PI3K/mTOR inhibitor to inhibit PI3K pathway signaling where GBM tumors reside, such mols. must be capable of penetrating the blood-brain barrier (BBB).  This chapter describes the medicinal chem. efforts that led to the discovery of GDC-0084, a BBB penetrating inhibitor of PI3K and mTOR, followed by the process chem. development that enabled its advancement to clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9WQRHVlURdrVg90H21EOLACvtfcHk0ljUKTsRS4tRbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislWmu7o%253D&md5=5a72c7a3576ec2bc840902befdd6c862</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbk-2016-1239.ch006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbk-2016-1239.ch006%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DMcClory%26aufirst%3DA.%26aulast%3DStumpf%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520and%2520process%2520chemistry%2520development%2520of%2520GDC-0084%252C%2520a%2520brain%2520penetrating%2520inhibitor%2520of%2520PI3K%2520and%2520mTOR%26jtitle%3DACS%2520Symp.%2520Ser.%26date%3D2016%26volume%3D1239%26spage%3D147%26epage%3D173%26doi%3D10.1021%2Fbk-2016-1239.ch006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchomel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duquette, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henne, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">San Miguel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vissinga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wannberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whoriskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalameda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span> <span> </span><span class="NLM_article-title">Discovery, optimization, and in vivo evaluation of benzimidazole derivatives AM-8508 and AM-9635 as potent and selective PI3Kδ inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01651</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=431-447&author=Y.+Shinauthor=J.+Suchomelauthor=M.+Cardozoauthor=J.+Duquetteauthor=X.+Heauthor=K.+Henneauthor=Y.-L.+Huauthor=R.+C.+Kellyauthor=J.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=T.+San+Miguelauthor=D.+Mohnauthor=T.+Tranauthor=C.+Vissingaauthor=S.+Wongauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=X.+Zhangauthor=T.+D.+Cushing&title=Discovery%2C+optimization%2C+and+in+vivo+evaluation+of+benzimidazole+derivatives+AM-8508+and+AM-9635+as+potent+and+selective+PI3K%CE%B4+inhibitors&doi=10.1021%2Facs.jmedchem.5b01651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors</span></div><div class="casAuthors">Shin, Youngsook; Suchomel, Julia; Cardozo, Mario; Duquette, Jason; He, Xiao; Henne, Kirk; Hu, Yi-Ling; Kelly, Ron C.; McCarter, John; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; San Miguel, Tisha; Mohn, Deanna; Tran, Thuy; Vissinga, Christine; Wong, Simon; Wannberg, Sharon; Whittington, Douglas A.; Whoriskey, John; Yu, Gang; Zalameda, Leeanne; Zhang, Xuxia; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">431-447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead optimization efforts resulted in the discovery of two potent, selective, and orally bioavailable PI3Kδ inhibitors, 1 (AM-8508) and 2 (AM-9635), with good pharmacokinetic properties.  The compds. inhibit B cell receptor (BCR)-mediated AKT phosphorylation (pAKT) in PI3Kδ-dependent in vitro cell based assays.  These compds. which share a benzimidazole bicycle are effective when administered in vivo at unbound concns. consistent with their in vitro cell potency as a consequence of improved unbound drug concn. with lower unbound clearance.  Furthermore, the compds. demonstrated efficacy in a Keyhole Limpet Hemocyanin (KLH) study in rats, where the blockade of PI3Kδ activity by inhibitors 1 and 2 led to effective inhibition of antigen-specific IgG and IgM formation after immunization with KLH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr81OyYoamY1rVg90H21EOLACvtfcHk0lhotpTCBNhT7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP&md5=258ce4cf8c13cf799f342ebab3137264</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01651%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSuchomel%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DVissinga%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%252C%2520optimization%252C%2520and%2520in%2520vivo%2520evaluation%2520of%2520benzimidazole%2520derivatives%2520AM-8508%2520and%2520AM-9635%2520as%2520potent%2520and%2520selective%2520PI3K%25CE%25B4%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D431%26epage%3D447%26doi%3D10.1021%2Facs.jmedchem.5b01651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunsire, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriskantharajah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montembault, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leemereise, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinanes-Garcia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirsten, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuhr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessel, E. M.</span></span> <span> </span><span class="NLM_article-title">Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.pupt.2017.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.pupt.2017.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=28823947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKnsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2017&pages=69-77&author=A.+Cahnauthor=J.+N.+Hamblinauthor=M.+Beggauthor=R.+Wilsonauthor=L.+Dunsireauthor=S.+Sriskantharajahauthor=M.+Montembaultauthor=C.+N.+Leemereiseauthor=L.+Galinanes-Garciaauthor=H.+Watzauthor=A.+M.+Kirstenauthor=R.+Fuhrauthor=E.+M.+Hessel&title=Safety%2C+pharmacokinetics+and+dose-response+characteristics+of+GSK2269557%2C+an+inhaled+PI3K%CE%B4+inhibitor+under+development+for+the+treatment+of+COPD&doi=10.1016%2Fj.pupt.2017.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD</span></div><div class="casAuthors">Cahn, A.; Hamblin, J. N.; Begg, M.; Wilson, R.; Dunsire, L.; Sriskantharajah, S.; Montembault, M.; Leemereise, C. N.; Galinanes-Garcia, L.; Watz, H.; Kirsten, A. M.; Fuhr, R.; Hessel, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-77</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">While current therapies reduce symptoms in chronic obstructive pulmonary disease (COPD) patients, substantial unmet need remains and novel treatments are highly desired.  Phosphoinositide 3-kinase δ (PI3Kδ) is a lipid kinase specifically expressed in leukocytes and involved in their recruitment and activation.  This study evaluated the safety, pharmacokinetics (PK) and dose-response characteristics of inhaled GSK2269557, a PI3Kδ inhibitor, in moderate-to-severe COPD patients with stable disease.  In this randomised, double-blind, placebo controlled, parallel group study, patients received once daily inhaled treatment with GSK2269557 1000 μg or placebo for 14 days (Part A, primary aim safety, N = 28 patients).  In part B of the study (primary aim pharmacodynamic dose-response, N = 36 patients), GSK2269557 100, 200, 500, 700, 1000, 2000 μg or placebo was given for 14 days.  In both Part A and B, GSK2269557 was added to the usual maintenance therapy.  Safety, PK assessments and induced sputum collection for cytokine anal. were conducted at baseline and after 7 and 14 days of treatment.  Adverse events (AEs) were monitored throughout.In Part A, mean age was 61.7 years (SD 6.7), 29% were females, and mean FEV1% predicted was 59.7% (SD 11.4)2.  In Part B, mean age was 63.3 years (SD 6.3), 44% were females, and mean FEV1% predicted was 56.5% (SD 11.5)2.  GSK2269557 was well tolerated in both parts of the study; the most commonly reported AEs were cough and headache, with cough being reported with a greater incidence in the GSK2269557 groups vs. placebo (Part A: 19% vs. 14% and Part B: range of 0-80% for different doses vs. 0% on placebo).  No drug-related serious AEs or clin. significant changes in any other safety parameters were reported.  GSK2269557 was rapidly absorbed into plasma following all doses with a max. peak at approx. 2 h.  Following repeat administration, accumulation in plasma was approx. 2-3 fold from Day 1 to Day 7.  At Day 14, relative to placebo, sputum interleukin (IL)-8 and IL-6 levels were reduced on av. by 32% and 29% resp. after inhalation of GSK2269557 1000 μg in Part A.  In Part B, although inhibition of both IL-8 and IL-6 levels was obsd., the levels were variable and there was insufficient evidence to support a monotonic dose-response.  In this study, inhaled GSK2269557 had an acceptable safety profile for progression into larger studies in COPD patients.  Moreover, inhalation of GSK2269557 resulted in suppression of sputum IL-8 and IL-6 levels, consistent with the known anti-inflammatory activity of a PI3Kδ inhibitor.  Inhibition of inflammatory cytokines in the airway compartment may contribute to the potential therapeutic benefit of a PI3Kδ inhibitor in chronically inflamed COPD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLev2M055yDLVg90H21EOLACvtfcHk0lhotpTCBNhT7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKnsb7M&md5=bf5733fdf1e02f3804724f1a523c758b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2017.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2017.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DCahn%26aufirst%3DA.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26aulast%3DBegg%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DR.%26aulast%3DDunsire%26aufirst%3DL.%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DMontembault%26aufirst%3DM.%26aulast%3DLeemereise%26aufirst%3DC.%2BN.%26aulast%3DGalinanes-Garcia%26aufirst%3DL.%26aulast%3DWatz%26aufirst%3DH.%26aulast%3DKirsten%26aufirst%3DA.%2BM.%26aulast%3DFuhr%26aufirst%3DR.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520dose-response%2520characteristics%2520of%2520GSK2269557%252C%2520an%2520inhaled%2520PI3K%25CE%25B4%2520inhibitor%2520under%2520development%2520for%2520the%2520treatment%2520of%2520COPD%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2017%26volume%3D46%26spage%3D69%26epage%3D77%26doi%3D10.1016%2Fj.pupt.2017.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlahos, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matter, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. F.</span></span> <span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">5241</span>– <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0lg7uBjxQ3ezKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gharbi, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuttleworth, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancox, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghir, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timms, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterfield, M. D.</span></span> <span> </span><span class="NLM_article-title">Exploring the specificity of the PI3K family inhibitor LY294002</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>404</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1042/BJ20061489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1042%2FBJ20061489" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=17302559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1ansr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=404&publication_year=2007&pages=15-21&author=S.+I.+Gharbiauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworthauthor=T.+Hancoxauthor=N.+Saghirauthor=J.+F.+Timmsauthor=M.+D.+Waterfield&title=Exploring+the+specificity+of+the+PI3K+family+inhibitor+LY294002&doi=10.1042%2FBJ20061489"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the specificity of the PI3K family inhibitor LY294002</span></div><div class="casAuthors">Gharbi, Severine I.; Zvelebil, Marketa J.; Shuttleworth, Stephen J.; Hancox, Tim; Saghir, Nahid; Timms, John F.; Waterfield, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">404</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The PI3Ks (phosphatidylinositol 3-kinases) regulate cellular signalling networks that are involved in processes linked to the survival, growth, proliferation, metab. and specialized differentiated functions of cells.  The subversion of this network is common in cancer and has also been linked to disorders of inflammation.  The elucidation of the physiol. function of PI3K has come from pharmacol. studies, which use the enzyme inhibitors Wortmannin and LY294002, and from PI3K genetic knockout models of the effects of loss of PI3K function.  Several reports have shown that LY294002 is not exclusively selective for the PI3Ks, and could in fact act on other lipid kinases and addnl. apparently unrelated proteins.  Since this inhibitor still remains a drug of choice in numerous PI3K studies (over 500 in the last year), it is important to establish the precise specificity of this compd.  We report here the use of a chem. proteomic strategy in which an analog of LY294002, PI828, was immobilized onto epoxy-activated Sepharose beads.  This affinity material was then used as a bait to fish-out potential protein targets from cellular exts.  Proteins with high affinity for immobilized PI828 were sepd. by one-dimensional gel electrophoresis and identified by liq. chromatog.-tandem MS.  The present study reveals that LY294002 not only binds to class I PI3Ks and other PI3K-related kinases, but also to novel targets seemingly unrelated to the PI3K family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1XNfuEAyf97Vg90H21EOLACvtfcHk0lg7uBjxQ3ezKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1ansr8%253D&md5=02996a8077f221689b6a6da0b111d3ae</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1042%2FBJ20061489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061489%26sid%3Dliteratum%253Aachs%26aulast%3DGharbi%26aufirst%3DS.%2BI.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26aulast%3DHancox%26aufirst%3DT.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DTimms%26aufirst%3DJ.%2BF.%26aulast%3DWaterfield%26aufirst%3DM.%2BD.%26atitle%3DExploring%2520the%2520specificity%2520of%2520the%2520PI3K%2520family%2520inhibitor%2520LY294002%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D404%26spage%3D15%26epage%3D21%26doi%3D10.1042%2FBJ20061489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacold, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perisic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span> <span> </span><span class="NLM_article-title">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">909</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(05)00089-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2FS1097-2765%2805%2900089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=11090628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=909-919&author=E.+H.+Walkerauthor=M.+E.+Pacoldauthor=O.+Perisicauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=M.+P.+Wymannauthor=R.+L.+Williams&title=Structural+determinants+of+phosphoinositide+3-kinase+inhibition+by+wortmannin%2C+LY294002%2C+quercetin%2C+myricetin%2C+and+staurosporine&doi=10.1016%2FS1097-2765%2805%2900089-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span></div><div class="casAuthors">Walker, Edward H.; Pacold, Michael E.; Perisic, Olga; Stephens, Len; Hawkins, Philip T.; Wymann, Matthias P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The specific phosphoinositide 3-kinase (P13K) inhibitors wortmannin and LY294002 have been invaluable tools for elucidating the roles of these enzymes in signal transduction pathways.  The X-ray crystallog. structures of P13K bound to these lipid kinase inhibitors and to the broad-spectrum protein kinase inhibitors quercetin, myricetin, and staurosporine reveal how these compds. fit into the ATP binding pocket.  With a nanomolar IC50, wortmannin most closely fits and fills the active site and induces a conformational change in the catalytic domain.  Surprisingly, LY294002 and the lead compd. on which it was designed, quercetin, as well as the closely related flavonoid myricetin bind P13K in remarkably different orientations that are related to each other by 1800 rotations.  Staurosporine/P13K interactions are reminiscent of low-affinity protein kinase/staurosporine complexes.  These results provide a rich basis for development of isoform-specific P13K inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgIbTky2xQmbVg90H21EOLACvtfcHk0liuc10PxDG_zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D&md5=5dd92f9b48c437e43c0023fdff10c1ac</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900089-4%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%2BH.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructural%2520determinants%2520of%2520phosphoinositide%25203-kinase%2520inhibition%2520by%2520wortmannin%252C%2520LY294002%252C%2520quercetin%252C%2520myricetin%252C%2520and%2520staurosporine%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D909%26epage%3D919%26doi%3D10.1016%2FS1097-2765%2805%2900089-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudge, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koos, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidialingam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">mTOR kinase structure, mechanism and regulation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>497</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1038/nature12122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnature12122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=23636326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFyns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2013&pages=217-224&author=H.+Yangauthor=D.+G.+Rudgeauthor=J.+D.+Koosauthor=B.+Vaidialingamauthor=H.+J.+Yangauthor=N.+P.+Pavletich&title=mTOR+kinase+structure%2C+mechanism+and+regulation&doi=10.1038%2Fnature12122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR kinase structure, mechanism and regulation</span></div><div class="casAuthors">Yang, Haijuan; Rudge, Derek G.; Koos, Joseph D.; Vaidialingam, Bhamini; Yang, Hyo J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">7448</span>),
    <span class="NLM_cas:pages">217-223</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer.  Here we report co-crystal structures of a complex of truncated mTOR and mammalian lethal with SEC13 protein 8 (mLST8) with an ATP transition state mimic (MgF3-) and with ATP-site inhibitors (Torin2, PP242, and PI-103).  The structures reveal an intrinsically active kinase conformation, with catalytic residues and a catalytic mechanism remarkably similar to canonical protein kinases.  The active site is highly recessed owing to the FKBP12-rapamycin-binding (FRB) domain and an inhibitory helix protruding from the catalytic cleft.  MTOR-activating mutations map to the structural framework that holds these elements in place, indicating that the kinase is controlled by restricted access.  In vitro biochem. shows that the FRB domain acts as a gatekeeper, with its rapamycin-binding site interacting with substrates to grant them access to the restricted active site.  Rapamycin-FKBP12 inhibits the kinase by directly blocking substrate recruitment and by further restricting active-site access.  The structures also reveal active-site residues and conformational changes that underlie inhibitor potency and specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjvPQtdm6yCbVg90H21EOLACvtfcHk0liuc10PxDG_zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFyns7k%253D&md5=07809555fbdf2004819a7f2da5727baf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnature12122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12122%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DRudge%26aufirst%3DD.%2BG.%26aulast%3DKoos%26aufirst%3DJ.%2BD.%26aulast%3DVaidialingam%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DH.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DmTOR%2520kinase%2520structure%252C%2520mechanism%2520and%2520regulation%26jtitle%3DNature%26date%3D2013%26volume%3D497%26spage%3D217%26epage%3D224%26doi%3D10.1038%2Fnature12122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döring, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drückes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Köppler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trappe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbauer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1021/jm501557a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501557a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=443-456&author=F.+Muthauthor=M.+G%C3%BCntherauthor=S.+M.+Bauerauthor=E.+D%C3%B6ringauthor=S.+Fischerauthor=J.+Maierauthor=P.+Dr%C3%BCckesauthor=J.+K%C3%B6pplerauthor=J.+Trappeauthor=U.+Rothbauerauthor=P.+Kochauthor=S.+A.+Laufer&title=Tetra-substituted+pyridinylimidazoles+as+dual+inhibitors+of+p38%CE%B1+mitogen-activated+protein+kinase+and+c-Jun+N-terminal+kinase+3+for+potential+treatment+of+neurodegenerative+diseases&doi=10.1021%2Fjm501557a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases</span></div><div class="casAuthors">Muth, Felix; Guenther, Marcel; Bauer, Silke M.; Doering, Eva; Fischer, Sabine; Maier, Julia; Drueckes, Peter; Koeppler, Juergen; Trappe, Joerg; Rothbauer, Ulrich; Koch, Pierre; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">443-456</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tetra-substituted imidazoles were designed as dual inhibitors of c-Jun N-terminal kinase (JNK) 3 and p38α mitogen-activated protein (MAP) kinase.  A library of 45 derivs. was prepd. and evaluated in a kinase activity assay for their ability to inhibit both kinases, JNK3 and p38α MAP kinase.  Dual inhibitors with IC50 values down to the low double-digit nanomolar range at both enzymes were identified.  The best balanced dual JNK3/p38α MAP kinase inhibitors are I (IC50: JNK3, 18 nM; p38α, 30 nM) and II (IC50: JNK3, 26 nM; p38α, 34 nM) featuring both excellent soly. and metabolic stability.  They may serve as useful tool compds. for preclin. proof-of-principle studies in order to validate the synergistic role of both kinases in the progression of Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNwp_1AD67j7Vg90H21EOLACvtfcHk0lh97SMGxAGfIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhsb%252FJ&md5=3b17ce2ed0396efcee28302d6f6910e7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm501557a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501557a%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DF.%26aulast%3DG%25C3%25BCnther%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DD%25C3%25B6ring%26aufirst%3DE.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DK%25C3%25B6ppler%26aufirst%3DJ.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DRothbauer%26aufirst%3DU.%26aulast%3DKoch%26aufirst%3DP.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DTetra-substituted%2520pyridinylimidazoles%2520as%2520dual%2520inhibitors%2520of%2520p38%25CE%25B1%2520mitogen-activated%2520protein%2520kinase%2520and%2520c-Jun%2520N-terminal%2520kinase%25203%2520for%2520potential%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D443%26epage%3D456%26doi%3D10.1021%2Fjm501557a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6746</span>– <span class="NLM_lpage">6754</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.bmc.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=25468038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=6746-6754&author=W.+Zhuauthor=C.+Sunauthor=S.+Xuauthor=C.+Wuauthor=J.+Wuauthor=M.+Xuauthor=H.+Zhaoauthor=L.+Chenauthor=W.+Zengauthor=P.+Zheng&title=Design%2C+synthesis%2C+anticancer+activity+and+docking+studies+of+novel+4-morpholino-7%2C8-dihydro-5H-thiopyrano%5B4%2C3-d%5Dpyrimidine+derivatives+as+mTOR+inhibitors&doi=10.1016%2Fj.bmc.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors</span></div><div class="casAuthors">Zhu, Wufu; Sun, Chengyu; Xu, Shan; Wu, Chunjiang; Wu, Jielian; Xu, Mengze; Zhao, He; Chen, Le; Zeng, Weipeng; Zheng, Pengwu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6746-6754</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivs. were designed, synthesized and their chem. structures were confirmed by 1H NMR, 13C NMR, MS and HRMS spectrum.  All the compds. were evaluated for the inhibitory activity against mTOR kinase at 10 μM level.  Five selected compds. were further evaluated for the inhibitory activity against PI3Kα at 10 μM level, and the IC50 values against mTOR kinase and two cancer cell lines.  Twelve of the target compds. exhibited moderate antitumor activities.  The most promising compd. I showed strong antitumor activities against mTOR kinase, H460 and PC-3 cell lines with IC50 values of 0.80 ± 0.15 μM, 7.43 ± 1.45 μM and 11.90 ± 0.94 μM, which were 1.28 to 1.71-fold more active than BMCL-200908069-1 (1.37 ± 0.07 μM, 9.52 ± 0.29 μM, 16.27 ± 0.54 μM), resp.  Structure-activity relationships (SARs) and docking studies indicated that the thiopyrano[4,3-d]pyrimidine scaffolds exerted little effect on antitumor activities of target compds.  Substitutions of the aryl group at the C-4 position had a significant impact on the antitumor activities, and 4-OH substitution produced the best potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQBsC6aipUe7Vg90H21EOLACvtfcHk0lh97SMGxAGfIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7zL&md5=bcf5b31e7aa3c7c4e87c8b8944e253d0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DDesign%252C%2520synthesis%252C%2520anticancer%2520activity%2520and%2520docking%2520studies%2520of%2520novel%25204-morpholino-7%252C8-dihydro-5H-thiopyrano%255B4%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520mTOR%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D6746%26epage%3D6754%26doi%3D10.1016%2Fj.bmc.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. K.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, A.</span></span> <span> </span><span class="NLM_article-title">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5114</span>– <span class="NLM_lpage">5117</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.05.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.bmcl.2012.05.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=22765900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5114-5117&author=K.+K.-C.+Liuauthor=S.+Baileyauthor=D.+M.+Dinhauthor=H.+Lamauthor=C.+Liauthor=P.+A.+Wellsauthor=M.-J.+Yinauthor=A.+Zou&title=Conformationally-restricted+cyclic+sulfones+as+potent+and+selective+mTOR+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2012.05.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Conformationally-restricted cyclic sulfones as potent and selective mTOR kinase inhibitors</span></div><div class="casAuthors">Liu, Kevin K.-C.; Bailey, Simon; Dinh, Dac M.; Lam, Hieu; Li, Chunze; Wells, Peter A.; Yin, Min-Jean; Zou, Aihua</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5114-5117</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Novel conformationally-restricted mTOR kinase inhibitors with cyclic sulfone scaffold were designed.  Synthesis and structure-activity relationship (SAR) studies are described with emphasis on optimization of the mTOR potency and selectivity against class I PI3Kα kinase.  PF-05139962 I was identified with excellent mTOR biochem. inhibition, cellular potency, kinase selectivity and in vitro ADME properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmuwjN05w_4LVg90H21EOLACvtfcHk0lgn-Emd7bIPYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Kmsro%253D&md5=c1abe951c4d17f22a2301004eff55d91</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.05.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.05.104%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DK.%2BK.-C.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DZou%26aufirst%3DA.%26atitle%3DConformationally-restricted%2520cyclic%2520sulfones%2520as%2520potent%2520and%2520selective%2520mTOR%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5114%26epage%3D5117%26doi%3D10.1016%2Fj.bmcl.2012.05.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bochevarov, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braden, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halls, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences</span>. <i>Int. J. Quantum Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2142</span>, <span class="refDoi"> DOI: 10.1002/qua.24481</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1002%2Fqua.24481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCqs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2013&pages=2110-2142&author=A.+D.+Bochevarovauthor=E.+Harderauthor=T.+F.+Hughesauthor=J.+R.+Greenwoodauthor=D.+A.+Bradenauthor=D.+M.+Philippauthor=D.+Rinaldoauthor=M.+D.+Hallsauthor=J.+Zhangauthor=R.+A.+Friesner&title=Jaguar%3A+A+high-performance+quantum+chemistry+software+program+with+strengths+in+life+and+materials+sciences&doi=10.1002%2Fqua.24481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences</span></div><div class="casAuthors">Bochevarov, Art D.; Harder, Edward; Hughes, Thomas F.; Greenwood, Jeremy R.; Braden, Dale A.; Philipp, Dean M.; Rinaldo, David; Halls, Mathew D.; Zhang, Jing; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Quantum Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2110-2142</span>CODEN:
                <span class="NLM_cas:coden">IJQCB2</span>;
        ISSN:<span class="NLM_cas:issn">0020-7608</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Jaguar is an ab initio quantum chem. program that specializes in fast electronic structure predictions for mol. systems of medium and large size.  Jaguar focuses on computational methods with reasonable computational scaling with the size of the system, such as d. functional theory (DFT) and local second-order Moller-Plesset perturbation theory.  The favorable scaling of the methods and the high efficiency of the program make it possible to conduct routine computations involving several thousand MOs.  This performance is achieved through a utilization of the pseudospectral approxn. and several levels of parallelization.  The speed advantages are beneficial for applying Jaguar in biomol. computational modeling.  Addnl., owing to its superior wave function guess for transition-metal-contg. systems, Jaguar finds applications in inorg. and bioinorg. chem.  The emphasis on larger systems and transition metal elements paves the way toward developing Jaguar for its use in materials science modeling.  The article describes the historical and new features of Jaguar, such as improved parallelization of many modules, innovations in ab initio pKa prediction, and new semiempirical corrections for nondynamic correlation errors in DFT.  Jaguar applications in drug discovery, materials science, force field parameterization, and other areas of computational research are reviewed.  Timing benchmarks and other results obtained from the most recent Jaguar code are provided.  The article concludes with a discussion of challenges and directions for future development of the program. © 2013 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt_0dnCf0Yq7Vg90H21EOLACvtfcHk0lhwYHDNE9583A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCqs7%252FP&md5=2fc119bb9e0501e55d7292f7735c24ea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fqua.24481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqua.24481%26sid%3Dliteratum%253Aachs%26aulast%3DBochevarov%26aufirst%3DA.%2BD.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DHughes%26aufirst%3DT.%2BF.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DBraden%26aufirst%3DD.%2BA.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRinaldo%26aufirst%3DD.%26aulast%3DHalls%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DJaguar%253A%2520A%2520high-performance%2520quantum%2520chemistry%2520software%2520program%2520with%2520strengths%2520in%2520life%2520and%2520materials%2520sciences%26jtitle%3DInt.%2520J.%2520Quantum%2520Chem.%26date%3D2013%26volume%3D113%26spage%3D2110%26epage%3D2142%26doi%3D10.1002%2Fqua.24481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodny, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: Importance of the morpholine ring</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1021/jm501026z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501026z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=41-71&author=M.+Andrsauthor=J.+Korabecnyauthor=D.+Junauthor=Z.+Hodnyauthor=J.+Bartekauthor=K.+Kuca&title=Phosphatidylinositol+3-kinase+%28PI3K%29+and+phosphatidylinositol+3-kinase-related+kinase+%28PIKK%29+inhibitors%3A+Importance+of+the+morpholine+ring&doi=10.1021%2Fjm501026z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring</span></div><div class="casAuthors">Andrs, Martin; Korabecny, Jan; Jun, Daniel; Hodny, Zdenek; Bartek, Jiri; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-71</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein kinases (PIKKs) are two related families of kinases that play key roles in regulation of cell proliferation, metab., migration, survival, and responses to diverse stresses including DNA damage.  To design novel efficient strategies for treatment of cancer and other diseases, these kinases have been extensively studied.  Despite their different nature, these two kinase families have related origin and share very similar kinase domains.  Therefore, chem. inhibitors of these kinases usually carry analogous structural motifs.  The most common feature of these inhibitors is a crit. hydrogen bond to morpholine oxygen, initially present in the early nonspecific PI3K and PIKK inhibitor 3 (LY294002), which served as a valuable chem. tool for development of many addnl. PI3K and PIKK inhibitors.  While several PI3K pathway inhibitors have recently shown promising clin. responses, inhibitors of the DNA damage-related PIKKs remain thus far largely in preclin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprPlvsq-HTebVg90H21EOLACvtfcHk0lhwYHDNE9583A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzE&md5=a8c22f580691084554036dec7d0cc95b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501026z%26sid%3Dliteratum%253Aachs%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DHodny%26aufirst%3DZ.%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520%2528PI3K%2529%2520and%2520phosphatidylinositol%25203-kinase-related%2520kinase%2520%2528PIKK%2529%2520inhibitors%253A%2520Importance%2520of%2520the%2520morpholine%2520ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D41%26epage%3D71%26doi%3D10.1021%2Fjm501026z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheijen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooijmans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toral-Barza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zask, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.bmcl.2009.11.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=19963384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=640-643&author=J.+Kaplanauthor=J.+C.+Verheijenauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=K.+Yuauthor=A.+Zask&title=Discovery+of+3%2C6-dihydro-2H-pyran+as+a+morpholine+replacement+in+6-aryl-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+and+2-arylthieno%5B3%2C2-d%5Dpyrimidines%3A+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29&doi=10.1016%2Fj.bmcl.2009.11.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span></div><div class="casAuthors">Kaplan, Joshua; Verheijen, Jeroen C.; Brooijmans, Natasja; Toral-Barza, Lourdes; Hollander, Irwin; Yu, Ker; Zask, Arie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">640-643</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The morpholine hinge-region binding group on a series of pyrazolopyrimidine and thienopyrimidine mammalian target of rapamycin (mTOR) inhibitors was replaced with 3,6-dihydro-2H-pyran (DHP), giving compds. of equiv. potency and selectivity vs. PI3K.  These results establish the DHP group as a hinge-region binding motif for the prepn. of highly potent and selective mTOR inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBTLsFT9FBubVg90H21EOLACvtfcHk0ljRO1V8wzUmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2itbfE&md5=9398107e05207e302a8358103f31fb2f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%2BC.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25203%252C6-dihydro-2H-pyran%2520as%2520a%2520morpholine%2520replacement%2520in%25206-aryl-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520and%25202-arylthieno%255B3%252C2-d%255Dpyrimidines%253A%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D640%26epage%3D643%26doi%3D10.1016%2Fj.bmcl.2009.11.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickett, S. D.</span></span> <span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0ljRO1V8wzUmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, S. J. F.</span></span> <span> </span><span class="NLM_article-title">Physicochemical descriptors of aromatic character and their use in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7215</span>, <span class="refDoi"> DOI: 10.1021/jm500515d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500515d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Wmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7206-7215&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonald&title=Physicochemical+descriptors+of+aromatic+character+and+their+use+in+drug+discovery&doi=10.1021%2Fjm500515d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical Descriptors of Aromatic Character and Their Use in Drug Discovery</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7206-7215</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Published physicochem. descriptors of mols. that convey aromaticity-related character are reviewed in the context of drug design and discovery.  Studies that have employed arom. descriptors are discussed, and several descriptors are compared and contrasted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogc1vxNtUQl7Vg90H21EOLACvtfcHk0lhOTQx6fk9_lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Wmsbw%253D&md5=7aca9f7309bb5dd806aeb4c2b4ff8eab</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm500515d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500515d%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DPhysicochemical%2520descriptors%2520of%2520aromatic%2520character%2520and%2520their%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7206%26epage%3D7215%26doi%3D10.1021%2Fjm500515d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from flatland: Increasing saturation as an approach to improving clinical success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+flatland%3A+Increasing+saturation+as+an+approach+to+improving+clinical+success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhOTQx6fk9_lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520flatland%253A%2520Increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland 2: complexity and promiscuity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1039/c2md20347b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1039%2Fc2md20347b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=515-519&author=F.+Lovering&title=Escape+from+Flatland+2%3A+complexity+and+promiscuity&doi=10.1039%2Fc2md20347b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland 2: complexity and promiscuity</span></div><div class="casAuthors">Lovering, Frank</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-519</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Toxicity plays a major role in attrition in the clinic and promiscuity has been linked to toxicity.  A no. of mol. descriptors have been identified that contribute to promiscuity including ionization and logP.  In this study we report on the relationship between complexity, as measured by two descriptors [fraction sp3 (Fsp3) where Fsp3 = (no. of sp3 hybridized carbons/total carbon count) and chiral carbon count], and promiscuity as well as Cyp450 inhibition.  We find that increasing complexity reduces promiscuity and Cyp450 inhibition.  As an understanding of key property descriptors has helped the pharmaceutical industry to address some of the deficiencies of compds. as pertains to bioavailability, awareness of the descriptors that impact promiscuity should allow us to better address toxicity in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJfDH0430P-bVg90H21EOLACvtfcHk0lhOTQx6fk9_lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFShtL0%253D&md5=c03d3b99da22a684cbbbb00fb1633342</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fc2md20347b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20347b%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26atitle%3DEscape%2520from%2520Flatland%25202%253A%2520complexity%2520and%2520promiscuity%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D515%26epage%3D519%26doi%3D10.1039%2Fc2md20347b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. J.</span></span> <span> </span><span class="NLM_article-title">Protonated cyclopropanes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/cr60260a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr60260a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADyaF1MXkvFSnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1969&pages=543-550&author=C.+J.+Collins&title=Protonated+cyclopropanes&doi=10.1021%2Fcr60260a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Protonated cyclopropanes</span></div><div class="casAuthors">Collins, Clair Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">543-50</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">A review and interpretation of the data with 33 references.  The existence of protonated cyclopropane intermediates is confirmed.  None of the data demands either a methyl-bridged ion or a face-protonated structure; some expts. require an edge-protonated intermediate.  In the case of the norbornyl cation, the face-protonated structure is excluded, and also the edge-protonated intermediates, at least as the sole cations involved in promoting hydride shift.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpikTawTqWZ3LVg90H21EOLACvtfcHk0lhOTQx6fk9_lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvFSnsbY%253D&md5=35628ed28b78a212d822244ae039280f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr60260a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60260a004%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DC.%2BJ.%26atitle%3DProtonated%2520cyclopropanes%26jtitle%3DChem.%2520Rev.%26date%3D1969%26volume%3D69%26spage%3D543%26epage%3D550%26doi%3D10.1021%2Fcr60260a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorko, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hencher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. H.</span></span> <span> </span><span class="NLM_article-title">The molecular structure of trimethylenecyclopropane</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1968</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2425</span>– <span class="NLM_lpage">2434</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)82515-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2FS0040-4020%2801%2982515-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADyaF1cXptVOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1968&pages=2425-2434&author=E.+A.+Dorkoauthor=J.+L.+Hencherauthor=S.+H.+Bauer&title=The+molecular+structure+of+trimethylenecyclopropane&doi=10.1016%2FS0040-4020%2801%2982515-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular structure of trimethylenecyclopropane</span></div><div class="casAuthors">Dorko, Ernest A.; Hencher, J. L.; Bauer, Simon Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1968</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2425-34</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The mol. structure of trimethylenecyclopropane has been detd. from electron diffraction data obtained on the vapor.  Planarity of the mol. was assumed and shrinkages were calcd. from the evaluated nonbonded C-C distances.  The geometric parameters calcd. by least sqs. from the mol. intensity are: C:C = 1.343 ± 0.02; C-C = 1.453 ± 0.02; C-H = 1.108 ± 0.015 A.; angle CCH = 121.8 ± 2°.  The calcd. shrinkages are: δC1C6 = 0.009; δC2C6 = 0.028 A.  The uncertainties quoted for the distances are twice the calcd. standard deviations.  A variation of Walsh's model for the bonding in cyclopropane is proposed, to account for reported differences in bond lengths between trimethylenecyclopropane and several related mols.  The structural data suggest that delocalization is present in these 3-member rings.  30 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpScVMRaYKgy7Vg90H21EOLACvtfcHk0ljtohWsf-jeTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXptVOjtQ%253D%253D&md5=08f0c6cb1bfe037792fca98b7cf82401</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2982515-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252982515-1%26sid%3Dliteratum%253Aachs%26aulast%3DDorko%26aufirst%3DE.%2BA.%26aulast%3DHencher%26aufirst%3DJ.%2BL.%26aulast%3DBauer%26aufirst%3DS.%2BH.%26atitle%3DThe%2520molecular%2520structure%2520of%2520trimethylenecyclopropane%26jtitle%3DTetrahedron%26date%3D1968%26volume%3D24%26spage%3D2425%26epage%3D2434%26doi%3D10.1016%2FS0040-4020%2801%2982515-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Meijere, A.</span></span> <span> </span><span class="NLM_article-title">Bonding properties of cyclopropane and their chemical consequences</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1002/anie.197908093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1002%2Fanie.197908093" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1979&pages=809-826&author=A.+de%0AMeijere&title=Bonding+properties+of+cyclopropane+and+their+chemical+consequences&doi=10.1002%2Fanie.197908093"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fanie.197908093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197908093%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMeijere%26aufirst%3DA.%26atitle%3DBonding%2520properties%2520of%2520cyclopropane%2520and%2520their%2520chemical%2520consequences%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1979%26volume%3D18%26spage%3D809%26epage%3D826%26doi%3D10.1002%2Fanie.197908093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span> <i>Molecular Operating
Environment (MOE)</i>; <span class="NLM_publisher-name">Chemical Computing Group,
University of Sherbrooke</span>: <span class="NLM_publisher-loc">1010 Sherbooke
St. West, Suite #910, Montreal, QC,
Canada, H3A 2R7</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment+%28MOE%29%3B+Chemical+Computing+Group%2C%0AUniversity+of+Sherbrooke%3A+1010+Sherbooke%0ASt.+West%2C+Suite+%23910%2C+Montreal%2C+QC%2C%0ACanada%2C+H3A+2R7%2C+2019."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%252C%250AUniversity%2520of%2520Sherbrooke%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Convery, M. A.</span>; <span class="NLM_string-name">Hobbs, H.</span>; <span class="NLM_string-name">Jamieson, C.</span>; <span class="NLM_string-name">Kennedy, A. R.</span>; <span class="NLM_string-name">Pal, S.</span>; <span class="NLM_string-name">Peace, S.</span>; <span class="NLM_string-name">Pogany, P.</span>; <span class="NLM_string-name">Upton, R.</span>; <span class="NLM_string-name">Summers, D.</span></span> <span> </span><span class="NLM_article-title">A theoretical and experimental investigation into the conformational bias of aryl cyclopropylpyrans, novel biosteres for <i>N</i>-aryl morpholines</span>, <span class="NLM_year">2018</span>, manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+A.+Convery&author=H.+Hobbs&author=C.+Jamieson&author=A.+R.+Kennedy&author=S.+Pal&author=S.+Peace&author=P.+Pogany&author=R.+Upton&author=D.+Summers&title=A+theoretical+and+experimental+investigation+into+the+conformational+bias+of+aryl+cyclopropylpyrans%2C+novel+biosteres+for+N-aryl+morpholines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DConvery%26aufirst%3DM.%2BA.%26atitle%3DA%2520theoretical%2520and%2520experimental%2520investigation%2520into%2520the%2520conformational%2520bias%2520of%2520aryl%2520cyclopropylpyrans%252C%2520novel%2520biosteres%2520for%2520N-aryl%2520morpholines%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smerdon, S. J.</span></span> <span> </span><span class="NLM_article-title">A year in structural signaling: mTOR—The PIKK of the bunch?</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">pe6</span>– <span class="NLM_lpage">pe6</span>, <span class="refDoi"> DOI: 10.1126/scisignal.2005174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1126%2Fscisignal.2005174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=24595107" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=pe6-pe6&author=S.+J.+Smerdon&title=A+year+in+structural+signaling%3A+mTOR%E2%80%94The+PIKK+of+the+bunch%3F&doi=10.1126%2Fscisignal.2005174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2005174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2005174%26sid%3Dliteratum%253Aachs%26aulast%3DSmerdon%26aufirst%3DS.%2BJ.%26atitle%3DA%2520year%2520in%2520structural%2520signaling%253A%2520mTOR%25E2%2580%2594The%2520PIKK%2520of%2520the%2520bunch%253F%26jtitle%3DSci.%2520Signaling%26date%3D2014%26volume%3D7%26spage%3Dpe6%26epage%3Dpe6%26doi%3D10.1126%2Fscisignal.2005174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, M. N.</span></span> <span> </span><span class="NLM_article-title">mTOR in aging, metabolism, and cancer</span>. <i>Curr. Opin. Genet. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1016/j.gde.2012.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.gde.2012.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=23317514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosF2ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=53-62&author=M.+Cornuauthor=V.+Albertauthor=M.+N.+Hall&title=mTOR+in+aging%2C+metabolism%2C+and+cancer&doi=10.1016%2Fj.gde.2012.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR in aging, metabolism, and cancer</span></div><div class="casAuthors">Cornu, Marion; Albert, Verena; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The target of rapamycin (TOR) is a highly conserved serine/threonine kinase that is part of two structurally and functionally distinct complexes, TORC1 and TORC2.  In multicellular organisms, TOR regulates cell growth and metab. in response to nutrients, growth factors and cellular energy.  Deregulation of TOR signaling alters whole body metab. and causes age-related disease.  This review describes the most recent advances in TOR signaling with a particular focus on mammalian TOR (mTOR) in metabolic tissues vis-a-vis aging, obesity, type 2 diabetes, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgrTlg2UvYbVg90H21EOLACvtfcHk0ljaoXp8iSPCUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosF2ntg%253D%253D&md5=674a12eb04fa17883aa593edc3ea5057</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2012.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2012.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCornu%26aufirst%3DM.%26aulast%3DAlbert%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DmTOR%2520in%2520aging%252C%2520metabolism%252C%2520and%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2013%26volume%3D23%26spage%3D53%26epage%3D62%26doi%3D10.1016%2Fj.gde.2012.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoncu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efeyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">mTOR: from growth signal integration to cancer, diabetes and ageing</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1038/nrm3025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1038%2Fnrm3025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=21157483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=21-35&author=R.+Zoncuauthor=A.+Efeyanauthor=D.+M.+Sabatini&title=mTOR%3A+from+growth+signal+integration+to+cancer%2C+diabetes+and+ageing&doi=10.1038%2Fnrm3025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR: from growth signal integration to cancer, diabetes and ageing</span></div><div class="casAuthors">Zoncu, Roberto; Efeyan, Alejo; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-35</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors.  Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt.  In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfHzFJues0NLVg90H21EOLACvtfcHk0ljaoXp8iSPCUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGqsbnK&md5=3631307dc34df2ecc2eb79900c10b74c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrm3025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3025%26sid%3Dliteratum%253Aachs%26aulast%3DZoncu%26aufirst%3DR.%26aulast%3DEfeyan%26aufirst%3DA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DmTOR%253A%2520from%2520growth%2520signal%2520integration%2520to%2520cancer%252C%2520diabetes%2520and%2520ageing%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D21%26epage%3D35%26doi%3D10.1038%2Fnrm3025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nho, R.</span></span> <span> </span><span class="NLM_article-title">The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">778</span>, <span class="refDoi"> DOI: 10.3390/ijms19030778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.3390%2Fijms19030778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOnt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=778&author=J.+Lawrenceauthor=R.+Nho&title=The+role+of+the+mammalian+target+of+rapamycin+%28mTOR%29+in+pulmonary+fibrosis&doi=10.3390%2Fijms19030778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis</span></div><div class="casAuthors">Lawrence, Jessica; Nho, Richard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">778/1-778/31</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)-dependent pathway is one of the most integral pathways linked to cell metab., proliferation, differentiation, and survival.  This pathway is dysregulated in a variety of diseases, including neoplasia, immune-mediated diseases, and fibroproliferative diseases such as pulmonary fibrosis.  The mTOR kinase is frequently referred to as the master regulator of this pathway.  Alterations in mTOR signaling are closely assocd. with dysregulation of autophagy, inflammation, and cell growth and survival, leading to the development of lung fibrosis.  Inhibitors of mTOR have been widely studied in cancer therapy, as they may sensitize cancer cells to radiation therapy.  Studies also suggest that mTOR inhibitors are promising modulators of fibroproliferative diseases such as idiopathic pulmonary fibrosis (IPF) and radiation-induced pulmonary fibrosis (RIPF).  Therefore, mTOR represents an attractive and unique therapeutic target in pulmonary fibrosis.  In this review, we discuss the pathol. role of mTOR kinase in pulmonary fibrosis and examine how mTOR inhibitors may mitigate fibrotic progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnLdBqLwSUL7Vg90H21EOLACvtfcHk0ljaoXp8iSPCUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOnt7zE&md5=a4b2c61ccf4a181fd74c4f13d1c30596</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3390%2Fijms19030778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19030778%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DJ.%26aulast%3DNho%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%2520in%2520pulmonary%2520fibrosis%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D778%26doi%3D10.3390%2Fijms19030778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holroyd, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michie, A. M.</span></span> <span> </span><span class="NLM_article-title">The role of mTOR-mediated signaling in the regulation of cellular migration</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2018.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2Fj.imlet.2018.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29408410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2018&pages=74-79&author=A.+K.+Holroydauthor=A.+M.+Michie&title=The+role+of+mTOR-mediated+signaling+in+the+regulation+of+cellular+migration&doi=10.1016%2Fj.imlet.2018.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mTOR-mediated signaling in the regulation of cellular migration</span></div><div class="casAuthors">Holroyd, Ailsa K.; Michie, Alison M.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-79</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mechanistic target for rapamycin (mTOR) is a serine/threonine protein kinase that forms two distinct complexes mTORC1 and mTORC2, integrating mitogen and nutrient signals to regulate cell survival and proliferation; processes which are commonly deregulated in human cancers.  MTORC1 and mTORC2 have divergent mol. assocns. and cellular functions: mTORC1 regulates in mRNA translation and protein synthesis, while mTORC2 is involved in the regulation of cellular survival and metab.  Through AKT phosphorylation/activation, mTORC2 has also been reported to regulate cell migration.  Recent attention has focused on the aberrant activation of the PI3K/mTOR pathway in B cell malignancies and there is growing evidence for its involvement in disease pathogenesis, due to its location downstream of other established novel drug targets that intercept B cell receptor (BCR) signals.  Shared pharmacol. features of BCR signal inhibitors include a striking "lymphocyte redistribution" effect whereby patients experience a sharp increase in lymphocyte count on initiation of therapy followed by a steady decline.  Chronic lymphocytic leukemia (CLL) serves as a paradigm for migration studies as lymphocytes are among the most widely travelled cells in the body, a product of their role in immunol. surveillance.  The subversion of normal lymphocyte movement in CLL is being elucidated; this review aims to describe the migration impairment which occurs as part of the wider context of cancer cell migration defects, with a focus on the role of mTOR in mediating migration effects downstream of BCR ligation and other microenvironmental signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcvLP5NpDTYrVg90H21EOLACvtfcHk0lhXzkoMzKDSYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVeqsbg%253D&md5=1aeba89015fcf2e4e34a02169b1caab0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2018.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DHolroyd%26aufirst%3DA.%2BK.%26aulast%3DMichie%26aufirst%3DA.%2BM.%26atitle%3DThe%2520role%2520of%2520mTOR-mediated%2520signaling%2520in%2520the%2520regulation%2520of%2520cellular%2520migration%26jtitle%3DImmunol.%2520Lett.%26date%3D2018%26volume%3D196%26spage%3D74%26epage%3D79%26doi%3D10.1016%2Fj.imlet.2018.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quek, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavin, M. F</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T. L</span></span> <span> </span><span class="NLM_article-title">PIKKing a way to regulate inflammation</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1111/imcb.1001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1111%2Fimcb.1001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29359354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2018&pages=8-20&author=H.+Quekauthor=Y.+C.+Limauthor=M.+F+Lavinauthor=T.+L+Roberts&title=PIKKing+a+way+to+regulate+inflammation&doi=10.1111%2Fimcb.1001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">PIKKing a way to regulate inflammation</span></div><div class="casAuthors">Quek, Hazel; Lim, Yi Chieh; Lavin, Martin F.; Roberts, Tara L.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-20</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">1440-1711</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Australia, Ltd.</span>)
        </div><div class="casAbstract">The phosphoinositide-3-kinase like kinases are a family of very large protein kinases.  These PI3-kinase like kinase (PIKK) proteins have well-established roles in detection and repair of damage to the genome, regulation of the transcriptome and cellular metab.  Recently there has emerged, evidence for links between these proteins and inflammation.  While some of these links come from an increased understanding of the impacts of damage to the cell on inflammatory responses, others suggest that PIKK proteins also have direct roles in regulation of immune responses.  Particularly evident is the link between DNA damage and innate immune response pathways.  Here, we review recent findings on the PIKK family of proteins and how they impact on inflammation, particularly activation of the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7h-dNfAS2U7Vg90H21EOLACvtfcHk0lhXzkoMzKDSYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb8%253D&md5=d362c6dbf38cb62ee44a0fcb3b4830cc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fimcb.1001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimcb.1001%26sid%3Dliteratum%253Aachs%26aulast%3DQuek%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DY.%2BC.%26aulast%3DLavin%26aufirst%3DM.%2BF%26aulast%3DRoberts%26aufirst%3DT.%2BL%26atitle%3DPIKKing%2520a%2520way%2520to%2520regulate%2520inflammation%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2018%26volume%3D96%26spage%3D8%26epage%3D20%26doi%3D10.1111%2Fimcb.1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, D. M.</span></span> <span> </span><span class="NLM_article-title">Twenty-five years of mTOR: Uncovering the link from nutrients to growth</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">11818</span>– <span class="NLM_lpage">11825</span>, <span class="refDoi"> DOI: 10.1073/pnas.1716173114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1073%2Fpnas.1716173114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=29078414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=11818-11825&author=D.+M.+Sabatini&title=Twenty-five+years+of+mTOR%3A+Uncovering+the+link+from+nutrients+to+growth&doi=10.1073%2Fpnas.1716173114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty-five years of mTOR: Uncovering the link from nutrients to growth</span></div><div class="casAuthors">Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">11818-11825</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  In my PNAS Inaugural Article, I describe the development of the mTOR field, starting with efforts to understand the mechanism of action of the drug rapamycin, which ∼25 y ago led to the discovery of the mTOR protein kinase.  I focus on insights that we have contributed and on work that has been particularly influential to me, as well as provide some personal reflections and stories.  We now appreciate that, as part of two distinct complexes, mTORC1 and mTORC2, mTOR is the major regulator of growth (mass accumulation) in animals and is the key link between the availability of nutrients in the environment and the control of most anabolic and catabolic processes.  Nutrients signal to mTORC1 through the lysosome-assocd. Rag GTPases and their many regulators and assocd. cytosolic and lysosomal nutrient sensors.  MTOR signaling is deregulated in common diseases, like cancer and epilepsy, and mTORC1 is a well-validated modulator of aging in multiple model organisms.  There is significant excitement around using mTORC1 inhibitors to treat cancer and neurol. disease and, potentially, to improve healthspan and lifespan.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDmRqhnDPEJrVg90H21EOLACvtfcHk0liC0xUcwJbucw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrsbfF&md5=feb38ce2f2314a76f8838828be4d38db</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1716173114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1716173114%26sid%3Dliteratum%253Aachs%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DTwenty-five%2520years%2520of%2520mTOR%253A%2520Uncovering%2520the%2520link%2520from%2520nutrients%2520to%2520growth%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D11818%26epage%3D11825%26doi%3D10.1073%2Fpnas.1716173114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeritt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culshaw, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pass, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, M. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Currie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, S. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of AZD3147: A potent, selective dual inhibitor of mTORC1 and mTORC2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2326</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1021/jm501778s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501778s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2326-2349&author=K.+G.+Pikeauthor=J.+Morrisauthor=L.+Rustonauthor=S.+L.+Passauthor=R.+Greenwoodauthor=E.+J.+Williamsauthor=J.+Demerittauthor=J.+D.+Culshawauthor=K.+Gillauthor=M.+Passauthor=M.+R.+V.+Finlayauthor=C.+J.+Goodauthor=C.+A.+Robertsauthor=G.+S.+Currieauthor=K.+Bladesauthor=J.+M.+Edenauthor=S.+E.+Pearson&title=Discovery+of+AZD3147%3A+A+potent%2C+selective+dual+inhibitor+of+mTORC1+and+mTORC2&doi=10.1021%2Fjm501778s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2</span></div><div class="casAuthors">Pike, Kurt G.; Morris, Jeff; Ruston, Linette; Pass, Sarah L.; Greenwood, Ryan; Williams, Emma J.; Demeritt, Julie; Culshaw, Janet D.; Gill, Kristy; Pass, Martin; Finlay, M. Raymond V.; Good, Catherine J.; Roberts, Craig A.; Currie, Gordon S.; Blades, Kevin; Eden, Jonathan M.; Pearson, Stuart E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2326-2349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High throughput screening followed by a lead generation campaign uncovered a novel series of urea contg. morpholinopyrimidine compds. which act as potent and selective dual inhibitors of mTORC1 and mTORC2.  The authors describe the continued compd. optimization campaign for this series, in particular focused on identifying compds. with improved cellular potency, improved aq. soly., and good stability in human hepatocyte incubations.  Knowledge from empirical SAR investigations was combined with an understanding of the mol. interactions in the crystal lattice to improve both cellular potency and soly., and the composite parameters of LLE and pIC50-pSoly. were used to assess compd. quality and progress.  Predictive models were employed to efficiently mine the attractive chem. space identified resulting in the discovery of I (AZD3147), an extremely potent and selective dual inhibitor of mTORC1 and mTORC2 with physicochem. and pharmacokinetic properties suitable for development as a potential clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVFrPEX3khBbVg90H21EOLACvtfcHk0ljFRw7JBuPprQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFeitL0%253D&md5=92d9596bf3c160bcde73fd9c586d6b84</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm501778s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501778s%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DK.%2BG.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DPass%26aufirst%3DS.%2BL.%26aulast%3DGreenwood%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DE.%2BJ.%26aulast%3DDemeritt%26aufirst%3DJ.%26aulast%3DCulshaw%26aufirst%3DJ.%2BD.%26aulast%3DGill%26aufirst%3DK.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DFinlay%26aufirst%3DM.%2BR.%2BV.%26aulast%3DGood%26aufirst%3DC.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DCurrie%26aufirst%3DG.%2BS.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DPearson%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520AZD3147%253A%2520A%2520potent%252C%2520selective%2520dual%2520inhibitor%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2326%26epage%3D2349%26doi%3D10.1021%2Fjm501778s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foote, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacq, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewsbury, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissink, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odedra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suleman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thommes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadhurst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2125</span>– <span class="NLM_lpage">2138</span>, <span class="refDoi"> DOI: 10.1021/jm301859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2125-2138&author=K.+M.+Footeauthor=K.+Bladesauthor=A.+Croninauthor=S.+Filleryauthor=S.+S.+Guichardauthor=L.+Hassallauthor=I.+Hicksonauthor=X.+Jacqauthor=P.+J.+Jewsburyauthor=T.+M.+McGuireauthor=J.+W.+M.+Nissinkauthor=R.+Odedraauthor=K.+Pageauthor=P.+Perkinsauthor=A.+Sulemanauthor=K.+Tamauthor=P.+Thommesauthor=R.+Broadhurstauthor=C.+Wood&title=Discovery+of+4-%7B4-%5B%283R%29-3-methylmorpholin-4-yl%5D-6-%5B1-%28methylsulfonyl%29cyclopropyl%5Dpyrimidin-2-yl%7D-1H-indole+%28AZ20%29%3A+A+potent+and+selective+inhibitor+of+ATR+protein+kinase+with+monotherapy+in+vivo+antitumor+activity&doi=10.1021%2Fjm301859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity</span></div><div class="casAuthors">Foote, Kevin M.; Blades, Kevin; Cronin, Anna; Fillery, Shaun; Guichard, Sylvie S.; Hassall, Lorraine; Hickson, Ian; Jacq, Xavier; Jewsbury, Philip J.; McGuire, Thomas M.; Nissink, J. Willem M.; Odedra, Rajesh; Page, Ken; Perkins, Paula; Suleman, Abid; Tam, Kin; Thommes, Pia; Broadhurst, Rebecca; Wood, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2125-2138</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ATR is an attractive new anticancer drug target whose inhibitors have potential as chemo- or radiation sensitizers or as monotherapy in tumors addicted to particular DNA-repair pathways.  We describe the discovery and synthesis of a series of sulfonylmorpholinopyrimidines that show potent and selective ATR inhibition.  Optimization from a high quality screening hit within tight SAR space led to compd. I (AZ20) which inhibits ATR immunopptd. from HeLa nuclear exts. with an IC50 of 5 nM and ATR mediated phosphorylation of Chk1 in HT29 colorectal adenocarcinoma tumor cells with an IC50 of 50 nM.  Compd. I potently inhibits the growth of LoVo colorectal adenocarcinoma tumor cells in vitro and has high free exposure in mouse following moderate oral doses.  At well tolerated doses I leads to significant growth inhibition of LoVo xenografts grown in nude mice.  Compd. I is a useful compd. to explore ATR pharmacol. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpY5_RVxXl9LVg90H21EOLACvtfcHk0ljFRw7JBuPprQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Ghsr0%253D&md5=60d2f6fe78e2b82695198b9cba930ae7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm301859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301859s%26sid%3Dliteratum%253Aachs%26aulast%3DFoote%26aufirst%3DK.%2BM.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DCronin%26aufirst%3DA.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DGuichard%26aufirst%3DS.%2BS.%26aulast%3DHassall%26aufirst%3DL.%26aulast%3DHickson%26aufirst%3DI.%26aulast%3DJacq%26aufirst%3DX.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DMcGuire%26aufirst%3DT.%2BM.%26aulast%3DNissink%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPerkins%26aufirst%3DP.%26aulast%3DSuleman%26aufirst%3DA.%26aulast%3DTam%26aufirst%3DK.%26aulast%3DThommes%26aufirst%3DP.%26aulast%3DBroadhurst%26aufirst%3DR.%26aulast%3DWood%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25204-%257B4-%255B%25283R%2529-3-methylmorpholin-4-yl%255D-6-%255B1-%2528methylsulfonyl%2529cyclopropyl%255Dpyrimidin-2-yl%257D-1H-indole%2520%2528AZ20%2529%253A%2520A%2520potent%2520and%2520selective%2520inhibitor%2520of%2520ATR%2520protein%2520kinase%2520with%2520monotherapy%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2125%26epage%3D2138%26doi%3D10.1021%2Fjm301859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">A new stereospecific cross-coupling by the palladium-catalyzed reaction of 1-alkenylboranes with 1-alkenyl or 1-alkynyl halides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3437</span>– <span class="NLM_lpage">3440</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(01)95429-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;key=10.1016%2FS0040-4039%2801%2995429-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1979&pages=3437-3440&author=N.+Miyauraauthor=K.+Yamadaauthor=A.+Suzuki&title=A+new+stereospecific+cross-coupling+by+the+palladium-catalyzed+reaction+of+1-alkenylboranes+with+1-alkenyl+or+1-alkynyl+halides&doi=10.1016%2FS0040-4039%2801%2995429-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2995429-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252995429-2%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DA%2520new%2520stereospecific%2520cross-coupling%2520by%2520the%2520palladium-catalyzed%2520reaction%2520of%25201-alkenylboranes%2520with%25201-alkenyl%2520or%25201-alkynyl%2520halides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1979%26volume%3D20%26spage%3D3437%26epage%3D3440%26doi%3D10.1016%2FS0040-4039%2801%2995429-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gujral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riyal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gahlot, V.</span></span> <span> </span><span class="NLM_article-title">Suzuki cross coupling reaction-a review</span>. <i>Indo Glob. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=351-367&author=S.+Gujralauthor=S.+Khatriauthor=P.+Riyalauthor=V.+Gahlot&title=Suzuki+cross+coupling+reaction-a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGujral%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DS.%26aulast%3DRiyal%26aufirst%3DP.%26aulast%3DGahlot%26aufirst%3DV.%26atitle%3DSuzuki%2520cross%2520coupling%2520reaction-a%2520review%26jtitle%3DIndo%2520Glob.%2520J.%2520Pharm.%2520Sci.%26date%3D2012%26volume%3D2%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i38"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00348">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57776"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00348">10.1021/acs.jmedchem.9b00348</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data for the small molecule crystal structure of <b>9b</b>; a low occupancy cocrystal structure of <b>12b</b>; protocols for the PI3K, mTOR, and Akt assays and experimental data for the remaining novel compounds <b>5</b>–<b>29</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formular strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_001.pdf">jm9b00348_si_001.pdf (419.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00348/suppl_file/jm9b00348_si_002.csv">jm9b00348_si_002.csv (3.78 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00348&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00348%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00348" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997d9809b523e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
